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The	  material	  in	  this	  Thesis	  has	  not	  previously	  been	  submitted	  for	  a	  
degree	  in	  any	  University.	  	  It	  contains,	  to	  the	  best	  of	  my	  knowledge,	  
no	  material	  written	  or	  published	  by	  another	  person	  except	  where	  
















This	  Thesis	  would	  not	  have	  been	  possible	  without	  the	  support	  of	  many	  people:	  	  Firstly,	  I	  am	  
tremendously	  grateful	  to	  Dr	  Pier	  Lambiase;	  his	  enthusiasm,	  patience	  and	  friendship	  made	  this	  
sometimes	  difficult	  journey	  a	  very	  enjoyable	  one.	  	  I	  likewise	  wish	  to	  thank	  Professor	  Andrew	  Taylor;	  
his	  knowledge	  and	  encouragement	  have	  been	  invaluable	  -­‐	  I	  consider	  myself	  blessed	  to	  have	  had	  two	  
such	  generous	  supervisors.	  	  
I	  am	  truly	  indebted	  to	  Dr	  Aidan	  Bolger	  for	  his	  advocacy,	  his	  commitment	  to	  the	  highest	  of	  standards	  
and	  his	  unwavering	  support	  despite	  the	  many	  obstacles	  along	  the	  way	  –	  thank	  you.	  
Profound	  gratitude	  is	  due	  to	  Dr	  Marina	  Hughes,	  who	  made	  cardiac	  MRI	  interesting	  and	  fun,	  and	  who	  
showed	  relentless	  patience	  despite	  my	  endless	  questions.	  	  	  
I	  would	  like	  to	  thank	  Malcolm	  Finlay	  for	  his	  friendship	  and	  good	  humour	  –	  I	  enjoyed	  our	  frequent	  
mutual	  commiserations	  over	  this	  shared	  experience.	  	  	  
This	  work	  would	  not	  have	  been	  possible	  without	  the	  financial	  support	  provided	  me	  by	  the	  British	  
Heart	  Foundation	  and	  the	  Fielding	  Medical	  Trust.	  	  I	  would	  also	  like	  to	  thank	  Dr	  Walker,	  Dr	  Cullen	  and	  
Prof	  Deanfield	  for	  their	  support	  throughout.	  
And	  finally	  –	  to	  my	  family	  who	  have	  put	  up	  with	  me	  over	  the	  past	  few	  years	  and	  have	  always	  
supported	  me	  -­‐	  ¡Muchísimas	  gracias!	  	  I	  am	  very	  grateful	  to	  my	  ever	  patient	  friend	  Sue,	  who	  was	  the	  
sounding	  board	  to	  many	  thoughts	  and	  ideas,	  and	  to	  Paul,	  who	  listened	  and	  watched,	  and	  who	  kept	  




	  Para	  ti	  –	  te	  quiero.	  	  Siempre.	  
	  
	  
“All	  men	  dream;	  but	  not	  equally.	  	  Those	  who	  dream	  by	  night	  in	  the	  dusty	  recesses	  of	  their	  minds	  
wake	  in	  the	  day	  to	  find	  it	  was	  vanity.	  	  But	  the	  dreamers	  of	  the	  day	  are	  dangerous	  men,	  for	  they	  may	  
act	  their	  dreams	  with	  open	  eyes,	  to	  make	  it	  possible”.	  	  	  	  
T	  E	  Lawrence	  
	  
	  




Heart	  failure	  (HF)	  and	  sudden	  cardiac	  death	  (SCD)	  in	  congenital	  heart	  disease	  (CHD)	  is	  prevalent	  and	  
can	  relate	  to	  abnormal	  right	  ventricular	  (RV)	  physiology	  and	  abnormalities	  of	  QRS	  duration,	  and	  QRS,	  
JT	  and	  QT	  dispersion	  (d).	  	  	  Characterising	  disease	  and	  identifying	  factors	  that	  may	  predict	  adverse	  
outcome	  in	  those	  with	  either	  a	  subpulmonary	  or	  subsystemic	  RV,	  as	  well	  as	  investigating	  potential	  
avenues	  to	  ameliorate	  abnormal	  RV	  physiology	  is	  necessary	  to	  improve	  outcomes	  in	  this	  young	  
population.	  
I	  undertook	  several	  studies	  during	  the	  course	  of	  this	  Thesis	  to	  examine	  and	  further	  understand	  these	  
two	  separate	  physiological	  substrates:	  	  In	  the	  first	  I	  studied	  the	  effect	  of	  isolated	  percutaneous	  
(PPVI)	  pulmonary	  valve	  implantation	  on	  surface	  ECG	  parameters.	  	  PPVI	  represents	  a	  pure	  model	  of	  
RV	  mechanical	  and	  electrophysiological	  changes	  post	  replacement	  as	  compared	  to	  surgical	  
replacement:	  	  Ninety	  nine	  PPVI	  procedures	  in	  patients	  with	  CHD	  (aged	  23.1±10	  yrs)	  were	  studied	  
pre,	  post	  and	  1-­‐year	  following	  PPVI	  with	  serial	  ECG’s	  and	  echocardiography/	  magnetic	  resonance	  
imaging	  (CMR).	  	  43%	  had	  pulmonary	  stenosis,	  27%	  pulmonary	  regurgitation	  (PR)	  and	  29%	  mixed	  
lesions.	  	  In	  those	  with	  predominantly	  PR	  (n=26),	  QRS	  duration	  decreased	  significantly	  (135±27	  to	  
128±29ms;	  p=0.007).	  	  However,	  in	  the	  total	  cohort	  no	  significant	  change	  in	  QRS	  duration	  at	  1	  year	  
was	  observed	  (137±29	  to	  134±29ms).	  	  QTc,	  QRSd,	  QTd	  and	  JTd	  all	  significantly	  reduced	  at	  1	  yr	  
(p≤0.001).	  RV	  EDV	  correlated	  with	  pre-­‐procedure	  QRS	  duration	  (r=0.34;	  p<0.002)	  but	  there	  was	  no	  
correlation	  after	  PPVI.	  	  This	  is	  the	  first	  study	  to	  report	  electrical	  remodelling	  following	  isolated	  PPVI	  
and	  it	  confirms	  that	  reductions	  in	  QRS	  duration	  occur	  post	  PPVI	  in	  PR,	  as	  reported	  for	  equivalent	  
surgical	  cohorts.	  	  Further,	  increased	  homogeneity	  of	  repolarisation,	  in	  combination	  with	  improved	  
conduction,	  may	  reduce	  arrhythmic	  events	  in	  congenital	  cardiac	  patients	  with	  pulmonary	  valvular	  
disease.	  
My	  second	  study	  sought	  to	  create	  an	  epicardial	  electroanatomic	  map	  of	  the	  RV	  and	  then	  apply	  post-­‐
operative	  targeted	  single	  and	  dual	  site	  RV	  temporary	  pacing	  with	  measurement	  of	  haemodynamic	  
parameters.	  	  I	  wished	  to	  determine	  the	  potential	  role	  of	  cardiac	  resynchronization	  therapy	  (CRT)	  in	  
the	  setting	  of	  RV	  dysfunction	  as	  little	  is	  known	  regarding	  the	  potential	  benefits	  of	  CRT	  in	  this	  setting.	  	  
Sixteen	  adults	  (age=32±8	  yrs,	  6M;	  10F)	  with	  right	  bundle	  branch	  block	  (RBBB)	  and	  repaired	  tetralogy	  
of	  Fallot	  (ToF;	  n=8)	  or	  corrected	  congenital	  pulmonary	  stenosis	  (n=8)	  undergoing	  surgical	  pulmonary	  
valve	  replacement	  (PVR)	  for	  PR	  underwent	  intra-­‐operative	  epicardial	  RV	  mapping	  and	  
haemodynamic	  assessment	  of	  random	  pacing	  configurations	  including	  site	  of	  latest	  RV	  activation.	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I	   found	   that	   the	   commonest	   site	   of	   latest	   activation	  was	   the	   RV	   free	  wall	  &	   dual	   chamber	   (DDD)	  
pacing	   here,	   alone	   or	   combined	  with	   RV	   apical	   pacing,	   resulted	   in	   significant	   increases	   in	   cardiac	  
output	   (CO)	   vs	   AAI	   pacing	   (p<0.01	   all	   measures).	   	   	   DDD	   RV	   alternative	   site	   pacing	   significantly	  
improved	  CO	  by	  16	  %	  vs	  AAI,	  and	  8.5%	  versus	  DDD	  RV	  apical	  pacing	  (p=0.02).	  	  Single	  site	  RV	  pacing	  
targeted	  to	  the	  region	  of	  latest	  activation	  in	  patients	  with	  RBBB	  undergoing	  PVR	  thus	  induces	  acute	  
improvements	  in	  haemodynamics	  and	  implies	  that	  targeted	  pacing	  in	  such	  patients	  has	  therapeutic	  
potential	  both	  post-­‐operatively	  and	  in	  the	  long	  term.	  	  
QRS	  duration	  is	  a	  strong	  predictor	  of	  survival	  in	  acquired	  left	  ventricular	  dysfunction,	  but	  equivalent	  
data	   in	  those	  with	  a	  systemic	  RV	   is	   lacking.	   	  My	  next	  studies	   investigated	  not	  only	  the	  relationship	  
between	  ECG	  parameters,	  arrhythmia	  burden	  and	  outcome	  in	  adults	  with	  transposition	  of	  the	  great	  
arteries	   (TGA)	   late	   after	   atrial	   switch	   repair,	   but	   also	   the	   interrelationships	   between	   various	   HF	  
markers	   in	   this	   cohort.	   	   Adults	   with	   Senning	   or	   Mustard	   palliation	   of	   TGA	   under	   follow	   up	   at	   a	  
dedicated	  congenital	  HF	  clinic	  and	  13	  similar	  adults	  who	  suffered	  a	  cardiac	  death	  were	  included	  for	  
study.	  	  Patients	  were	  subdivided	  by	  arrhythmic	  history,	  surgical	  intervention	  and	  death.	  	  Assessment	  
included	   symptom	   assessment,	   venous	   blood	   sampling	   for	   circulating	   N-­‐terminal	   pro	   brain	  
natriuretic	  peptide	  (NT-­‐proBNP)	  levels,	  measurement	  of	  surface	  ECG	  and	  CMR	  for	  the	  assessment	  of	  
RV	  systolic	  function	  and	  determination	  of	  indexed	  RV	  volumes.	  
I	  found	  that	  QRS	  duration	  (p=0.0003)	  and	  QTc	  interval	  (p=0.0009)	  increase	  significantly	  with	  
changing	  arrhythmia	  subtype,	  and	  that	  both	  QRS	  and	  QTc	  were	  independently	  associated	  with	  
increased	  risk	  of	  death:	  for	  1ms	  increase	  in	  QRS	  HR	  15	  [95%	  CI	  3.3-­‐68.6]	  and	  for	  QTc	  HR	  10.7	  [95%	  CI	  
2.3-­‐49]	  (p<0.0001	  for	  both).	  	  QRS	  >104ms	  and	  QTc	  >406ms	  had	  a	  sensitivity/specificity	  for	  predicting	  
death	  of	  96%/66%	  and	  96%/56%	  respectively.	  	  Two	  year	  mortality	  was	  36%	  when	  QRS<104ms	  and	  
88%	  when	  >104ms	  (p<0.0001	  for	  difference).	  	  	  Further,	  compared	  to	  those	  with	  uncomplicated	  
surgery,	  patients	  with	  complex	  surgical	  history	  had	  higher	  NT-­‐proBNP	  levels	  (55±26	  vs	  20±35pmol/L;	  
P=0.002)	  and	  longer	  QRS	  duration	  (116±28ms	  vs	  89±11ms;	  P=0.0004)	  whilst	  showing	  no	  difference	  
in	  NYHA	  class	  and	  RV	  function.	  There	  was	  a	  significant	  relationship	  between	  diastolic	  and	  systolic	  RV	  
volumes	  and	  both	  NT-­‐proBNP	  levels	  (r=0.43,	  P=0.01;	  r=0.53,	  P=0.001	  respectively)	  and	  QRS	  duration	  
(r=0.47,	  P=0.004;	  r=0.53,	  P=0.001	  respectively).	  
These	  findings	  suggest	  that	  QRS	  width	  and	  corrected	  QTc	  interval	  on	  surface	  ECG	  are	  associated	  with	  
increased	   risk	   of	   death	   in	   adults	   late	   after	   atrial	   switch	   repair	   of	   TGA.	   	   Given	   that	   a	   QRS	   of	   only	  
104ms	  defines	  a	  high	  risk	  population,	  careful	  examination	  of	  the	  ECG	  is	  desirable	  in	  all	  patients	  and	  
therapy	   to	   reduce	   risk	   attempted.	   	   Further,	   together	   with	   these	   simple	   surface	   ECG	   parameters,	  
circulating	  NT-­‐proBNP	  levels	  constitute	  safe,	  cost	  effective	  and	  widely	  available	  surrogate	  markers	  of	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systemic	  RV	  function	  and	  provide	  additional	  information	  on	  heart	  failure	  status.	  Both	  measures	  hold	  
promise	  as	  prognostic	  markers	  and	  their	  association	  with	  long-­‐term	  outcome	  should	  be	  determined.	  
Lastly,	   I	   examined	   the	  mechanisms	   of	   late	   RV	   failure	   and	   studied	   their	   relationship	   to	   subjective	  
quality	  of	   life	  assessment	  as	   this	  are	  poorly	  characterised.	   	  Equilibrium	  Contrast	  CMR	   imaging	  was	  
used	  to	  quantify	  extracellular	  volume	  (ECV)	  in	  the	  septum	  and	  RV	  free	  wall	  of	  adults	  presenting	  to	  a	  
specialist	   clinic	   late	  after	  atrial	   redirection	  surgery	   for	  TGA.	   	  These	  were	  compared	   to	  age	  and	  sex	  
matched	   healthy	   volunteers.	   	   Patients	  were	   also	   assessed	  with	   a	   standardised	   CMR	  protocol,	   NT-­‐
proBNP	  and	  surface	  ECG	  measurement,	  and	  cardiopulmonary	  exercise	  (CPEX)	  testing.	  	  Patients	  also	  
completed	  a	  Minnesota	  Living	  With	  Heart	  Failure	  Questionnaire	  (MLHFQ)	  self	  assessment.	  
I	  determined	  that	  mean	  septal	  ECV	  was	  significantly	  higher	  in	  patients	  than	  controls	  (0.254±0.036,	  vs	  
0.230±0.032;	  p=0.03).	  	  NT-­‐proBNP	  positively	  related	  to	  septal	  ECV	  (p=0.04;	  r=0.55)	  but	  chronotropic	  
index	  (CI)	  during	  CPEX	  testing	  negatively	  related	  to	  ECV	  (p=0.04;	  r=-­‐0.58).	  	  No	  relationship	  was	  seen	  
with	  other	  CMR	  or	  CPEX	  parameters.	   	   	  Median	  MLHFQ	   score	  was	  6(2-­‐19),	  median	  NT-­‐pro	  BNP	  24	  
(16-­‐43)	  and	  mean	  peak	  VO2	  24±7mL/kg/min.	   	  There	  was	  a	  significant	  positive	  correlation	  between	  
MLHFQ	  score	  and	  NT-­‐proBNP	  (p=0.001,	  r=0.34)	  and	  a	  significant	  negative	  correlation	  with	  peak	  VO2	  
(p=0.001,	  r=0.49.	  	  ).	  
Septal	  interstitial	  expansion	  is	  seen	  in	  adults	  late	  after	  atrial	  redirection	  surgery	  for	  TGA.	  It	  correlates	  
well	  with	  NT-­‐proBNP	  and	  CI	  and	  may	  have	  a	  role	  in	  the	  development	  of	  RV	  systolic	  impairment.	  The	  
MLHFQ	   correlates	   highly	   with	   NT-­‐proBNP	   and	   exercise	   capacity	   in	   patients	   with	   systemic	   RV	  
impairment.	   The	   ability	   of	   the	  MLHFQ	   in	   predicting	   HF	   events	   and	   prognosis	   in	   adults	   with	   CHD	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ABBREVIATIONS	  AND	  DEFINITIONS	  
	  
AAI	   	   -­‐	   Atrial	  Demand	  Inhibited	  Pacing	  
APD	   	   -­‐	   Action	  potential	  duration	  
AV	   	   -­‐	   Atrioventricular	  (delay;	  ms)	  
CHD	   	   -­‐	   Congenital	  heart	  disease	  
CI	   	   -­‐	   Cardiac	  Index	  (L/m2)	  
ChI	   	   -­‐	   Chronotropic	  Incompetence	  
CMR	   	   -­‐	   Cardiac	  magnetic	  resonance	  
CO	   	   -­‐	   Cardiac	  Output	  (L/min)	  
CRT	   	   -­‐	   Cardiac	  resynchronisation	  therapy	  
CPEX	   	   -­‐	   Cardiopulmonary	  exercise	  testing	  
DDD	   	   -­‐	   Dual	  chamber	  pacemaker	  device	  
ECG	   	   -­‐	   Electrocardiography	  
ECV	   	   -­‐	   Extracellular	  volume	  
EDV(i)	   	   -­‐	   End	  diastolic	  volume	  (indexed	  –	  ml/m2)	  
EF	   	   -­‐	   Ejection	  fraction	  (%)	  
EGM	   	   -­‐	   Electrogram	  
ESV(i)	   	   -­‐	   End	  systolic	  volume	  (indexed	  –	  ml/m2)	  
HF	   	   -­‐	   Heart	  failure	  
ICD	   	   -­‐	   Implantable	  cardioverter	  defibrillator	  
LBBB	   	   -­‐	   Left	  bundle	  branch	  block	  
LGE	   	   -­‐	   Late	  Gadolinium	  enhancement	  
LV	   	   -­‐	   Left	  ventricle	  
MAP	  	   	   -­‐	   Mean	  arterial	  pressure	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MLWHFQ	   -­‐	   Minnesota	  living	  with	  heart	  failure	  questionnaire	  
NT-­‐proBNP	   -­‐	   Brain	  Natriuretic	  Peptide	  (pmol/L)	  
NYHA	   	   -­‐	   New	  York	  Heart	  Association	  (functional	  class)	  
PPVI	   	   -­‐	   Percutaneous	  pulmonary	  valve	  implantation	  
PR	   	   -­‐	   	  Pulmonary	  regurgitation	  
PS	   	   -­‐	   Pulmonary	  stenosis	  
PVR	   	   -­‐	   Pulmonary	  valve	  replacement	  (surgical)	  
RBBB	   	   -­‐	   Right	  bundle	  branch	  block	  
RV	   	   -­‐	   Right	  ventricle	  
RVOT	   	   -­‐	   Right	  ventricular	  outflow	  tract	  
SCD	   	   -­‐	   Sudden	  cardiac	  death	  
SV	   	   -­‐	   Stroke	  volume	  (ml/min)	  
SVT	   	   -­‐	   Supraventricular	  tachycardia	  
TGA	   	   -­‐	   Transposition	  of	  the	  Great	  Arteries	  
ToF	   	   -­‐	   Tetralogy	  of	  Fallot	  
UE	   	   -­‐	   Urea	  &	  electrolytes	  
VE/VCO2	   -­‐	   Minute	  ventilation-­‐carbon	  dioxide	  production	  relationship	  	  
VO2	   	   -­‐	   Oxygen	  uptake	  (on	  exercise)	  
VT	   	   -­‐	   Ventricular	  tachycardia	  
	  








1. Congenital	  Heart	  Disease	  
	  1.1	  	  	  Definition	  and	  Incidence	  
Congenital	  heart	  disease	  (CHD)	  can	  be	  defined	  as	  any	  malformation	  of	  the	  heart	  or	  intrathoracic	  
great	  vessels	  that	  is	  present	  from	  birth.	  	  It	  encompasses	  a	  wide	  range	  of	  anatomic	  variety,	  from	  the	  
intuitively	  minor	  patent	  foramen	  ovale	  to	  the	  gross	  malformations	  of	  cardiac	  structure	  as	  might	  
occur	  in	  hypoplastic	  left	  heart	  syndrome.	  	  	  
	  
Recent	  advances	  in	  surgical	  and	  catheter	  interventions	  have	  ensured	  that	  those	  born	  with	  
haemodynamically	  significant	  lesions	  are	  surviving	  longer,	  and	  as	  a	  consequence,	  the	  end	  of	  this	  last	  
decade	  saw	  the	  same	  number	  of	  adults	  as	  children	  alive	  with	  complex	  CHD	  for	  the	  first	  time1.	  	  Given	  
that	  the	  incidence	  of	  all	  forms	  of	  CHD	  is	  placed	  at	  between	  4	  to	  19	  per	  1000	  live	  births1,2,	  there	  are	  
an	  estimated	  2-­‐4	  million	  patients	  alive	  in	  Europe	  of	  whom	  1.2-­‐2.7	  million	  are	  aged	  greater	  than	  15	  
years3.	  
	  
The	  significance	  of	  the	  size	  of	  this	  population	  is	  made	  starkly	  clear	  when	  one	  considers	  the	  average	  
age	  of	  death	  of	  the	  total	  cohort:	  37±15	  years.	  	  Leading	  causes	  of	  death	  comprise	  heart	  failure	  (HF)	  
and	  sudden	  cardiac	  death	  (SCD)4,5.	  	  Despite	  such	  remarkable	  progress	  therefore	  over	  the	  past	  few	  
decades,	  these	  patients	  retain	  a	  high	  burden	  of	  morbidity	  and	  mortality	  compared	  to	  their	  healthy	  
peers.	  	  There	  is	  a	  paucity	  of	  evidence	  based	  medicine	  to	  identify	  patients	  at	  risk	  of	  adverse	  events	  
and	  a	  further	  lack	  of	  empirical	  outcome	  assessed	  research.	  	  Such	  lack	  of	  data	  is	  in	  part,	  due	  to	  the	  
wide	  variety	  of	  anatomic	  lesions	  comprising	  the	  total	  cohort	  –	  comparison	  within	  haemodynamic	  
subtypes	  has	  often	  entailed	  few	  numbers,	  certainly	  not	  on	  the	  scale	  that	  has	  driven	  research	  in	  
those	  with	  acquired	  or	  cardiomyopathic	  heart	  disease.	  	  
	  
There	  is,	  in	  the	  young	  and	  burgeoning	  high	  risk	  population	  with	  CHD,	  a	  pressing	  need	  to	  understand	  
the	  pathophysiological	  mechanisms	  underlying	  the	  different	  anatomic	  substrates	  and	  to	  develop	  
effective	  therapeutic	  strategies.	  	  To	  that	  end,	  this	  Thesis	  will	  study	  two	  different	  models	  of	  right	  
ventricular	  pathophysiology	  occurring	  in	  CHD	  –	  the	  subpulmonary	  right	  ventricle	  such	  as	  in	  repaired	  
tetralogy	  of	  Fallot,	  and	  the	  systemic	  right	  ventricle	  as	  it	  occurs	  in	  palliated	  transposition	  of	  the	  great	  
arteries.	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1.2 The	  Right	  Ventricle	  	  
The	  RV	  is	  the	  most	  anterior	  cardiac	  structure,	  lying	  immediately	  posterior	  to	  the	  sternum.	  	  Its	  
anatomic	  boundaries	  are	  the	  tricuspid	  valve	  and	  the	  pulmonary	  valve,	  and	  it	  is	  comprised	  of	  three	  
distinct	  regions:	  the	  inlet	  includes	  the	  tricuspid	  valve	  with	  its	  chordate	  tendinae	  and	  papillary	  
muscles,	  the	  apical	  portion	  is	  heavily	  trabeculated	  and	  contains	  the	  chamber-­‐defining	  moderator	  
band,	  and	  lastly	  the	  infundibulum	  which	  forms	  the	  continuous	  smooth,	  muscular	  outflow	  tract6.	  	  	  
	  
The	  primary	  function	  of	  the	  normal	  RV	  is	  to	  pump	  blood	  from	  the	  systemic	  venous	  circulation	  to	  the	  
lungs	  via	  the	  pulmonary	  arteries.	  	  It	  forms	  a	  circuit	  with	  the	  LV	  and	  maintains	  a	  similar	  stroke	  
volume;	  however,	  the	  RV	  is	  a	  thin-­‐walled	  structure	  encompassing	  a	  low-­‐pressure	  environment.	  	  Its	  
geometry	  is	  complex	  and	  visualisation	  by	  traditional	  imaging	  methods	  challenging.	  	  	  	  
	  
In	  CHD,	  the	  RV	  is	  often	  subpulmonary,	  but	  it	  can	  also	  occur	  in	  the	  subaortic	  position	  (serving	  the	  
systemic	  circulation)	  or	  be	  a	  solitary	  ventricle	  maintaining	  both	  circulations.	  	  Disease	  in	  CHD	  more	  
commonly	  involves	  the	  RV	  irrespective	  of	  its	  anatomic	  location,	  and	  can	  occur	  as	  a	  result	  of	  a	  
number	  of	  underlying	  processes,	  including	  dilatation	  through	  volume	  loading,	  such	  as	  occurs	  in	  
repaired	  ToF,	  or	  the	  pressure	  loading	  more	  often	  associated	  with	  the	  systemic	  or	  solitary	  type.	  	  In	  
either	  situation,	  the	  underlying	  pathophysiology	  leading	  to	  HF	  or	  SCD	  is	  necessarily	  different	  than	  
that	  which	  affects	  the	  morphologic	  and	  systemic	  LV.	  	  Certainly,	  in	  the	  population	  without	  CHD	  the	  
commonest	  cause	  of	  RV	  dysfunction	  is	  secondary	  to	  left	  sided	  disease.	  	  Further,	  the	  mechanism,	  
timing	  and	  severity	  of	  injury	  and	  potential	  adaptability	  of	  the	  RV	  to	  stress	  leads	  to	  differing	  
responses	  in	  terms	  of	  neurohormonal	  activation,	  ventricular	  myocardial	  remodelling	  and	  underlying	  
gene	  expression,	  myocardial	  ischaemia	  resulting	  from	  the	  original	  insult	  and/or	  subsequent	  
compromise	  and	  importantly,	  the	  impact	  on	  local	  and	  ventricular	  electromechanical	  interactions.	  	  
This	  infers	  that	  pathophysiological	  changes	  occurring	  in	  the	  RV	  cannot	  be	  directly	  transferred	  from	  
the	  general	  population,	  and	  neither	  can	  the	  process	  be	  applied	  to	  all	  substrates	  of	  CHD.	  	  Currently	  
however,	  prognostication,	  investigation	  and	  treatment	  of	  RV	  disease	  are	  applied	  from	  evidence	  
gathered	  in	  those	  with	  LV	  disease;	  the	  transfer	  value	  to	  RV	  pathophysiology	  in	  CHD	  has	  not	  been	  
formally	  assessed.	  	  	  
	  
1.2.1	  	  The	  Subpulmonary	  Right	  Ventricle	  	  
The	  model	  I	  have	  chosen	  for	  this	  anatomy	  is	  repaired	  tetralogy	  of	  Fallot	  (ToF).	  	  ToF	  is	  the	  commonest	  
cyanotic	  congenital	  heart	  defect	  with	  an	  estimated	  incidence	  of	  0.3	  per	  1000	  live	  births7.	  	  The	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average	  age	  at	  death	  in	  this	  cohort	  is	  41±15	  years,	  with	  SCD	  (31%),	  HF	  (25%)	  and	  perioperative	  
mortality	  (8%)	  constituting	  the	  commonest	  modes	  of	  death4.	  
	  
The	  four	  features	  typical	  of	  ToF	  include	  an	  overriding	  aorta,	  unrestrictive	  ventricular	  septal	  defect,	  
right	  ventricular	  outflow	  tract	  obstruction	  (infundibular	  stenosis)	  and	  a	  compensatory	  right	  



























Figure	  1:	  	  Anatomic	  representation	  of	  the	  typical	  features	  of	  tetralogy	  of	  Fallot:	  Ventricular	  septal	  defect,	  
overriding	  aorta,	  RV	  hypertrophy	  and	  RV	  outflow	  tract	  obstruction	  (pulmonary	  stenosis).	  	  From	  Brickner	  ME,	  
Hillis	  LD,	  Lange	  RA.	  Congenital	  heart	  disease	  in	  adults.	  N	  Engl	  J	  Med.	  2000	  Feb	  3;342(5):334-­‐42	  Copyright	  ©	  
(2014)	  Massachusetts	  Medical	  Society.	  Reprinted	  with	  permission.	  
	  
The	  underlying	  pathology	  arises	  as	  a	  consequence	  of	  underdevelopment	  of	  the	  RV	  infundibulum	  
causing	  malalignment	  of	  the	  infundibular	  septum.	  	  Males	  and	  females	  are	  affected	  equally,	  and	  the	  
incidence	  is	  sporadic.	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Infants	  diagnosed	  with	  ToF	  nowadays	  undergo	  successful	  repair	  between	  the	  ages	  of	  3-­‐6	  months8.	  	  
The	  techniques	  used	  to	  correct	  the	  underlying	  anatomy	  have	  evolved	  considerably	  since	  first	  
attempted	  in	  the	  1950’s:	  Extensive	  right	  ventriculotomy	  and	  trans-­‐annular	  intervention	  is	  avoided	  
where	  possible	  now	  in	  favour	  of	  less	  invasive	  approaches.	  	  It	  is	  not	  uncommon	  however,	  to	  
encounter	  a	  young	  adult	  at	  follow-­‐up	  with	  progressive	  RV	  dilatation,	  RV	  dysfunction	  and	  significant	  
pulmonary	  valve	  regurgitation.	  	  Due	  to	  such	  residual	  lesions	  following	  primary	  repair,	  patients	  often	  
require	  further	  surgery	  in	  their	  20’s	  and	  30’s	  to	  implant	  a	  competent	  pulmonary	  valve.	  	  The	  
haemodynamic	  impact	  of	  early	  surgery	  and	  progressive	  pulmonary	  valvular	  insufficiency	  in	  this	  
cohort	  leads	  to	  a	  primarily	  volume	  overloaded	  pathophysiology	  of	  the	  RV.	  
	  
1.2.2	  	  	  The	  Systemic	  Right	  Ventricle	  
There	  is	  an	  anatomic	  subtype	  of	  CHD	  where	  the	  normal	  ventriculo-­‐arterial	  relationship	  is	  inverted.	  	  
Complete	  transposition	  of	  the	  great	  arteries	  (TGA)	  is	  the	  commonest	  cause	  of	  neonatal	  cyanosis	  with	  
an	  incidence	  of	  2-­‐3	  per	  10,000	  live	  births9.	  	  In	  this	  anatomy	  there	  is	  atrio-­‐ventricular	  concordance	  
with	  ventriculo-­‐arterial	  discordance	  such	  that	  a	  parallel	  circulation	  is	  in	  effect,	  allowing	  no	  mixing	  of	  
pulmonary	  and	  systemic	  blood	  unless	  a	  concomitant	  defect	  also	  exists,	  most	  commonly	  a	  septal	  
defect	  at	  atrial	  or	  ventricular	  level	  (Figure	  2).	  	  Palliation	  is	  achieved	  via	  atrial	  switch	  redirection	  
surgery	  (Mustard	  or	  Senning	  procedure),	  which	  was	  routinely	  undertaken	  prior	  to	  the	  advent	  of	  the	  
arterial	  switch,	  or	  Jatene,	  procedure	  in	  the	  mid-­‐1980’s.	  	  Co-­‐existing	  ventricular	  septal	  defects	  are	  
closed	  at	  the	  time	  of	  surgery;	  however	  they	  enable	  further	  differentiation	  of	  anatomy	  into	  simple	  –	  
intact	  ventricular	  septum,	  and	  complex	  –	  with	  ventricular	  septal	  defect.	  	  	  
	  
	  
The	  atrial	  switch	  operations	  restore	  a	  physiologic	  ‘in	  series’	  circulation	  by	  redirecting	  venous	  return	  
at	  atrial	  level	  via	  the	  creation	  of	  pathways,	  or	  ‘baffles’,	  however	  they	  commit	  the	  morphologic	  RV	  to	  
the	  subaortic	  position	  and	  lifelong	  maintenance	  of	  the	  systemic	  circulation	  (Figure	  3).	  	  The	  Mustard	  
procedure	  uses	  autologous	  or	  synthetic	  material	  to	  create	  the	  intra-­‐atrial	  baffle10,	  whereas	  the	  
Senning	  procedure	  utilises	  native	  right	  atrial	  or	  intra-­‐atrial	  wall	  tissue11.	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Figure	  2:	  Complete	  transposition	  of	  the	  great	  arteries	  with	  intact	  ventricular	  septum.	  	  The	  systemic	  venous	  
return	  to	  the	  heart	  enters	  the	  right	  ventricle	  and	  subsequently	  returns	  to	  the	  body	  via	  the	  aorta.	  	  Meanwhile,	  
the	  morphologic	  LV	  pumps	  pulmonary	  venous	  return	  back	  into	  the	  pulmonary	  circulation.	  	  Without	  a	  
concomitant	  atrial,	  ventricular	  or	  ductal	  defect,	  infants	  with	  this	  anatomy	  cannot	  survive.	  	  From	  Brickner	  ME,	  
Hillis	  LD,	  Lange	  RA.	  Congenital	  heart	  disease	  in	  adults.	  N	  Engl	  J	  Med.	  2000	  Feb	  3;342(5):334-­‐42	  Copyright	  ©	  
(2014)	  Massachusetts	  Medical	  Society.	  Reprinted	  with	  permission.	  
	  
	  
The	  later	  developed	  Jatene	  procedure12	  switches	  both	  the	  aorta	  and	  pulmonary	  artery	  at	  root	  level	  
such	  that	  the	  normal	  ventriculo-­‐arterial	  anatomic	  relationships	  are	  re-­‐established	  and	  preserved.	  	  
Providing	  that	  anatomy	  is	  favourable,	  the	  so-­‐called	  arterial	  switch	  operation	  is	  the	  procedure	  of	  
choice;	  patients	  are	  only	  now	  starting	  to	  enter	  long-­‐term	  care	  as	  adults.	  	  This	  Thesis	  will	  only	  concern	  
itself	  with	  the	  atrial	  switch	  procedures	  and	  the	  resultant	  systemic	  RV	  physiology.	  
	  
In	  this	  cohort	  of	  patients,	  the	  life-­‐long	  maintenance	  of	  the	  systemic	  circulation	  by	  the	  morphologic	  
RV	  leads	  to	  a	  pressure	  loaded	  pathophysiological	  system.	  	  The	  consequences	  of	  such	  a	  burden	  on	  
this	  chamber	  are	  reflected	  in	  the	  poor	  long	  term	  outcomes	  of	  those	  with	  TGA	  palliated	  by	  either	  
Mustard	  or	  Senning	  procedure:	  Gelatt	  et	  al	  found	  a	  survival	  rate	  of	  89%	  at	  5	  years	  and	  76%	  at	  20	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years	  of	  age13.	  	  Oechslin	  and	  colleagues	  established	  a	  mean	  age	  of	  death	  of	  27±7	  years	  in	  this	  
cohort4.	  	  HF	  and	  SCD	  again	  constitute	  the	  commonest	  modes	  of	  death4,14,15	  and	  outcome	  is	  related	  to	  




Figure	  3:	  	  TGA	  with	  atrial	  redirection	  surgery.	  	  Systemic	  venous	  return	  to	  the	  right	  atrium	  is	  baffled	  to	  the	  
morphologic	  LV	  where	  it	  is	  circulated	  to	  the	  lungs.	  	  Pulmonary	  venous	  return	  enters	  the	  left	  atrium	  to	  be	  
redirected	  to	  the	  morphologic,	  and	  now	  systemic,	  RV.	  From	  Brickner	  ME,	  Hillis	  LD,	  Lange	  RA.	  Congenital	  heart	  
disease	  in	  adults.	  N	  Engl	  J	  Med.	  2000	  Feb	  3;342(5):334-­‐42	  Copyright	  ©	  (2014)	  Massachusetts	  Medical	  Society.	  
Reprinted	  with	  permission.	  
	  
1.2.3	   Ventricular	  Interdependence	  
Although	  this	  Thesis	  concerns	  itself	  with	  the	  RV,	  it	  is	  neither	  possible	  nor	  correct	  to	  examine	  this	  
chamber	  in	  isolation.	  	  Ventricular	  interdependence	  refers	  to	  the	  concept	  that	  the	  function	  and	  size	  
of	  one	  ventricle	  invariably	  and	  immediately	  affects	  the	  other,	  such	  that	  the	  impact	  of	  disease	  of	  one	  
ventricle	  is	  never	  isolated	  to	  that	  chamber.	  	  Ventricular	  interdependence	  can	  be	  diastolic	  and	  
systolic	  in	  nature	  and	  is	  mediated	  most	  commonly	  by	  the	  interventricular	  septum	  and/or	  
pericardium	  (Figure	  4).	  	  This	  phenomenon	  was	  first	  alluded	  to	  by	  Dexter	  in	  the	  1950’s	  who	  described	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a	  possible	  ‘reverse	  of	  Bernheim’s	  syndrome’	  in	  patients	  with	  atrial	  septal	  defect	  and	  compression	  of	  
the	  LV	  by	  the	  interventricular	  septum18.	  	  In	  such	  patients	  with	  RV	  volume	  overload	  associated	  with	  
atrial	  septal	  defects,	  device	  closure	  of	  the	  defect	  was	  found	  to	  affect	  an	  immediate	  improvement	  in	  
LV	  physiology19.	  	  Therefore	  the	  presence	  of	  RV	  disease	  on	  the	  LV	  and	  possible	  beneficial	  impact	  on	  
this	  chamber	  following	  therapy	  will	  also	  be	  discussed.	  
	  
	  
Figure	  4:	  Ventricular	  interdependence	  in	  RV	  failure.	  Normal	  geometry	  is	  shown	  on	  the	  left,	  however	  with	  RV	  
dilatation,	  as	  seen	  with	  volume	  overload,	  the	  interventricular	  septum	  is	  shifted	  toward	  the	  LV,	  changing	  the	  
geometry	  of	  this	  chamber.	  	  Pericardial	  constraint	  may	  also	  occur	  (arrows).	  These	  changes	  may	  contribute	  to	  
abnormal	  LV	  physiology	  in	  the	  absence	  of	  disease	  directly	  affecting	  this	  chamber.	  	  Image	  courtesy	  of	  Haddad	  F	  
et	  al.	  Circulation	  2008;117:1717-­‐1731	  
	  
	  
2. Electromechanics	  and	  myocardial	  conduction	  
2.1	  	  Normal	  myocardial	  conduction	  
In	  health,	  ventricular	  activation	  is	  propagated	  via	  the	  right	  and	  left	  bundle	  branches	  to	  the	  Purkinje	  
network	  before	  spreading	  to	  the	  right	  and	  left	  ventricles	  from	  endocardium	  to	  epicardium.	  	  RV	  
activation	  precedes	  LV	  activation,	  the	  earliest	  epicardial	  RV	  breakthrough	  site	  occurring	  at	  the	  
anterior	  paraseptal	  region	  with	  subsequent	  radial	  spread	  towards	  the	  apex	  and	  base20,21,22	  (Figure	  5).	  
	  
Descriptions	  of	  normal	  LV	  activation	  sequence	  are	  less	  consistent.	  	  Early	  breakthrough	  at	  the	  
anterior	  paraseptal	  region	  close	  to	  the	  atrio-­‐ventricular	  (AV)	  sulcus	  or	  midway	  between	  apex	  and	  
base,	  and	  at	  a	  posterior	  paraseptal	  area	  have	  been	  described20.	  	  Others	  report	  earliest	  breakthrough	  
at	  the	  anterolateral	  region21,	  near	  the	  apex	  inferiorly	  and	  laterally22	  with	  progression	  towards	  the	  
posterolateral	  base23.	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Figure	  5:	  Isochronal	  activation	  map	  of	  the	  right	  ventricle	  in	  the	  structurally	  normal	  heart	  showing	  electrical	  
activity	  spreading	  radially	  towards	  apex	  and	  base	  from	  the	  site	  of	  earliest	  breakthrough,	  at	  the	  anterior	  
paraseptal	  region.	  	  
	  
2.2	  	  Abnormal	  myocardial	  conduction	  and	  bundle	  branch	  block	  	  
Electromechanics	  defines	  the	  interaction	  between	  the	  electrical	  activation	  sequence	  of	  the	  heart	  
and	  the	  local	  mechanical	  response	  to	  this	  sequence.	  	  Delay	  of	  electrical	  propagation	  through	  the	  
myocardium	  manifests	  as	  prolongation	  of	  the	  QRS	  duration	  on	  the	  surface	  electrocardiogram	  (ECG),	  
classically	  described	  in	  terms	  of	  a	  left	  bundle	  branch	  block	  (LBBB)	  or	  right	  bundle	  branch	  block	  
(RBBB)	  pattern.	  	  Delay	  in	  electrical	  propagation	  results	  in	  delayed	  regional	  myocardial	  contraction,	  
causing	  mechanical	  dyssynchrony	  between	  ventricles	  (interventricular	  dyssynchrony)	  or	  within	  a	  
ventricular	  chamber	  (intraventricular	  dyssynchrony),	  a	  phenomenon	  now	  readily	  quantified	  
echocardiographically	  or	  using	  magnetic	  resonance	  imaging24,25.	  	  Such	  intraventricular	  and	  
interventricular	  dyssynchrony	  results	  in	  a	  disparity	  in	  regional	  and	  global	  myocardial	  cellular	  stress	  
and	  strain26,	  leading	  to	  an	  inefficiency	  of	  local	  energy	  production	  and	  consumption.	  	  This	  in	  turn	  
increases	  the	  demand	  for	  myocardial	  oxygen,	  a	  supply	  which	  is	  often	  already	  compromised	  in	  those	  
with	  bundle	  branch	  block.	  	  	  
	  
2.2.1	  	  Acquired	  Heart	  Disease	  	  
Canine	  models	  have	  shown	  that	  in	  the	  presence	  of	  LBBB	  (Figure	  6),	  activation	  of	  the	  LV	  occurs	  by	  
right	  to	  left	  trans-­‐septal	  activation,	  followed	  by	  activation	  of	  the	  rest	  of	  the	  LV27.	  	  Auricchio	  and	  
colleagues	  refined	  these	  findings,	  noting	  that	  the	  activation	  wave	  front	  is	  unable	  to	  reach	  the	  LV	  
lateral	  wall	  via	  the	  anterior	  wall	  due	  to	  a	  variable	  line	  of	  functional	  block	  (area	  of	  myocardium	  that	  
transiently	  fails	  to	  propagate	  depolarisation	  wavefronts	  due	  to	  rate	  dependent	  changes	  in	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refratoriness),	  oriented	  from	  base	  to	  apex,	  i.e.,	  promoting	  a	  U-­‐shaped	  activation	  sequence	  in	  the	  LV	  
via	  the	  apex28.	  	  This	  group	  confirmed	  that	  LBBB	  is	  a	  ‘complex	  electrical	  disease’	  involving	  several	  
anatomic	  locations	  and	  levels	  of	  activation	  delay	  within	  the	  LV,	  and	  further	  described	  that	  those	  
patients	  with	  LBBB	  and	  a	  QRS	  duration	  of	  less	  than	  150ms	  had	  a	  more	  homogenous	  pattern	  of	  
activation	  as	  compared	  to	  those	  similar	  patients	  with	  a	  QRS	  duration	  >150ms.	  	  This	  more	  
homogenous	  pattern	  was	  associated	  with	  a	  normalised	  trans-­‐septal	  conduction	  time	  and	  a	  different	  
location	  of	  LV	  breakthrough	  site,	  located	  further	  away	  to	  the	  functional	  line	  of	  block28.	  	  Non-­‐contact	  
endocardial	  mapping	  studies	  have	  revealed	  further	  underlying	  inhomogeneity	  of	  the	  depolarisation	  
pattern	  encompassing	  the	  coronary	  sinus29.	  	  RV	  activation	  sequence	  remains	  unchanged	  in	  patients	  
with	  LBBB,	  although	  activation	  time	  is	  prolonged30.	  	  
	  
	  
Figure	  6:	  Isochronal	  map	  illustrating	  LBBB	  in	  the	  left	  ventricle	  of	  a	  patient	  with	  ischaemic	  heart	  disease.	  The	  
activation	  wavefront	  is	  seen	  migrating	  from	  the	  anterior	  (Ant)	  to	  the	  posterolateral	  (Lat)	  wall	  of	  the	  ventricle	  
rotating	  around	  a	  line	  of	  functional	  block	  illustrated	  by	  the	  crowded	  isochrones	  on	  the	  anterolateral	  wall.	  The	  
timing	  sequence	  is	  initiated	  from	  the	  onset	  of	  the	  QRS	  on	  surface	  ECG.	  It	  takes	  at	  least	  90msec	  for	  the	  
activation	  wavefront	  to	  migrate	  to	  the	  lateral	  wall.	  
	  
In	  the	  presence	  of	  RBBB	  (Figure	  7),	  RV	  activation	  is	  delayed	  with	  breakthrough	  occurring	  after	  LV	  
breakthrough	  via	  trans-­‐septal	  conduction	  from	  the	  left	  side.	  	  There	  appears	  to	  be	  similar	  overall	  
delay	  in	  LV	  activation	  in	  the	  presence	  of	  RBBB	  as	  seen	  with	  LBBB31.	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Figure	  7:	  	  Isochronal	  map	  illustrating	  right	  bundle	  branch	  block	  as	  seen	  in	  a	  structurally	  normal	  heart.	  Right	  
ventricular	  activation	  is	  delayed	  in	  right	  bundle	  branch	  block,	  with	  breakthrough	  occurring	  after	  left	  ventricular	  
breakthrough	  via	  trans-­‐septal	  conduction	  from	  the	  left	  side.	  	  	  
	  
2.2.2	  	  Congenital	  Heart	  Disease	  
In	  describing	  a	  functional	  line	  of	  block	  in	  patients	  with	  LBBB,	  whose	  location	  and	  length	  can	  not	  only	  
vary	  between	  patients	  but	  can	  also	  be	  significantly	  ameliorated	  with	  pacing,	  Auricchio	  and	  
colleagues	  studied	  only	  patients	  with	  dilated	  cardiomyopathy,	  less	  than	  30%	  of	  whom	  had	  coronary	  
artery	  disease	  as	  a	  cause	  of	  disease28.	  	  This	  is	  relevant	  as	  often	  it	  is	  those	  with	  ischaemic	  
cardiomyopathy	  who	  suffer	  transmural	  scarring	  and	  by	  extension,	  fixed	  lines	  of	  block.	  	  Bleeker	  et	  al	  
found	  that	  patients	  in	  whom	  a	  posterolateral	  transmural	  scar	  was	  identified	  by	  cardiac	  magnetic	  
resonance	  imaging	  did	  not	  respond	  to	  conventional	  CRT	  despite	  having	  no	  other	  significant	  
difference	  in	  entry	  criteria	  for	  delivery32.	  	  	  This	  is	  particularly	  significant	  when	  the	  role	  and	  
application	  of	  CRT	  are	  being	  transferred	  to	  any	  patients	  with	  CHD.	  	  	  
	  
Less	  information	  exists	  regarding	  the	  electrical	  activation	  sequence	  in	  patients	  with	  CHD.	  	  It	  varies	  
widely	  according	  to	  underlying	  anatomy	  and	  effects	  of	  previous	  palliative	  or	  reparative	  surgery.	  	  
RBBB	  occurs	  frequently	  and	  is	  often	  iatrogenic,	  secondary	  to	  cardiac	  surgery33.	  Horowitz	  and	  co-­‐
workers	  described	  pre-­‐operative	  RV	  activation	  (without	  RBBB)	  preceding	  LV	  activation	  in	  a	  
conventional	  manner.	  	  Post-­‐operatively,	  three	  levels	  of	  block	  to	  the	  right	  bundle	  were	  found	  
(proximal,	  distal	  and	  terminal),	  each	  associated	  with	  a	  particular	  approach	  to	  surgical	  
ventriculotomy34,35.	  	  Although	  all	  these	  levels	  of	  block	  manifest	  different	  electrical	  activation	  
sequences	  on	  electrophysiological	  mapping,	  all	  are	  represented	  by	  the	  same	  RBBB	  pattern	  on	  the	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surface	  ECG.	  	  These	  fixed	  levels	  of	  block,	  apparent	  post	  surgical	  repair	  in	  patients	  with	  CHD,	  would	  
suggest	  that	  the	  blind	  transfer	  of	  CRT	  would	  impart	  no	  significant	  value	  to	  the	  congenital	  patient.	  	  	  
	  
It	  is	  important	  to	  note	  that	  increases	  in	  ventricular	  volumes	  and	  pressure	  can	  also	  induce	  QRS	  
prolongation	  over	  time36.	  	  RBBB	  resulting	  from	  ventriculotomy	  during	  repair	  of	  ToF	  for	  example,	  
broadens	  further	  during	  follow-­‐up	  in	  association	  with	  pulmonary	  regurgitation	  (PR)	  and	  increases	  in	  
RV	  size37.	  	  Depolarisation	  and	  repolarisation	  abnormalities	  in	  this	  population	  are	  in	  turn	  predictive	  of	  
life-­‐threatening	  arrhythmias,	  particularly	  with	  a	  QRS	  duration	  greater	  than	  180ms38.	  	  	  
	  
Patients	  undergoing	  surgical	  pulmonary	  valve	  replacement	  (PVR)	  for	  significant	  PR	  in	  ToF	  
demonstrate	  significant	  subsequent	  improvements	  in	  RV	  end	  diastolic	  volume	  (EDV)39,40,	  despite	  this	  
however,	  evidence	  for	  improvement	  of	  electromechanics	  in	  this	  cohort	  remains	  contradictory41,42,43.	  	  	  
Percutaneous	  pulmonary	  valve	  implantation	  (PPVI)	  is	  an	  established	  minimally	  invasive	  procedure	  
that	  can	  provide	  an	  alternative	  to	  surgery	  in	  selected	  patients.	  	  This	  procedure	  is	  unique	  in	  that	  it	  
permits	  the	  study	  of	  the	  effect	  of	  reductions	  in	  RV	  volume	  on	  electrical	  remodelling,	  independent	  of	  
surgical	  incision	  in	  the	  ventricular	  myocardium,	  additional	  surgical	  intervention	  at	  the	  time	  of	  valve	  
replacement	  or	  cardiopulmonary	  bypass.	  	  Published	  data	  have	  confirmed	  that	  this	  mode	  of	  relief	  of	  
pulmonary	  outflow	  obstruction	  and/or	  regurgitation,	  as	  with	  its	  surgical	  counterpart,	  does	  lead	  to	  
reductions	  in	  RV	  EDV,	  RV	  end	  systolic	  volume	  (ESV)	  and	  RV	  systolic	  pressure44,45,46.	  	  	  
	  
The	  pressure	  loaded	  systemic	  RV	  is	  also	  often	  associated	  with	  a	  RBBB	  pattern	  to	  the	  surface	  ECG	  and	  
it	  may	  be	  that	  the	  electrophysiological	  compromises	  suffered	  over	  time	  may	  also	  be	  resolved	  by	  
correcting	  underlying	  progressive	  haemodynamic	  lesions.	  	  
	  
2.3	  	  Mechanical	  dyssynchrony	  
Abnormal	  electromechanical	  interactions	  may	  result	  in	  dyssynchrony	  of	  such	  magnitude	  so	  as	  to	  
translate	  to	  a	  measurable	  reduction	  in	  cardiac	  output,	  independent	  of	  the	  total	  systolic	  function	  of	  
all	  contracting	  segments.	  	  In	  a	  heart	  compromised	  by	  inadequate	  systolic	  function	  the	  addition	  of	  
mechanical	  dyssynchrony	  can	  result	  in	  a	  further	  fall	  in	  cardiac	  output	  –	  dyssynchrony	  generates	  
marked	  regional	  heterogeneity	  of	  both	  function	  and	  loading	  of	  myocardium.	  	  Consequently	  
LBBB47,48,49	  and	  RBBB50	  have	  both	  been	  associated	  with	  higher	  morbidity	  and	  mortality	  in	  patients	  
with	  acquired	  HF.	  	  Arrhythmia	  and	  progressive	  heart	  failure	  are	  also	  the	  leading	  causes	  of	  death	  in	  
patients	  with	  CHD2,4	  and,	  in	  keeping	  with	  the	  finding	  of	  increased	  heterogeneity	  of	  activation	  with	  
increasing	  prolongation28,	  QRS	  duration	  also	  relates	  to	  worse	  prognosis	  in	  such	  cohorts51,52.	  	  A	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potential	  cause	  of	  arrhythmogenicity	  in	  the	  setting	  of	  mechanical	  dyssynchrony,	  even	  in	  the	  absence	  
of	  underlying	  HF,	  has	  been	  proposed	  by	  Spragg	  et	  al	  who	  describe	  regional	  ventricular	  
electrophysiological	  remodelling,	  most	  marked	  in	  the	  lateral	  LV	  wall	  in	  adult	  dogs	  with	  LBBB53.	  	  
Disparities	  in	  intraventricular	  action	  potential	  duration	  (APD)	  and	  conduction	  velocity	  between	  the	  
lateral	  and	  anterior	  LV	  wall	  may	  comprise	  part	  of	  a	  set	  of	  unfavourable	  conditions	  which	  together,	  
predispose	  to	  a	  lethal	  pro-­‐arrhythmic	  substrate.	  	  
	  
2.3.1	  	  Mechanical	  dyssynchrony	  in	  CHD	  	  
Several	  investigators	  have	  described	  the	  presence	  of	  mechanical	  dyssynchrony	  in	  both	  the	  right	  and	  
left	  ventricles	  in	  patients	  with	  repaired	  ToF,	  often	  in	  association	  with	  RBBB.	  Using	  long-­‐axis	  M-­‐mode	  
echocardiography,	  Uebing	  et	  al54	  found	  that,	  with	  respect	  to	  the	  RV,	  the	  free	  wall	  and	  outflow	  tract	  
exhibit	  the	  greatest	  delay	  in	  activation	  and	  overall	  RV	  ejection	  time	  is	  prolonged.	  Using	  tissue	  
Doppler	  echocardiography	  Abd	  El	  Rahman	  describe	  delayed	  activation	  of	  the	  LV	  in	  around	  half	  of	  
patients	  with	  repaired	  ToF	  and	  RBBB55.	  	  The	  pattern	  differed	  from	  that	  seen	  in	  patients	  with	  dilated	  
cardiomyopathy	  and	  RBBB,	  affecting	  the	  ventricular	  septum	  and	  not	  the	  lateral	  LV	  wall.	  In	  a	  recent	  
retrospective	  analysis	  of	  75	  patients	  with	  repaired	  TOF,	  Tzemos	  and	  co-­‐workers	  noted	  a	  significant	  
associated	  between	  QRS	  duration	  and	  adverse	  LV	  volume,	  activation	  delay	  and	  septal	  strain56.	  In	  
contrast,	  Friedli	  et	  al,	  in	  a	  more	  limited	  study,	  found	  delayed	  RV	  apical	  activation	  in	  children	  with	  
TOF	  and	  RBBB	  but	  no	  LV	  activation	  delay57.	  	  	  
	  
Taken	  together	  these	  findings	  suggest	  that	  in	  the	  presence	  of	  RBBB,	  mechanical	  dyssynchrony	  occurs	  
not	  only	  within	  the	  RV	  but	  can	  also	  be	  found	  in	  the	  LV	  in	  adults	  with	  repaired	  ToF.	  This	  
electromechanical	  interaction	  between	  the	  two	  ventricles	  may	  be	  an	  important,	  if	  somewhat	  poorly	  
understood,	  aspect	  of	  ventricular	  underperformance	  and	  clinical	  outcome	  in	  CHD.	  	  	  
	  
The	  phenomenon	  of	  ventricular	  interdependence	  may	  be	  relevant	  in	  this	  scenario.	  	  Certainly	  the	  
impact	  of	  RV	  intervention	  on	  the	  LV	  in	  adults	  with	  ToF	  has	  not	  been	  extensively	  studied,	  however	  
the	  Toronto	  group	  recently	  published	  their	  investigation	  into	  this	  cohort	  of	  patients	  undergoing	  
surgical	  correction	  of	  clinically	  important	  PR.	  	  They	  describe	  a	  significant	  improvement	  in	  LV	  function	  
at	  1.5-­‐3.5	  years	  following	  intervention,	  unrelated	  to	  either	  preoperative	  RV	  volumes	  or	  degree	  of	  RV	  
remodelling,	  proposing	  a	  ‘ventricular-­‐ventricular	  interaction’58.	  	  It	  is	  therefore	  entirely	  possible	  that	  
the	  chamber-­‐specific	  ventricular	  remodelling	  that	  would	  be	  expected	  to	  accompany	  RV	  cardiac	  
resynchronisation	  therapy	  (CRT)	  	  would	  also	  beneficially	  impact	  the	  LV.	  	  This	  has	  yet	  to	  be	  studied	  in	  
detail.	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2.3.2	  	  Pacemaker-­‐related	  dyssynchrony	  
Mechanical	  dyssynchrony	  can	  be	  observed	  during	  cardiac	  pacing,	  particularly	  when	  the	  heart	  is	  
activated	  from	  the	  RV	  apex,	  during	  which	  LBBB	  develops.	  The	  deleterious	  impact	  on	  LV	  function	  
resulting	  from	  RV	  apical	  pacing	  is	  well	  documented59,60	  and	  appears	  to	  be	  proportional	  to	  the	  overall	  
pacing	  burden61	  and	  underlying	  function	  of	  the	  LV62.	  	  Stimulating	  the	  RV	  from	  alternative	  sites	  may	  
abrogate	  iatrogenic	  dyssynchrony63,64,65	  although	  pacing	  the	  LV	  via	  the	  cardiac	  veins	  remains	  the	  gold	  
standard	  technique	  for	  avoiding	  this	  complication	  and	  indeed	  reducing	  dyssynchronous	  contraction.	  
	  
The	  possibility	  of	  pacemaker-­‐related	  mechanical	  dyssynchrony	  of	  the	  unpaced/sub-­‐aortic	  ventricle	  
should	  therefore	  be	  considered	  in	  patients	  with	  CHD.	  	  Piran	  et	  al	  found	  that	  68%	  of	  adults	  with	  a	  
single	  or	  systemic	  right	  ventricle	  and	  overt	  HF	  had	  a	  permanent	  pacemaker	  and	  in	  those	  that	  had	  
succumbed	  with	  heart	  failure,	  62%	  were	  paced66.	  Janousek	  and	  colleagues	  go	  further,	  describing	  
mechanical	  dyssynchrony	  associated	  with	  single	  site	  ventricular	  pacing	  as	  the	  commonest	  reason	  
(77%	  of	  total)	  for	  upgrade	  to	  CRT	  in	  a	  large	  cohort	  with	  structural	  or	  congenital	  heart	  disease67.	  	  The	  
same	  authors	  have	  described	  ‘LV-­‐induced	  RV	  dyssynchronisation’	  in	  a	  group	  of	  patients	  with	  a	  
systemic	  right	  ventricle	  receiving	  sub-­‐pulmonary	  left-­‐ventricular	  pacing68.	  	  They	  suggest	  that	  such	  an	  
approach	  (akin	  to	  RV	  apical	  pacing	  in	  the	  structurally	  normal	  heart)	  is	  deleterious,	  exacerbating	  
mechanical	  dyssynchrony	  in	  the	  presence	  of	  pre-­‐existing	  RV	  systolic	  dysfunction.	  
	  
3. Cardiac	  Resynchronisation	  Therapy	  
Cardiac	  resynchronisation	  therapy	  (CRT)	  refers	  to	  the	  use	  of	  permanent	  pacing	  systems	  to	  stimulate	  
myocardium	  usually	  subject	  to	  delayed	  activation,	  correcting,	  to	  a	  greater	  or	  lesser	  extent,	  
mechanical	  dyssynchrony.	  CRT	  can	  improve	  cardiac	  output	  and	  other	  measures	  of	  cardiac	  function,	  
and	  has	  proven	  very	  effective	  at	  alleviating	  symptoms	  of	  HF	  and	  improving	  survival	  in	  acquired	  heart	  
disease69,70.	  	  	  
	  
CRT	  devices	  tend	  to	  have	  three	  pacing	  leads,	  traditionally	  placed	  at	  the	  right	  atrium,	  right	  ventricle	  
and	  coronary	  sinus	  (lateral	  LV	  wall)	  (Figure	  8).	  	  Atrio-­‐ventricular	  and	  inter	  ventricular	  synchrony	  can	  
thus	  be	  optimised	  in	  an	  attempt	  to	  improve	  global	  cardiac	  function	  via	  electrical	  pre-­‐excitation	  of	  
late	  contracting	  areas.	  	  CRT	  is	  sufficiently	  effective	  that	  it	  has	  been	  incorporated	  into	  therapeutic	  
guidelines	  for	  the	  management	  of	  refractory	  heart	  failure:	  both	  the	  American	  Heart	  Association	  and	  
the	  United	  Kingdom’s	  National	  Institute	  for	  Clinical	  Excellence	  recommend	  CRT	  to	  reduce	  morbidity	  
and	  mortality	  in	  patients	  in	  New	  York	  Heart	  Association	  (NYHA)	  class	  III-­‐IV	  with	  symptoms,	  despite	  
optimal	  medical	  therapy	  and	  who	  have	  a	  reduced	  ejection	  fraction	  (LVEF<35%)	  and	  QRS	  
Carla	  Plymen	  MD	  (Res)	   Page	  29	  
	  
prolongation	  ≥120ms71,72.	  	  In	  patients	  for	  whom	  standard	  biventricular	  pacing	  is	  not	  technically	  
feasible,	  dual	  site	  RV	  pacing	  has	  also	  shown	  promise73.	  
	  
	  
Figure	  8:	  Diagram	  showing	  traditional	  lead	  placement	  for	  CRT.	  	  Optimisation	  of	  therapy	  is	  undertaken	  
subsequent	  to	  implantation	  via	  echocardiographic	  guidance.	  	  	  Source:	  http://knol.google.com/k/-­‐/-­‐
/lAmNkcMc/I3szpw/biv.png,	  embedded	  from	  http://knol.google.com/k/gregory-­‐marcus-­‐md-­‐mas-­‐
facc/pacemakers/lAmNkcMc/EOUWRA;	  author	  Gregory	  Marcus,	  MD,	  MAS,	  FACC	  
	  
3.1	  	  Cellular	  basis	  of	  function	  of	  CRT	  
Mechanical	  dyssynchrony	  alters	  the	  loading	  of	  the	  affected	  myocardium	  such	  that	  the	  area	  of	  early	  
activation	  has	  a	  lesser	  load	  than	  the	  later	  activated,	  and	  therefore	  stretched,	  opposite	  wall.	  	  These	  
latter	  regions	  are	  subject	  to	  pre-­‐stretch	  and	  therefore	  work	  at	  higher	  loads,	  requiring	  greater	  
energy74.	  	  CRT	  negates	  these	  effects	  by	  increasing	  homogeneity	  of	  LV	  myocardial	  activation,	  
specifically	  by	  shortening	  APD	  in	  the	  lateral	  LV	  wall75,	  and	  consequently	  ensuring	  more	  equal	  loading	  
throughout	  the	  LV,	  enabling	  a	  more	  efficient	  pump.	  	  	  
	  
Studies	  have	  confirmed	  that	  LBBB	  induces	  regional	  increases	  in	  LV	  wall	  mass	  as	  a	  consequence	  of	  
this	  phenomenon76:	  Application	  of	  resynchronisation	  therapy	  to	  such	  hearts	  has	  revealed	  
normalisation	  of	  wall	  mass	  with	  time.	  	  Examination	  of	  these	  events	  at	  genetic	  levels	  finds	  that	  LBBB	  
is	  associated	  with	  increased	  local	  expression	  of	  genes	  coding	  for	  stretch,	  remodelling	  and	  cell	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regeneration	  contributing	  to	  myocardial	  hypertrophy.	  	  Subsequent	  biventricular	  stimulation	  in	  these	  
hyper-­‐productive	  systems	  results	  in	  a	  reversal	  of	  this	  over-­‐expression	  within	  only	  a	  few	  months77,	  
and	  is	  also	  associated	  with	  reduced	  apoptosis78.	  	  At	  the	  cellular	  level,	  up-­‐	  and	  down-­‐regulation	  of	  
various	  calcium,	  sodium	  and	  potassium	  channels	  are	  thought	  to	  mediate	  changes	  in	  local	  cell	  
reactivity,	  both	  to	  exacerbate	  heterogeneity	  of	  APD	  in	  LBBB,	  and	  in	  most	  cases,	  to	  restore	  it	  
following	  CRT.	  	  The	  specific	  mechanism	  behind	  these	  findings	  remains	  controversial	  however79.	  	  	  
	  
3.2	  CRT	  in	  right	  bundle	  branch	  block	  
The	  vast	  majority	  of	  patients	  with	  acquired	  heart	  failure	  and	  QRS	  prolongation	  have	  LBBB.	  	  Less	  is	  
known	  about	  the	  effectiveness	  of	  CRT	  in	  the	  presence	  of	  RBBB,	  underrepresented	  in	  clinical	  trials,	  
though	  interest	  is	  growing	  in	  this	  area80.	  	  In	  animal	  studies	  Byrne	  and	  colleagues	  found	  less	  
mechanical	  dyssynchrony	  for	  the	  same	  degree	  of	  LV	  dysfunction	  and	  QRS	  prolongation	  with	  RBBB	  
compared	  to	  LBBB81.	  	  The	  authors	  also	  describe	  a	  blunted	  effect	  of	  CRT	  on	  improving	  LV	  synchrony	  in	  
those	  with	  RBBB,	  establishing	  that	  conventional	  atrioventricular	  RV	  pacing	  was	  at	  least	  as	  efficacious	  
as	  biventricular	  CRT	  in	  this	  group.	  	  This	  latter	  finding	  may	  be	  relevant	  in	  patients	  with	  CHD	  and	  RBBB	  
in	  whom	  sub-­‐pulmonary	  RV	  dysfunction	  is	  the	  principal	  electromechanical	  problem.	  
	  
Closer	  scrutiny	  of	  those	  patients	  with	  RBBB	  who	  have	  undergone	  CRT	  insertion	  would	  suggest	  that	  
outcome	  is	  inferior	  compared	  with	  their	  counterparts	  with	  LBBB82,83,84.	  	  It	  is	  interesting	  to	  note	  
however,	  that	  symptomatic	  improvement	  is	  noted82.	  	  Regardless,	  the	  small	  numbers	  with	  RBBB	  and	  
the	  probable	  differences	  in	  underlying	  pathophysiology	  (predominantly	  RV	  disease)	  and	  
requirements	  for/at	  optimisation	  of	  delivery,	  dictates	  that	  this	  remains	  a	  matter	  for	  further	  study.	  	  	  
No	  clear	  criteria	  based	  on	  directly	  observed	  measures	  or	  patterns	  of	  mechanical	  dyssynchrony	  have	  
been	  consistently	  found	  to	  distinguish	  responders	  from	  non-­‐responders	  amongst	  patients	  with	  
acquired	  heart	  disease85,86.	  	  The	  evidence	  base	  for	  helping	  select	  patients	  with	  CHD	  for	  CRT	  is	  even	  
smaller.	  Some	  have	  suggested	  that	  as	  many	  as	  9%	  of	  unselected	  patients	  with	  a	  systemic	  RV	  are	  
potential	  candidates	  for	  CRT	  based	  on	  conventional	  CRT	  trial	  entry	  criteria87.	  The	  use	  of	  published	  
guidelines	  on	  patient	  selection	  for	  CRT	  (systemic	  ventricular	  ejection	  fraction	   0.35,	  QRS	  >120	  ms,	  
sinus	  rhythm,	  NYHA	  class	  III	  or	  IV71,72)	  seems	  a	  pragmatic	  approach.	  Care	  should	  then	  be	  taken	  to	  
document	  baseline	  and	  outcome	  data	  in	  order	  to	  enhance	  the	  evidence	  base.	  
	  
3.2	  CRT	  in	  CHD	  and	  subpulmonary	  RV	  dysfunction	  
As	  the	  outflow	  tract	  (RVOT)	  and	  free	  wall	  of	  the	  RV	  show	  latest	  activation	  in	  patients	  with	  repaired	  
ToF54	  these	  sites	  intuitively	  constitute	  targets	  for	  lead	  placement	  when	  delivering	  CRT.	  	  Rigorous	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testing	  of	  this	  hypothesis	  is	  lacking	  however.	  	  The	  different	  electrophysiological	  consequences	  of	  
surgical	  intervention	  and	  disease	  progression	  over	  time	  would	  infer	  that	  specific	  and	  standard	  CRT	  
lead	  placement	  in	  all	  patients	  would	  not	  necessarily	  generate	  a	  positive	  outcome.	  Indeed,	  
conventional	  lead	  positions	  have	  been	  shown	  to	  provide	  excellent	  clinical	  response:	  Kirsch	  and	  
colleagues	  report	  that,	  in	  a	  child	  with	  repaired	  ToF	  presenting	  with	  heart	  failure,	  upgrading	  a	  dual	  
chamber	  pacemaker	  with	  epicardial	  RVOT	  lead	  to	  a	  biventricular	  device	  with	  an	  RV	  apical	  lead	  
provided	  the	  best	  haemodynamic	  and	  symptomatic	  response88.	  
	  	  
Dubin	  et	  al	  studied	  the	  acute	  haemodynamic	  effects	  of	  RV	  pacing	  in	  7	  patients	  with	  CHD	  (6	  with	  
repaired	  ToF),	  all	  of	  whom	  had	  RBBB	  and	  RV	  dysfunction	  and	  determined	  that	  atrioventricular	  
pacing	  resulted	  in	  significant	  haemodynamic	  improvement89.	  	  Leads	  were	  positioned	  at	  the	  apex,	  
RVOT	  or	  ventricular	  septum	  and	  the	  greatest	  increase	  in	  cardiac	  index	  was	  associated	  with	  the	  
narrowest	  paced	  QRS	  duration.	  
	  
AV	  delay	  optimisation	  would	  also	  appear	  important	  when	  pacing	  patients	  with	  sub-­‐pulmonary	  RV	  
dysfunction.	  	  Stephenson	  et	  al	  found	  that	  in	  patients	  with	  repaired	  ToF,	  RV	  apical	  pacing	  with	  AV	  
delay	  optimisation	  produced	  a	  significantly	  narrower	  QRS	  duration	  than	  RV	  apical	  pacing	  without	  
such	  programming90.	  	  By	  optimising	  AV	  delay	  immediately	  post-­‐operatively	  Janousek	  and	  co-­‐workers	  
improved	  electrical	  and	  haemodynamic	  parameters91	  in	  children	  with	  conduction	  delay	  with	  further	  
enhancement	  with	  inter/intraventricular	  resynchronisation.	  	  	  
	  
Acute	  improvements	  in	  central	  haemodynamics	  can	  therefore	  be	  achieved	  using	  standard	  
univentricular	  pacing	  in	  these	  groups.	  The	  potential	  benefits	  of	  this	  approach	  should	  not	  be	  
outweighed	  by	  iatrogenic	  dyssynchrony	  in	  the	  sub-­‐aortic	  LV,	  especially	  if	  the	  systolic	  function	  of	  this	  
chamber	  is	  impaired.	  Nonetheless,	  this	  approach	  raises	  the	  tantalising	  prospect	  of	  using	  “sub-­‐
pulmonary	  RV	  CRT”	  to	  improve	  RV	  performance	  and	  clinical	  endpoints	  in	  outpatient	  populations.	  	  	  
	  
A	  recent	  prospective	  study	  from	  France	  examined	  the	  effects	  of	  stand	  alone	  RV	  pacing	  and	  
biventricular	  stimulation	  in	  eight	  patients	  with	  repaired	  ToF	  (RV	  apex	  only)	  and	  12	  surgically	  created	  
swine	  models	  	  (RV	  apical,	  lateral	  or	  anterior	  wall)92.	  	  In	  these	  animal	  models,	  biventricular	  
stimulation	  was	  associated	  with	  improved	  LV	  and	  RV	  dP/dt	  (n=7)	  as	  measured	  invasively,	  compared	  
with	  RV	  pacing	  alone.	  	  A	  further	  five	  animals	  underwent	  electroanatomic	  mapping	  and	  a	  significant	  
decrease	  in	  dyssynchrony	  was	  found	  with	  biventricular	  pacing	  as	  measured	  by	  echocardiography.	  	  
The	  eight	  adults	  studied	  with	  repaired	  TOF	  all	  had	  RV	  dysfunction,	  QRS	  prolongation	  and	  a	  measure	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of	  pulmonary	  regurgitation.	  	  Biventricular	  stimulation	  resulted	  in	  improvements	  in	  both	  RV	  and	  LV	  
dP/dt	  compared	  to	  sinus	  rhythm	  (p<0.05),	  though	  RV	  activation	  alone	  also	  decreased	  RV	  dP/dt.	  	  QRS	  
duration	  was	  noted	  to	  broaden	  from	  baseline	  with	  RV	  pacing,	  but	  decreased	  when	  biventricular	  
pacing	  was	  applied.	  	  These	  patients	  did	  not	  undergo	  electroanatomic	  mapping	  and	  LV	  function	  was	  
not	  defined.	  	  This	  latter	  is	  relevant	  given	  that	  the	  superiority	  of	  biventricular	  pacing	  over	  stand	  alone	  
RV	  pacing	  described	  suggests	  possible	  associated	  LV	  impairment.	  	  Further,	  there	  is	  no	  evidence	  to	  
suggest	  that	  RV	  apical	  activation	  was	  delayed	  with	  respect	  to	  the	  rest	  of	  the	  RV	  myocardium.	  	  Future	  
studies	  to	  elucidate	  electrical	  activation	  at	  the	  RV	  and	  target	  delivery	  are	  necessary,	  as	  well	  as	  
delineating	  between	  those	  with	  associated	  LV	  dysfunction.	  
	  
Several	  studies	  have	  also	  confirmed	  that	  across	  all	  patient	  groups	  with	  CHD,	  including	  those	  with	  
ToF,	  surgery	  is	  linked	  to	  a	  decrease	  in	  ventricular	  contractile	  function,	  most	  marked	  on	  the	  second	  
post-­‐operative	  day93.	  	  A	  sub-­‐group	  of	  patients	  with	  ToF	  also	  have	  a	  significantly	  poorer	  post-­‐
operative	  course,	  linked	  to	  a	  restrictive	  cardiac	  physiology,	  requiring	  longer	  intensive	  care	  recovery	  
with	  prolonged	  inotropic	  support94.	  	  The	  application	  of	  acute,	  temporary,	  CRT	  in	  these	  patients	  
would	  also	  be	  beneficial	  should	  appropriate	  targets	  be	  found	  for	  delivery.	  	  
	  
4. Outcome	  in	  CHD:	  The	  rationale	  for	  risk	  stratification	  
Morbidity	  and	  mortality	  statistics	  for	  adults	  with	  CHD	  necessarily	  differ	  between	  the	  heterogeneous	  
anatomical	  cohorts	  studied.	  	  Even	  within	  similar	  physiologic	  substrates,	  different	  surgical	  techniques	  
and	  ongoing	  advances	  further	  dictate	  that	  outcomes	  will	  vary.	  	  Regardless,	  it	  is	  established	  that	  
compared	  to	  their	  age-­‐matched	  healthy	  peers,	  adults	  with	  CHD	  suffer	  significantly	  higher	  burdens	  of	  
morbidity	  and	  premature	  death:	  This	  is	  greatest	  in	  those	  with	  a	  single	  ventricle	  and	  in	  those	  in	  whom	  
the	  morphologic	  RV	  is	  in	  the	  systemic	  position,	  such	  as	  in	  TGA.	  	  	  
	  
In	  this	  latter	  population,	  HF	  and	  SCD	  are	  the	  leading	  causes	  of	  demise,	  with	  the	  average	  age	  at	  death	  
placed	  at	  a	  tragically	  young	  27±7	  years4.	  	  A	  recent	  long-­‐term	  follow-­‐up	  study	  found	  that	  HF	  
accounted	  for	  38%	  of	  deaths	  in	  patients	  with	  TGA,	  and	  SCD	  30%	  of	  deaths5.	  	  Despite	  this	  there	  is	  
very	  little	  evidence	  to	  identify	  those	  at	  risk,	  or	  guide	  the	  timely	  use	  of	  therapeutic	  strategies	  for	  
either	  mode	  of	  demise	  as	  compared	  to	  those	  available	  in	  patients	  with	  acquired	  and	  
cardiomyopathic	  heart	  disease.	  	  Further,	  despite	  objective	  measurements	  of	  sub-­‐maximal	  exercise	  
capacity	  and	  evidence	  of	  cardiac	  dysfunction	  on	  echocardiographic	  and	  magnetic	  resonance	  
imaging,	  it	  is	  common	  to	  encounter	  patients	  at	  all	  levels	  of	  CHD	  who	  subjectively	  feel	  well	  and	  define	  
themselves	  as	  asymptomatic.	  	  This	  suggests	  that	  reliance	  on	  symptoms,	  as	  is	  frequent	  in	  clinical	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practice,	  in	  selecting	  those	  at	  high	  risk	  of	  SCD	  and	  HF	  events	  may	  neglect	  an	  important,	  and	  possibly	  
large,	  group	  of	  patients	  who	  would	  benefit	  from	  early	  and	  targeted	  therapeutic	  intervention.	  	  	  	  
	  
	  
4.1	  Definition	  and	  Incidence	  
4.1.1	  Heart	  Failure	  
Heart	  failure	  is	  a	  syndrome	  with	  systemic	  implications	  in	  which	  the	  heart	  is	  unable	  to	  supply	  
sufficient	  blood	  flow	  to	  meet	  the	  demands	  of	  the	  body.	  	  It	  is	  a	  common	  condition	  in	  the	  general	  
population,	  affecting	  2%	  of	  adults,	  and	  6-­‐10%	  of	  those	  aged	  over	  65	  years95.	  	  In	  the	  western	  world,	  
the	  commonest	  causes	  are	  ventricular	  dysfunction	  (through	  ischaemic	  or	  other	  cardiomyopathy)	  and	  
hypertension.	  	  Extensive	  research	  into	  the	  pathophysiology	  of	  HF	  has	  led	  to	  improved	  treatment	  
options	  and	  decreased	  mortality:	  The	  use	  of	  β-­‐blockers	  and	  angiotensin-­‐converting	  enzyme	  
inhibitors	  specifically,	  have	  improved	  survival	  by	  decreasing	  both	  sudden	  deaths	  and	  progressive	  HF	  
deaths.	  	  CRT,	  as	  discussed,	  has	  revolutionised	  device	  therapy	  of	  HF.	  	  Several	  evidence	  based	  
guidelines	  exist	  for	  the	  diagnosis	  and	  treatment	  of	  HF	  in	  those	  without	  congenital	  heart	  disease	  both	  
in	  Europe96,97	  and	  the	  United	  States98.	  	  	  
	  
In	  patients	  with	  CHD,	  HF	  can	  be	  acute	  or	  chronic.	  	  The	  underlying	  cause	  tends	  to	  be	  varied	  and	  often	  
multifactorial.	  	  Most	  often	  acute	  HF	  occurs	  in	  the	  post-­‐operative	  period	  in	  children	  and	  adults	  
following	  either	  primary	  repair,	  palliative	  surgery	  or	  other	  later	  surgical	  interventions.	  	  Studies	  
suggest	  that	  those	  anatomies	  requiring	  greater	  surgical	  intervention	  (such	  as	  ventricular	  septal	  
defect	  repair	  over	  atrial	  septal	  defect)	  are	  associated	  with	  the	  greatest	  post-­‐operative	  impairment	  of	  
ventricular	  myocardial	  systolic	  performance	  due	  to	  greater	  intra-­‐operative	  trauma93.	  	  On	  occasion	  
however,	  it	  is	  surgery	  that	  is	  required	  to	  alleviate	  HF	  in	  those	  with	  very	  complex	  anatomy,	  as	  in	  
hypoplastic	  left	  heart	  syndrome.	  	  Acute	  post-­‐operative	  HF,	  though	  far	  from	  benign,	  is	  often	  transient	  
and	  ventricular	  function	  does	  improve.	  	  	  
	  
Chronic	  HF	  is	  a	  pervasive	  disease	  in	  CHD;	  it	  has	  been	  proposed	  that	  CHD	  in	  fact	  forms	  the	  
quintessential	  HF	  syndrome99,	  fulfilling	  as	  it	  does	  several	  criteria	  for	  diagnosis,	  including	  structural	  
cardiac	  abnormality,	  neurohormonal	  activation	  and	  objective	  exercise	  intolerance.	  	  HF	  may	  result	  
from	  dysfunction	  of	  either	  the	  left	  or	  right	  ventricle,	  whether	  these	  latter	  be	  subpulmonary	  or	  
systemic	  in	  nature,	  or	  both55,56.	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Smaller	  population	  numbers	  contributes	  to	  a	  paucity	  of	  data	  in	  determining	  factors	  that	  predict	  HF	  
death	  in	  the	  CHD	  population:	  Currently,	  methods	  of	  HF	  prognostication	  are	  taken	  from	  evidence	  
gathered	  in	  those	  with	  acquired	  or	  cardiomyopathic	  heart	  disease	  –	  few	  are	  tested	  in	  the	  adult	  CHD	  
population.	  	  	  
	  
4.1.2	  	  Sudden	  Cardiac	  Death	  
Sudden	  cardiac	  death	  (SCD)	  is	  an	  unexpected	  death	  due	  to	  cardiac	  causes	  which	  occurs	  within	  one	  
hour	  of	  the	  onset	  of	  symptoms	  in	  a	  person	  with	  known	  or	  unknown	  cardiac	  disease.	  	  It	  accounts	  for	  
at	  least	  half	  of	  all	  causes	  of	  cardiovascular	  mortality	  in	  the	  United	  Kingdom.	  	  It	  is	  an	  important	  cause	  
of	  death	  in	  HF,	  and	  ischaemic	  heart	  disease	  is	  the	  most	  prevalent	  aetiology	  in	  adults100.	  	  	  Although	  
mortality	  increases	  with	  increasing	  severity	  of	  symptomatic	  HF,	  rates	  of	  sudden	  death	  are	  greatest	  in	  
those	  with	  mild	  to	  moderate	  HF101.	  	  	  
	  
Although	  medications,	  in	  particular	  β	  blockade,	  can	  significantly	  ameliorate	  risk,	  the	  introduction	  of	  
the	  implantable	  cardioverter	  defibrillator	  (ICD)	  revolutionised	  outcomes	  in	  those	  at	  risk	  of	  SCD.	  	  As	  in	  
the	  general	  HF	  population	  (without	  CHD),	  there	  exists	  a	  broad	  evidence	  base	  to	  guide	  identification,	  
risk	  stratification	  and	  therapeutic	  options	  in	  those	  at	  risk	  of	  primary	  or	  secondary	  sudden	  cardiac	  
death102.	  	  	  
	  
In	  CHD,	  in	  particular	  adults	  with	  a	  systemic	  RV,	  SCD	  is	  often	  due	  to	  malignant	  tachyarrhythmia103.	  	  
Predicting	  which	  patients	  are	  at	  risk	  of	  such	  arrhythmias	  remains	  elusive	  –	  in	  clinical	  practice,	  the	  
majority	  of	  patients	  with	  ICDs	  are	  those	  in	  whom	  it	  was	  given	  for	  secondary	  prevention.	  	  The	  use	  of	  
ICD’s	  in	  this	  way	  has,	  mainly,	  been	  extrapolated	  from	  ischaemic	  and	  dilated	  cardiomyopathy	  
literature;	  ICD’s	  for	  primary	  prevention	  has	  a	  less	  clear-­‐cut	  transfer	  value.	  	  	  
	  
Evidence	  from	  patients	  with	  repaired	  ToF	  suggests	  that	  there	  may	  be	  easily	  measured	  surface	  ECG	  
markers	  that	  predict	  risk	  in	  terms	  of	  malignant	  arrhythmia	  and	  SCD,	  including	  prolonged	  QRS	  
duration	  and	  QRS,	  QT	  and	  JT	  dispersions38.	  	  This	  is	  in	  the	  context	  of	  a	  subpulmonary	  RV	  however;	  
early	  research	  in	  patients	  with	  a	  systemic	  RV	  has	  found	  that	  similar	  abnormalities	  may	  be	  relevant	  





Carla	  Plymen	  MD	  (Res)	   Page	  35	  
	  
4.2	  	  Investigative	  tools	  and	  predictors	  of	  outcome	  
4.2.1	  	  Cardiac	  Magnetic	  Resonance	  Imaging	  
Cardiac	  magnetic	  resonance	  imaging	  (CMR)	  is	  a	  tool	  for	  the	  non-­‐invasive	  assessment	  of	  the	  function	  
and	  structure	  of	  the	  cardiovascular	  system.	  	  It	  is	  derived	  from	  and	  based	  on	  the	  same	  basic	  
principles	  as	  magnetic	  resonance	  imaging	  but	  is	  optimised	  for	  use	  in	  the	  cardiovascular	  system:	  This	  
principally	  involves	  the	  use	  of	  ECG	  gating	  (where	  image	  acquisition	  is	  triggered	  by	  the	  R	  wave)	  and	  
rapid	  imaging	  sequences.	  	  Images	  can	  be	  acquired	  in	  several	  different	  planes,	  including	  coronal,	  axial	  
and	  sagittal	  and	  are	  presented	  in	  the	  short	  axis	  view,	  four	  and	  two	  chamber	  views,	  as	  still	  images	  or	  
cines.	  	  CMR	  imaging	  can	  provide	  information	  on	  cardiac	  function	  and	  morphology,	  myocardial	  
viability	  and	  perfusion,	  and	  flow	  and	  velocity	  through	  various	  structures.	  	  Advances	  in	  spatial	  and	  
temporal	  resolution	  and	  increased	  imaging	  speed	  has	  ensured	  that	  CMR	  has	  become	  one	  of	  the	  
most	  valuable	  diagnostic	  tools	  for	  heart	  disease.	  
	  
Although	  echocardiography	  and	  X-­‐ray	  guided	  catheterisation	  remain	  vital	  and	  valuable	  clinical	  tools	  
for	  the	  investigation	  of	  cardiovascular	  disease,	  CMR	  imaging	  is	  now	  being	  used	  in	  many	  centres	  and	  
with	  increasing	  frequency,	  for	  the	  diagnosis	  and	  follow-­‐up	  of	  paediatric	  and	  adult	  patients	  with	  
CHD108,109.	  	  CMR	  provides	  a	  powerful	  investigative	  tool,	  giving	  morphologic	  and	  haemodynamic	  
information	  that	  echocardiography	  and	  catheterisation	  alone	  do	  not	  provide:	  Extracardiac	  anatomy,	  
including	  the	  great	  arteries,	  systemic	  and	  pulmonary	  veins,	  can	  be	  delineated	  with	  high	  spatial	  
resolution,	  in	  any	  imaging	  plane,	  irrespective	  of	  body	  habitus.	  	  Vascular	  and	  valvular	  flow	  patterns	  
and	  volumes	  can	  be	  assessed110,	  shunts	  can	  be	  quantified111	  and	  myocardial	  function	  can	  be	  
measured	  accurately	  and	  with	  high	  reproducibility112,	  regardless	  of	  ventricular	  morphology.	  	  Finally	  
CMR	  surpasses	  both	  catheterisation	  and	  echocardiography	  in	  providing	  high	  resolution,	  isotropic	  
three	  dimensional	  data	  sets	  (Figure	  9).	  	  This	  allows	  for	  reconstruction	  of	  data	  in	  any	  anatomical	  
imaging	  plane,	  giving	  complete	  visualisation	  of	  complex	  congenital	  cardiac	  anomalies	  without	  the	  
use	  of	  ionising	  radiation.	  
	  
The	  asymmetric	  morphology	  of	  the	  RV,	  the	  anterior	  location	  of	  the	  ventricle	  and	  the	  coarse	  
endocardial	  trabeculations	  renders	  echocardiographic	  assessment	  of	  this	  chamber	  difficult.	  	  CMR	  is	  
currently	  the	  gold	  standard	  imaging	  method	  of	  accurately	  assessing	  RV	  volumes	  and	  ejection	  
fraction113.	  	  However	  there	  remains	  much	  inter-­‐centre	  variation	  in	  the	  specific	  post-­‐processing	  
methods	  by	  which	  to	  measure	  the	  ventricle	  after	  imaging,	  and	  no	  universal,	  standardised	  method	  
has	  yet	  been	  agreed114.	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Figure	  9:	  These	  are	  images	  of	  a	  typical	  adult	  patient	  late	  after	  the	  Senning	  procedure	  for	  TGA.	  The	  images	  are	  
created	  from	  data	  acquired	  using	  the	  3D	  “whole-­‐heart”	  sequence.	  This	  image	  data	  is	  a	  white	  blood	  sequence,	  
with	  data	  acquired	  in	  isotropic	  voxels,	  during	  the	  diastolic	  phase	  of	  the	  cardiac	  cycle.	  This	  enables	  multiplanar	  
reformatting	  in	  any	  plane	  and	  allows	  detailed	  morphological	  analysis.	  These	  images	  are	  thin	  maximal	  intensity	  
projections	  in	  3	  planes:	  
a)	  Through	  the	  superior	  and	  inferior	  caval	  baffles	  (*short	  and	  long	  white	  arrows,	  respectively)	  
b)	  Through	  the	  ventricles,	  in	  a	  4	  chamber	  view,	  and	  showing	  the	  pulmonary	  venous	  connection	  to	  the	  RV.	  
c)	  Through	  the	  ventricles	  in	  the	  outflow	  tract	  view,	  showing	  the	  aorta	  arising	  from	  the	  morphological	  RV	  and	  
the	  pulmonary	  artery	  arising	  from	  the	  LV.	  




Long-­‐term	  outcome	  in	  adults	  with	  atrial	  switch	  palliation	  of	  TGA	  is	  known	  to	  relate	  to	  the	  function	  of	  
the	  systemic	  RV16.	  	  Despite	  being	  the	  most	  accurate	  and	  reproducible	  tool	  for	  assessing	  this,	  CMR	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imaging	  is	  time	  consuming	  and	  availability	  is	  often	  restricted	  to	  specialist	  centres	  and	  specialist	  
operators.	  	  Moreover,	  referral	  tends	  to	  be	  prompted	  on	  clinical	  grounds	  in	  a	  population	  of	  patients	  
who	  notoriously	  underreport	  symptoms	  and	  functional	  ability115.	  	  In	  addition,	  there	  is	  a	  high	  
prevalence	  of	  implanted	  pacing/defibrillator	  devices	  in	  this	  population	  and	  the	  small	  but	  significant	  
proportion	  of	  patients	  with	  claustrophobia	  can	  also	  limit	  its	  use.	  	  	  The	  development	  and	  validation	  of	  
surrogate	  clinical	  markers	  that	  relate	  to	  ventricular	  function	  as	  determined	  by	  CMR	  would	  
consequently	  be	  highly	  desirable.	  
	   	  
4.2.2	  	  Electrocardiography	  
Electrocardiography	  is	  a	  simple,	  cheap	  and	  easily	  reproducible	  tool	  frequently	  available	  in	  the	  
outpatient	  setting.	  	  It	  is	  a	  painless	  investigation	  that	  records	  potential	  differences	  between	  defined	  
sites	  on	  the	  body	  surface	  that	  vary	  during	  the	  cardiac	  cycle,	  providing	  information	  about	  heart	  rate	  
and	  heart	  rhythm,	  as	  well	  as	  several	  other	  parameters	  of	  repolarisation	  and	  depolarisation.	  	  	  
	  
	  
Figure	  10:	  Traditional	  measurements	  on	  the	  surface	  12	  lead	  ECG.	  	  Image	  courtesy	  of	  Heart	  Rhythm	  Guide,	  ©	  
2013	  
	  
Several	  defined	  parameters	  exist	  that	  are	  routinely	  measured	  on	  a	  12	  lead	  ECG	  (Figure	  10),	  the	  
commonest	  being	  QRS	  duration,	  QTc	  and	  PR	  intervals.	  	  In	  the	  general,	  healthy,	  population	  these	  
parameters	  have	  so-­‐called	  ‘normal’	  ranges	  as	  follows:	  
	   PR	  interval:	  	  120-­‐200ms	  
	   QRS	  duration:	  	  <110-­‐120ms	  
	   QT	  interval:	  	  <420ms	  (Corrected	  QT	  interval	  determined	  by	  dividing	  the	  QT	  interval	  by	  the	  
square	  root	  of	  the	  preceding	  R-­‐R	  interval).	  	  
	  
These	  surface	  ECG	  parameters	  have	  been	  associated	  with	  both	  risk	  of	  malignant	  arrhythmia	  and	  
adverse	  outcome,	  in	  terms	  of	  HF	  and	  SCD.	  	  These	  parameters,	  and	  others,	  are	  well	  established	  in	  the	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general	  adult	  population;	  however,	  their	  relevance,	  value	  and	  associated	  relationships	  in	  the	  those	  
with	  CHD	  as	  yet	  remains	  to	  be	  fully	  elucidated.	  
	  
4.2.2.1	  	  QRS	  Duration	  
QRS	  duration	  is	  a	  measurement	  of	  ventricular	  depolarisation,	  and	  prolongation	  of	  this	  parameter	  
beyond	  120ms	  is,	  as	  already	  intimated,	  associated	  with	  adverse	  outcome:	  In	  the	  Framingham	  cohort,	  
longer	  QRS	  duration	  was	  related	  to	  an	  increased	  risk	  of	  later	  HF	  development116	  as	  well	  as	  increased	  
LV	  wall	  mass	  and	  decrease	  in	  LV	  systolic	  function117.	  	  QRS	  duration	  is	  an	  established	  predictor	  of	  all	  
cause	  mortality118,	  including	  SCD119,	  and	  prolongation	  of	  this	  parameter	  has	  been	  incorporated	  into	  
guidelines	  for	  application	  of	  device	  therapy	  for	  HF71,72.	  	  
	  
Within	  the	  CHD	  population,	  the	  most	  extensively	  studied	  cohort	  are	  those	  with	  repaired	  ToF.	  	  
Gatzoulis	  et	  al	  describe	  a	  significant	  risk	  of	  death	  and	  malignant	  tachyarrhythmias	  in	  those	  with	  QRS	  
duration	  >180ms51,	  and	  in	  this	  substrate	  QRS	  duration	  is	  related	  to	  increasing	  RV	  EDV	  associated	  
with	  progressive	  PR;	  in	  some	  cohorts	  QRS	  duration	  has	  been	  found	  to	  shorten	  with	  successful	  
haemodynamic	  correction43–	  though	  this	  is	  not	  a	  universal	  finding41,120	  .	  	  All	  cohorts	  so	  far	  studied	  
with	  this	  substrate	  have	  undergone	  surgical	  correction	  of	  PR,	  and	  it	  is	  possible	  that	  concurrent	  
myocardial	  stunning	  and	  injury	  suffered	  at	  the	  time	  of	  surgery	  affects	  this	  outcome	  variable:	  The	  
availability	  of	  percutaneous	  intervention	  to	  correct	  pulmonary	  valvular	  insufficiency	  or	  stenosis	  
provides	  an	  excellent	  opportunity	  to	  study	  the	  electrical	  effects	  without	  the	  added	  confounding	  
affects	  of	  surgery.	  	  It	  might	  be	  expected	  that	  if	  QRS	  duration	  relates	  to	  risk	  of	  ventricular	  arrhythmia,	  
then	  correction	  of	  an	  aggravating	  haemodynamic	  pathology	  might	  ameliorate	  this	  risk	  –	  this	  has	  yet	  
to	  be	  positively	  verified42.	  
	  
Schwerzmann	  and	  colleagues	  describe	  an	  increased	  rate	  of	  death	  in	  those	  with	  a	  QRS>140ms	  and	  
previous	  Mustard	  palliation	  of	  TGA105;	  however,	  other	  studies	  have	  not	  described	  any	  difference	  in	  
QRS	  duration	  in	  those	  who	  suffered	  a	  SCD	  versus	  those	  who	  did	  not	  with	  similar	  palliative	  
operation106,107.	  	  	  
	  
4.2.2.2	  	  QRS	  dispersion	  
QRS	  dispersion	  (QRSd)	  is	  the	  measurement	  obtained	  when	  subtracting	  the	  narrowest	  QRS	  duration	  
in	  any	  of	  the	  12	  leads	  from	  the	  broadest.	  	  Whilst	  still	  an	  indicator	  of	  ventricular	  depolarisation,	  QRSd	  
provides	  information	  concerning	  the	  heterogeneity	  of	  this	  event,	  but	  is	  not	  routinely	  measured	  as	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part	  of	  the	  12	  lead	  examination.	  	  QRSd	  has	  been	  found	  to	  be	  associated	  with	  LV	  systolic	  function121,	  
and	  with	  increased	  risk	  of	  sudden	  death122,123.	  
	  
In	  adults	  with	  ToF,	  the	  association	  of	  a	  QRS>180ms	  with	  a	  prolonged	  QRSd	  (>35ms)	  was	  determined	  
to	  be	  a	  highly	  specific	  and	  sensitive	  marker	  of	  identifying	  those	  at	  risk	  of	  sustained	  ventricular	  
tachycardia.	  	  Certainly	  in	  adults	  with	  both	  ToF	  and	  TGA,	  QRSd	  was	  found	  to	  increase	  with	  time	  of	  
follow-­‐up36;	  however,	  no	  further	  studies	  have	  as	  yet,	  been	  undertaken	  to	  ascertain	  relationship	  of	  
this	  parameter	  with	  other	  variables,	  or	  indeed	  further	  consolidate	  predictive	  risk.	  	  
	  
4.2.2.3	  QT	  interval	  
The	  QT	  interval	  is	  defined	  as	  the	  interval	  from	  the	  onset	  of	  the	  QRS	  complex	  (onset	  of	  ventricular	  
depolarisation)	  to	  the	  end	  of	  the	  T	  wave	  (end	  of	  ventricular	  repolarisation)	  and	  as	  such	  is	  an	  
indicator	  of	  ventricular	  depolarisation	  and	  repolarisation.	  	  Measurement	  is	  usually	  corrected	  for	  
heart	  rate,	  and	  presented	  as	  QTc.	  	  Prolongation	  of	  QTc	  interval	  >500ms	  is	  associated	  with	  risk	  of	  
malignant	  ventricular	  arrhythmia,	  specifically	  torsade	  des	  pointes,	  and	  subsequent	  possible	  
degeneration	  to	  ventricular	  fibrillation.	  	  	  
	  
In	  those	  with	  genetic	  abnormalities,	  most	  notably	  long	  QT	  syndrome,	  QTc	  prolongation	  is	  an	  
established	  risk	  factor	  for	  malignant	  arrhythmia	  and	  SCD.	  	  In	  such	  high-­‐risk	  families,	  QTc	  
prolongation	  can	  be	  profound,	  and	  the	  underlying	  pathology	  due	  to	  ion	  channel	  dysregulation.	  	  	  
	  
In	  those	  without	  a	  genetic	  basis	  for	  disease,	  QTc	  interval	  prolongation	  tends	  to	  be	  less	  excessive.	  	  
Certainly	  medications	  can	  cause	  problems,	  specifically	  some	  anti-­‐arrhythmics,	  anti-­‐histamines	  and	  
antibiotics,	  and	  several	  have	  been	  withdrawn	  as	  a	  result	  (Cisapride).	  	  In	  the	  general	  population;	  
however,	  with	  HF	  and/or	  ischaemic	  heart	  disease,	  the	  relevance	  of	  QTc	  prolongation	  to	  risk	  remains	  
unclear:	  the	  UK-­‐HEART	  study	  from	  the	  end	  of	  the	  last	  decade	  looked	  at	  500	  patients	  followed	  up	  for	  
an	  average	  of	  2	  years,	  and	  determined	  no	  relation	  of	  QTc	  interval	  to	  risk	  of	  progressive	  HF,	  SCD	  or	  all	  
cause	  mortality124.	  	  A	  subsequent	  qualitative	  overview	  of	  7	  prospective	  studies	  found	  QTc	  interval	  to	  
not	  be	  a	  reliable	  indicator	  of	  future	  risk,	  even	  in	  those	  with	  established	  cardiovascular	  disease125.	  	  
However,	  when	  prolongation	  occurs	  alongside	  an	  elevated	  BNP	  >400pg/mL	  in	  those	  with	  established	  
HF,	  QTc	  interval	  becomes	  a	  strong	  independent	  predictor	  of	  risk126.	  
	  
There	  is	  very	  little	  literature	  regarding	  QTc	  in	  those	  with	  CHD.	  	  Certainly	  Roos-­‐Hesselink	  and	  
colleagues16	  found	  that	  QTc	  interval	  did	  not	  prolong	  with	  long-­‐term	  follow	  up	  in	  adults	  with	  Mustard	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palliation	  of	  TGA.	  	  Kammeraad	  et	  al	  found	  no	  significant	  difference	  in	  QTc	  interval	  in	  similar	  adults	  
who	  had	  suffered	  a	  sudden	  death	  compared	  to	  those	  that	  had	  not107.	  	  Both	  studies	  involved	  small	  
cohort	  sizes;	  further	  study	  will	  be	  necessary	  to	  establish	  whether	  this	  parameter	  carries	  any	  
prognostic	  information.	  
	  
4.2.2.4	  QT	  dispersion	  
QT	  dispersion	  (QTd)	  is	  the	  difference	  between	  the	  QT	  interval	  at	  its	  maximal	  and	  least	  duration	  
across	  all	  12	  ECG	  leads.	  	  It	  is	  an	  indirect	  measure	  of	  inhomogeneity	  of	  ventricular	  repolarisation127	  
and	  is	  associated	  with	  both	  frequency	  of	  ventricular	  ectopy	  post	  acute	  myocardial	  infarct128,	  
incidence	  of	  ventricular	  tachycardia	  and	  fibrillation129	  and	  mortality	  in	  HF122.	  	  In	  a	  large	  prospective	  
study	  of	  American	  Indians,	  QTd	  was	  found	  to	  be	  a	  significant	  predictor	  of	  all-­‐cause	  and	  
cardiovascular	  mortality	  in	  univariate	  Cox	  analysis130.	  	  	  
	  
Its	  role	  as	  a	  marker	  or	  substrate	  for	  arrhythmogenesis	  remains	  controversial	  however131,	  and	  it	  does	  
not	  yet	  form	  a	  routine	  part	  of	  surface	  ECG	  assessment132.	  	  As	  a	  marker	  of	  heterogeneity	  of	  
myocardial	  repolarisation	  however,	  and	  as	  such	  a	  potential	  marker	  of	  underlying	  malignant	  
tachyarrhythmia,	  QTd	  measurement	  remains	  an	  important	  and	  widely	  used	  research	  tool.	  	  Normal	  
values	  are	  generally	  quoted	  as	  being	  between	  30-­‐60ms133,134,135.	  
	  
As	  a	  marker	  of	  risk	  in	  CHD,	  several	  studies	  have	  positively	  linked	  QTd	  to	  malignant	  arrhythmia	  and	  
outcome	  in	  both	  ToF103	  and	  TGA106,52;	  however,	  these	  results	  have	  not	  been	  consistent	  with	  
Kammeraad	  and	  colleagues	  finding	  no	  significant	  difference	  in	  QTd	  in	  those	  with	  TGA	  that	  suffered	  a	  
SCD	  compared	  to	  those	  whom	  had	  not107.	  	  Further	  research	  is	  required	  to	  establish	  whether	  this	  
measurement	  of	  repolarisation	  heterogeneity	  can	  indeed	  provide	  valuable	  prognostic	  information.	  	  
	  
4.2.2.5	  	  JT	  dispersion	  
	  JT	  dispersion	  (JTd)	  is	  the	  difference	  between	  the	  maximal	  and	  minimal	  JT	  durations	  across	  a	  12	  lead	  
ECG.	  	  Less	  literature	  exists	  on	  this	  parameter,	  again,	  not	  routinely	  used	  in	  ECG	  assessment.	  	  As	  
another	  marker	  of	  heterogeneity	  of	  repolarisation,	  it	  has	  also	  been	  linked	  to	  risk	  of	  malignant	  
tachyarrhythmias136;	  in	  children	  with	  long	  QT	  syndrome,	  JTd	  >55ms	  was	  linked	  with	  risk	  of	  
ventricular	  tachyarrhythmias137.	  	  Increased	  JTd	  has	  also	  been	  associated	  with	  hypertension	  and	  LV	  
wall	  mass138.	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Gatzoulis	  and	  co-­‐workers	  also	  studied	  this	  parameter	  and	  found	  that	  when	  >65ms	  in	  association	  
with	  a	  QRS	  >180ms	  it	  was	  highly	  specific	  and	  sensitive	  in	  determining	  risk	  of	  sustained	  VT38.	  
	  
4.2.3	  N	  Terminal-­‐pro	  Brain	  Natriuretic	  Peptide	  
Neurohormonal	  activation	  characterises	  the	  chronic	  heart	  failure	  syndrome139.	  	  Several	  systems	  exist	  
to	  combat	  the	  pathophysiological	  consequences	  of	  heart	  failure,	  including	  the	  sympathetic	  nervous	  
system,	  the	  renin-­‐angiotensin-­‐aldosterone	  system,	  the	  kallikrein-­‐kininogen-­‐kinin	  system,	  the	  
vasopressinergic	  system,	  the	  natriuretic	  peptide	  systems	  and	  endothelin.	  	  Of	  these,	  the	  natriuretic	  
peptide	  system	  has	  been	  most	  extensively	  studied.	  
	  
NT-­‐pro	  Brain	  Natriuretic	  Peptide	  (NT-­‐proBNP)	  is	  a	  76	  amino	  acid	  protein	  synthesized	  and	  released	  
into	  the	  circulation	  by	  the	  ventricular	  myocardium	  in	  increased	  quantities	  under	  conditions	  of	  
cardiac	  haemodynamic	  stress.	  	  It	  is	  an	  inactive	  protein,	  cleaved	  from	  its	  precursor	  pro-­‐BNP,	  and	  co-­‐
secreted	  alongside	  its	  active	  cousin,	  BNP	  (Figure	  11).	  	  The	  half-­‐life	  of	  NT-­‐proBNP	  is	  1.5	  to	  2	  hours	  
versus	  20	  minutes	  for	  BNP.	  	  The	  physiologic	  actions	  of	  natriuretic	  peptides	  include	  lowering	  systemic	  
vascular	  resistance	  and	  central	  venous	  pressure,	  and	  increasing	  natriuresis,	  thereby	  causing	  a	  
decrease	  in	  both	  blood	  volume	  and	  cardiac	  output.	  
	  
Figure	  11:	  ProBNP	  cleaved	  into	  (inactive)	  NT-­‐proBNP	  and	  (active)BNP.	  	  Image	  from	  Hall	  C	  Eur	  J	  Heart	  Fail	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In	  acquired	  and	  cardiomyopathic	  heart	  failure,	  BNP	  is	  a	  reliable	  predictor	  of	  all	  cause	  mortality	  
and/or	  HF	  admission.	  	  It	  has	  an	  established	  role	  in	  detecting	  asymptomatic	  left	  ventricular	  
dysfunction	  in	  high	  risk	  populations140,	  predicting	  cardiovascular	  events	  in	  those	  with	  preserved	  
ventricular	  function141,	  and	  providing	  prognostic	  information	  with	  serial	  measurement142.	  	  BNP	  levels	  
correlate	  with	  modalities	  commonly	  used	  for	  HF	  diagnosis	  and	  monitoring	  of	  disease	  
progression143,144,145.	  	  Further,	  BNP	  has	  a	  major	  role	  in	  excluding	  left	  ventricular	  dysfunction	  and	  HF	  in	  
those	  in	  whom	  there	  is	  diagnostic	  doubt,	  leading	  to	  the	  incorporation	  of	  this	  haemodynamic	  marker	  
into	  European	  guidelines	  for	  HF	  diagnosis96.	  	  Further,	  a	  meta-­‐analysis	  of	  published	  literature	  
concluded	  that	  BNP	  is	  also	  a	  powerful	  indicator	  of	  SCD	  and	  risk	  of	  malignant	  arrhythmia,	  
independent	  of	  reduced	  LV	  ejection	  fraction146.	  	  	  
	  
BNP	  levels	  have	  been	  found	  to	  correlate	  significantly	  with	  increasing	  age	  and	  decreasing	  creatinine	  
clearance.	  	  Although	  levels	  are	  generally	  consistently	  higher	  in	  females	  than	  males,	  a	  significant	  
difference	  between	  the	  two	  genders	  has	  not	  been	  established.	  	  	  
	  
In	  mixed	  cohorts	  of	  patients	  with	  CHD,	  BNP	  has	  been	  shown	  to	  relate	  to	  systemic	  ventricular	  
function	  as	  determined	  by	  echocardiography	  (Figure	  12)147	  and	  to	  function	  of	  the	  pressure	  
overloaded	  systemic	  and	  sub-­‐pulmonary	  RV	  as	  determined	  by	  CMR148.	  	  The	  role	  and	  applicability	  of	  
BNP	  in	  adults	  with	  a	  systemic	  RV,	  specifically	  TGA	  corrected	  by	  atrial	  redirection	  surgery,	  has	  had	  
early,	  encouraging	  results149,150:	  BNP	  levels	  have	  been	  shown	  to	  relate	  to	  the	  severity	  of	  tricuspid	  
regurgitation	  and	  RV	  volume	  overload	  following	  Mustard	  and	  Senning	  surgery149,151,152;	  Tulevski	  and	  
colleagues	  included	  9	  patients	  with	  TGA	  palliated	  by	  Mustard	  or	  Senning	  procedure	  in	  a	  
heterogeneous	  group	  and	  found	  that	  RVEF,	  measured	  by	  CMR,	  correlated	  negatively	  to	  BNP	  levels	  
(r=	  -­‐0.65)148;	  	  Garg	  and	  co-­‐workers	  found	  no	  correlation	  between	  RVEF	  and	  BNP	  in	  patients	  with	  
systemic	  RV	  physiology,	  although	  there	  was	  a	  strong	  correlation	  with	  atrial	  natriuretic	  peptide	  
(ANP);	  a	  somewhat	  surprising	  result	  as	  both	  ANP	  and	  BNP	  correlate	  exceptionally	  closely	  (r=0.91,	  
P<0.0001)	  in	  adults	  with	  congenital	  heart	  disease153.	  	  	  
	  
Although	  similar	  relationships	  between	  BNP	  levels	  and	  RV	  volumes	  have	  also	  been	  described	  in	  the	  
context	  of	  sub-­‐pulmonary	  RV	  anatomy154,	  Neffke	  et	  al	  found	  only	  a	  weak	  correlation	  between	  BNP	  
and	  RVEDV	  in	  a	  heterogeneous	  cohort	  with	  systemic	  or	  subpulmonary	  RV	  physiology36	  suggesting	  
that	  the	  pathophysiological	  responses	  may	  differ	  between	  settings	  and	  should	  perhaps	  be	  
investigated	  in	  isolation.	  	  	  The	  relation	  of	  BNP	  to	  functional	  capacity	  and	  parameters	  of	  RV	  function	  
remain	  to	  be	  elucidated	  however.	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Figure	  12:	  	  BNP	  levels	  according	  to	  NYHA	  functional	  class	  and	  systemic	  ventricular	  impairment	  in	  patients	  with	  
CHD.	  	  Image	  courtesy	  of	  Aidan	  Bolger	  
	  
	  
4.2.4	  Cardio	  Pulmonary	  Exercise	  Testing	  
Cardio	  Pulmonary	  Exercise	  (CPEX)	  testing	  is	  a	  stress	  test	  that	  simultaneously	  assesses	  cardiac	  and	  
respiratory	  function,	  including	  gas	  exchange	  at	  the	  cellular	  level.	  	  During	  the	  CPEX,	  continuous	  12	  
lead	  ECG	  monitoring	  enables	  examination	  of	  myocardial	  ischaemia	  and	  arrhythmia,	  as	  well	  as	  
determination	  of	  heart	  rate	  response	  and	  variability.	  	  Exercise	  is	  undertaken	  on	  a	  treadmill	  or	  cycle	  
ergometer	  and	  a	  gas	  mask	  is	  fitted	  for	  the	  duration.	  	  Computerised	  breath-­‐by-­‐breath	  analysis	  allows	  
quantification	  of	  oxygen	  uptake	  (VO2),	  carbon	  dioxide	  output	  (VCO2)	  and	  determination	  of	  the	  
anaerobic	  threshold.	  	  Outcome	  measures	  are	  scored	  against	  age	  and	  gender	  matched	  controls	  and	  
recorded	  as	  a	  percentage	  of	  the	  predicted	  outcome.	  	  	  
	  
CPEX	  testing	  is	  an	  established	  tool	  in	  pre-­‐operative	  risk	  assessment,	  routinely	  used	  to	  determine	  
cardiorespiratory	  fitness	  in	  select	  patients	  prior	  to	  major	  surgery.	  	  In	  those	  with	  established	  or	  early	  
HF	  it	  is	  used	  to	  determine	  clinical	  status	  as	  well	  as	  for	  risk	  stratification:	  Peak	  VO2	  levels	  of	  less	  than	  
14ml/min/kg	  are	  predictive	  of	  a	  less	  favourable	  outcome,	  independent	  of	  other	  clinical	  and	  
haemodynamic	  findings155,156.	  	  In	  addition,	  the	  ventilatory	  response	  to	  exercise,	  defined	  as	  the	  
relation	  between	  carbon	  dioxide	  production	  (VCO2)	  and	  minute	  ventilation	  (VE),	  also	  relates	  to	  
outcome	  in	  HF,	  providing	  supplemental	  information	  in	  addition	  to	  peak	  VO2157.	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There	  has	  recently	  emerged	  an	  early	  evidence	  base	  for	  all	  cause	  mortality	  among	  adults	  with	  CHD:	  	  
In	  patients	  with	  repaired	  ToF	  peak	  VO2	  and	  VE/VCO2	  slope	  were	  found	  to	  be	  independent	  predictors	  
for	  adverse	  cardiac	  events158,	  and	  peak	  VO2	  recently	  found	  to	  be	  prognostic	  in	  those	  with	  Ebstein’s	  
anomaly159.	  	  In	  a	  cohort	  of	  noncyanotic	  patients,	  Dimopoulous	  et	  al	  determined	  that	  those	  with	  a	  
VE/VCO2	  slope	  >38	  had	  a	  higher	  risk	  of	  dying	  within	  two	  years	  (13%)	  than	  those	  who	  did	  not	  (1%)160.	  	  
Colleagues	  from	  the	  same	  institution	  previously	  published	  their	  finding	  that	  a	  peak	  VO2	  cut-­‐off	  of	  
<15.5ml/kg/min	  was	  associated	  with	  a	  2.9	  fold	  increased	  risk	  of	  admission	  or	  cardiac	  death	  
compared	  to	  those	  who	  achieved	  a	  peak	  VO2	  >15.5ml/kg/min161.	  	  Giardini	  and	  colleagues	  studied	  
adults	  with	  a	  systemic	  RV	  and	  previous	  Mustard	  or	  Senning	  palliation	  and	  proposed	  a	  VE/VCO2	  slope	  
cut-­‐off	  >35.4	  as	  being	  predictive	  of	  four	  year	  mortality	  or	  cardiac	  related	  admission.	  	  In	  this	  study	  
however,	  VE/VCO2	  slope	  was	  related	  to	  the	  age	  of	  the	  patient	  undertaking	  the	  test,	  and	  also	  age	  at	  
original	  palliation162.	  	  Given	  that	  RV	  function	  deteriorates	  with	  age	  at	  follow-­‐up,	  then	  their	  results	  
are	  perhaps	  not	  surprising	  but	  do	  provide	  a	  quantitative	  target.	  	  Further	  useful	  data	  on	  exercise	  
testing	  including	  observation	  and	  calculation	  of	  heart	  rate	  reserve	  and	  chronotropic	  index	  (ChI).	  	  
Both	  have	  been	  found	  to	  provide	  prognostic	  and	  predictive	  outcome	  data	  in	  general	  cohorts	  with	  
CHD	  and	  in	  those	  with	  a	  systemic	  RV161161,163.	  
	  
CPEX	  testing	  is	  a	  highly	  reproducible	  investigation,	  incorporated	  into	  both	  general	  HF	  and	  adult	  CHD	  
guidelines95,164;	  however,	  it	  suffers	  a	  number	  of	  potential	  disadvantages;	  it	  can	  be	  a	  time-­‐consuming	  
and	  expensive	  investigation	  not	  readily	  available	  outside	  of	  tertiary	  centres.	  	  It	  is	  hence	  not	  routinely	  
applicable	  as	  a	  rapid	  diagnostic	  test	  in	  an	  ambulatory	  setting	  of	  a	  HF	  clinic	  despite	  being	  a	  valuable	  
diagnostic	  and	  prognostic	  tool.	  
	  
At	  my	  study	  institution,	  CPEX	  testing	  certainly	  forms	  part	  of	  the	  clinical	  repertoire	  in	  following	  up	  
patients,	  including	  those	  with	  TGA.	  	  However,	  despite	  objective	  measurements	  of	  sub-­‐maximal	  
exercise	  capacity	  and	  evidence	  of	  cardiac	  dysfunction	  on	  echocardiographic	  and	  CMR	  imaging,	  it	  is	  
common	  to	  encounter	  patients	  who	  subjectively	  feel	  well	  and	  define	  themselves	  as	  
asymptomatic115,165.	  	  This	  suggests	  that	  reliance	  on	  symptoms,	  as	  can	  occur	  in	  clinical	  practice,	  in	  
referring	  patients	  for	  further	  investigations	  may	  disregard	  those	  who	  would	  benefit	  from	  early	  and	  
targeted	  therapeutic	  intervention.	  	  	  
	  
4.2.5	  	  Quality	  of	  Life	  Assessment	  	  
The	  Minnesota	  Living	  with	  Heart	  Failure	  Questionnaire	  (MLWHFQ)	  is	  a	  21	  question	  self	  assessment	  
tool	  that	  measures	  the	  effects	  of	  symptoms,	  functional	  limitations	  and	  psychological	  distress	  on	  an	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individual’s	  quality	  of	  life	  (Appendix	  A).	  	  The	  questionnaire	  is	  primarily	  used	  as	  a	  research	  tool	  in	  
adults	  with	  acquired	  heart	  failure;	  however,	  it	  is	  a	  valid	  and	  reliable	  indicator	  of	  the	  impact	  of	  the	  
disease	  on	  a	  patients’	  quality	  of	  life166.	  	  	  
	  
Figure	  13:	  	  Taken	  from	  ‘Overview	  of	  the	  Minnesota	  Living	  with	  Heart	  Failure®	  Questionnaire’	  by	  Thomas	  Rector	  
showing	  the	  relationship	  between	  reported	  self	  assessment	  and	  clinical	  assessment	  of	  functional	  status	  by	  
NYHA	  Class.	  	  	  	  
	  
The	  MLWHFQ	  provides	  the	  clinician	  with	  a	  subjective	  assessment	  of	  function,	  enabling	  recording	  of	  
day-­‐to-­‐day	  limitations	  and	  psychological	  impact	  of	  disease	  as	  compared	  to	  the	  more	  widely	  used	  but	  
objective	  method	  of	  capacity,	  the	  New	  York	  Heart	  Association	  classification.	  
	  
Although	  this	  questionnaire	  has	  not	  been	  validated	  for	  use	  in	  patients	  with	  CHD,	  it	  is	  however,	  a	  
simple	  and	  straightforward	  means	  of	  assessment	  that	  is	  highly	  portable	  and	  inexpensive	  to	  use.	  	  As	  
such	  it	  will	  be	  included	  in	  this	  study	  and	  comparison	  made	  with	  other	  diagnostic	  and	  prognostic	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AIMS	  &	  OBJECTIVES	  
	  
The	  aims	  of	  this	  research	  are	  twofold:	  	  Firstly	  to	  examine	  the	  electromechanical	  interactions	  
occurring	  in	  the	  right	  ventricle	  in	  adults	  with	  congenital	  heart	  disease,	  both	  directly	  via	  
electroanatomic	  mapping,	  and	  indirectly	  via	  measurement	  of	  surface	  electrocardiographic	  
parameters.	  	  Subsequently,	  this	  Thesis	  will	  study	  the	  electromechanical	  consequences	  of	  altering	  RV	  
electrical	  activation	  directly	  by	  targeted	  pacing	  of	  this	  chamber,	  or	  by	  correcting	  underlying	  RV	  
anatomic	  pathophysiology	  in	  isolation.	  
	  
Secondly,	  this	  Thesis	  will	  undertake	  an	  analysis	  of	  current	  status	  and	  functional	  ability	  in	  those	  with	  a	  
systemic	  right	  ventricle	  in	  order	  to	  understand	  and	  develop	  a	  practical	  characterisation	  of	  disease	  
severity	  in	  this	  cohort.	  	  Parameters	  validated	  in	  the	  general	  population	  without	  congenital	  heart	  
disease	  as	  being	  predictive	  of	  risk	  and	  outcome	  will	  be	  applied	  to	  this	  substrate	  and	  include	  
neurohormonal,	  electrocardiographic	  and	  imaging	  tools.	  	  The	  interrelationships	  between	  these	  
markers	  will	  be	  studied.	  
	  
The	  hypotheses	  of	  this	  research	  are	  therefore:	  
1. There	  are	  significant	  changes	  in	  measurable	  surface	  electrical	  parameters	  
following	  isolated	  correction	  of	  abnormal	  haemodynamics.	  	  
2. There	  are	  significant	  changes	  in	  cardiac	  haemodynamics	  with	  targeted	  dual-­‐site	  
RV	  pacing.	  
3. There	  is	  a	  significant	  relationship	  between	  surface	  electrical	  measurements	  and	  
various	  neurohormonal	  and	  imaging	  markers	  of	  heart	  failure	  status.	  
4. Diffuse	  myocardial	  fibrosis	  as	  a	  novel	  imaging	  biomarker	  is	  present	  in	  
significantly	  greater	  quantities	  in	  the	  ventricles	  of	  those	  with	  a	  systemic	  right	  
heart	  compared	  to	  normals.	  	  
5. The	  clinical	  characteristics	  of	  adults	  with	  a	  systemic	  right	  ventricle	  are	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MATERIALS	  AND	  METHODS	  
	  
3.1	  	  Electroanatomic	  mapping	  
Electroanatomic	  mapping	  of	  the	  electrical	  activation	  sequence	  of	  the	  RV	  took	  place	  on	  previously	  
consented	  patients	  intraoperatively,	  following	  completion	  of	  the	  surgical	  procedure.	  	  All	  patients	  
had	  been	  rewarmed	  and	  were	  off	  cardiopulmonary	  bypass.	  	  All	  were	  haemodynamically	  stable,	  in	  
sinus	  rhythm,	  and	  remained	  under	  general	  anaesthesia.	  	  	  
i. A	  unipolar	  electrode	  (Convenience	  6494,	  Medtronic,	  Mn,	  USA)	  was	  placed	  at	  the	  anatomical	  RV	  
apex	  and	  the	  metallic	  sternal	  retractor	  used	  as	  a	  unipolar	  reference.	  	  	  
ii. A	  second	  roving	  unipolar	  electrode	  was	  sequentially	  placed	  at	  preselected	  locations	  on	  the	  
epicardial	  surface	  of	  the	  RV	  as	  determined	  by	  a	  9-­‐point	  grid	  system	  where	  the	  RV	  apex	  was	  point	  
9	  (Figure	  14).	  	  
iii. Unipolar	  electrograms	  were	  recorded	  at	  1000Hz	  	  (LabSystem™	  PRO	  EP	  Recording	  System,	  Bard	  
Clearsign™,	  Bard	  Inc,	  MA,	  USA).	  	  The	  fastest	  downstroke	  of	  the	  unipolar	  electrogram	  (dV/dt	  min)	  
was	  taken	  as	  local	  activation	  and	  times	  of	  roving	  activation	  were	  taken	  in	  comparison	  to	  local	  
activation	  at	  the	  apex.	  	  	  
iv. Unipolar	  pacing	  electrodes	  were	  then	  fixed	  to	  the	  RV	  apex	  and	  at	  the	  latest	  activation	  as	  
determined	  by	  electrophysiological	  mapping.	  	  
v. Two	  further	  atrial	  leads	  were	  placed	  as	  per	  usual	  by	  the	  operating	  surgeon	  prior	  to	  the	  insertion	  
of	  two	  chest	  drains	  and	  closure	  of	  the	  midline	  sternotomy	  in	  the	  usual	  fashion.	  	  	  
	  
	  
Figure	  14:	  	  Pictorial	  representation	  of	  the	  exposed	  RV	  surface	  (right)	  with	  9	  preselected	  areas	  to	  guide	  surgical	  
placement	  of	  the	  epicardial	  electrode.	  	  The	  left	  panel	  shows	  a	  representation	  of	  the	  roaming	  and	  reference	  
EGM	  with	  determination	  of	  activation	  of	  onset.	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3.2 	  Acute	  haemodynamic	  study	  	  
This	  was	  performed	  in	  all	  consented	  patients	  within	  three	  hours	  of	  surgery	  ending.	  	  In	  all	  cases,	  
patients	  were	  haemodynamically	  stable,	  off	  inotropic	  support	  and	  remained	  under	  general	  
anaesthetic	  on	  the	  Intensive	  care	  unit.	  	  There	  were	  no	  pacing	  related	  complications.	  	  	  
i. Invasive	  haemodynamic	  monitoring	  was	  available	  via	  an	  arterial	  line;	  the	  Edwards	  Flotrac	  
System167	  (already	  in	  use	  on	  the	  intensive	  care	  department)	  uses	  peripheral	  arterial	  waveform	  
analysis	  to	  	  present	  continuous	  measures	  of	  cardiac	  output	  (CO),	  cardiac	  index	  (CI),	  stroke	  
volume	  (SV),	  and	  mean	  arterial	  pressure	  (MAP)	  from	  which	  baseline	  and	  study	  measurements	  
were	  derived.	  	  The	  device	  was	  set	  up	  and	  monitored	  pre-­‐,	  intra-­‐	  and	  post-­‐operatively.	  
ii. A	  patient	  return	  electrode	  was	  attached	  to	  the	  patient’s	  lateral	  chest	  wall	  and	  connected	  to	  the	  
pacing	  device	  to	  correct	  for	  unipolar	  pacing	  leads.	  	  	  	  	  
iii. An	  atrial	  epicardial	  pacing	  wire	  was	  connected	  to	  the	  atrial	  port	  of	  the	  external	  pacing	  device	  
(SJM	  3085	  dual	  chamber	  temporary	  pacemaker)	  and	  the	  ventricular	  epicardial	  pacing	  wires	  
were	  connected	  as	  necessary	  so	  as	  to	  subsequently	  generate	  DDD	  RV	  (apical),	  DDD	  RValt	  or	  
DDD	  BiRV	  pacing.	  	  	  	  
iv. Pacing	  order	  was	  determined	  using	  an	  online	  random	  sequence	  generator	  for	  each	  individual	  
patient,	  and	  further	  randomly	  repeated	  at	  each	  site	  three	  times	  to	  take	  into	  account	  normal	  
physiologic	  changes	  that	  may	  occur	  during	  the	  study	  period.	  	  A	  return	  to	  baseline	  was	  allowed	  
between	  each	  period	  of	  pacing.	  	  Pacing	  was	  programmed	  to	  each	  site	  for	  at	  least	  30	  secs	  (max	  1	  
min)	  as	  Flotrac	  interprets	  over	  20	  seconds	  of	  continuous	  data.	  	  	  
v. In	  addition,	  two	  different	  AV	  delays	  at	  20	  msec	  and	  40	  msec	  less	  than	  patients	  own	  intrinsic	  PR	  
interval	  were	  programmed	  at	  each	  site.	  	  Pacing	  was	  repeated	  at	  each	  of	  the	  RV	  sites	  (single	  and	  
dual)	  for	  duration	  30	  secs	  to	  1	  minute	  for	  these	  two	  AV	  delays.	  	  Haemodynamic	  effects	  to	  be	  
monitored	  via	  the	  Edwards’	  Flotrac	  system	  as	  above	  with	  return	  to	  baseline	  between	  pacing	  
periods.	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Therefore	  (in	  random	  order):-­‐	  
	   	   AAI	  
	   	   AAI	  	  
	   	   AAI	  	  	  
	   	   DDD	  RV	  with	  AV	  delay	  minus	  20	  ms	  	  
	   	   DDD	  RV	  with	  AV	  delay	  minus	  40	  ms	  	  
	   	   DDD	  RValt	  with	  AV	  delay	  minus	  20	  ms	  
	   	   DDD	  RValt	  with	  AV	  delay	  minus	  40	  ms	  	  
	   	   DDD	  BiRV	  with	  AV	  delay	  minus	  20	  ms	  	  
	   	   DDD	  BiRV	  with	  AV	  delay	  minus	  40	  ms	  	  
	  
	  
3.3	  	  	  	  Sub-­‐acute	  echocardiographic	  study	  
On	  post-­‐operative	  day	  3	  or	  day	  4,	  patients	  were	  again	  assessed	  but	  on	  this	  occasion	  under	  
echocardiographic	  guidance	  and	  with	  a	  conscious	  patient.	  	  There	  were	  no	  pacing-­‐related	  
complications.	  	  Baseline	  echocardiography	  (without	  pacing)	  was	  performed	  first	  as	  follows	  by	  the	  
same	  operator	  (JO’L):	  
Left	  ventricular	  function	  
i. Apical	  4	  chamber:	  Tissue	  Doppler	  of	  septal	  and	  lateral	  mitral	  annulus	  
ii. CW	  Doppler	  Aortic	  flow	  (apical	  5	  chamber)	  and	  LV	  outflow	  tract	  diameter	  in	  
parasternal	  long-­‐axis	  view	  for	  stroke	  volume.	  
iii. Measure	  mitral	  inflow	  
Right	  ventricular	  function	  
iv. Apical	  4	  chamber:	  	  Tissue	  Doppler	  of	  lateral	  tricuspid	  annulus.	  
v. Continuous	  wave	  (CW)	  Doppler	  Pulmonary	  flow	  and	  RVOT	  diameter	  in	  
parasternal	  short-­‐axis	  view.	  	  
vi. Measure	  tricuspid	  inflow	  
vii. Pulmonary	  VTI	  	  
viii. Tricuspid	  regurgitation	  jet	  measurements	  for	  RV	  dP/dt168	  
ix. Determine	  severity	  of	  mitral	  and/or	  tricuspid	  regurgitation	  (affects	  stroke	  
volume	  calculations).	  
AV	  delay	  optimisation	  
x. Determine	  LV	  filling	  time	  –	  pulsed	  wave	  Doppler	  of	  mitral	  inflow	  
xi. Aortic	  VTI	  –	  CW	  Doppler	  of	  Aortic	  flow	  (trace	  area)	  
Total	  number	  of	  pacing	  cycles	  –	  21	  –	  
with	   a	   return	   to	   baseline	   between	  
each	  cycle	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Epicardial	  pacing	  wires	  were	  connected	  to	  the	  external	  pacing	  generator	  as	  described	  above	  and	  all	  
pacing	  modes	  again	  undertaken	  randomly.	  	  A	  patient	  return	  electrode	  was	  again	  necessary	  to	  
compensate	  for	  the	  unipolar	  temporary	  pacing	  wires.	  	  
	  
Pacing	  was	  delivered	  as	  previously	  described	  and	  lasted	  long	  enough	  to	  complete	  the	  echo	  protocol	  
(approximately	  3-­‐4	  minutes).	  	  On	  this	  occasion,	  pacing	  cycles	  were	  only	  delivered	  once	  –	  there	  were	  
no	  repeats.	  	  
	  
Therefore	  (in	  random	  order):-­‐	  
	   AAI	  	  
	   DDD	  RV	  with	  AV	  delay	  minus	  20	  ms	  	  	   	   	  
	   DDD	  RV	  with	  AV	  delay	  minus	  40	  ms	  	  
	   DDD	  RValt	  with	  AV	  delay	  minus	  20	  ms	  	  
	   DDD	  RValt	  with	  AV	  delay	  minus	  40	  ms	  	  
	   DDD	  BiRV	  with	  AV	  delay	  minus	  20	  ms	  
	   DDD	  BiRV	  with	  AV	  delay	  minus	  40	  ms	  
	  
Temporary	  pacing	  wires	  were	  removed	  as	  deemed	  clinically	  necessary	  on	  day	  4	  or	  5.	  	  	  
	  
3.4	  	  Electrocardiography	  	  
Twelve	  lead	  electrocardiograms	  (ECG)	  were	  undertaken	  throughout	  this	  Thesis.	  	  The	  settings	  of	  each	  
ECG	  were	  identical	  for	  each	  patient	  (paper	  speed	  25mm/s).	  	  These	  standard	  original	  hard	  copies	  
were	  then	  scanned	  for	  online	  analysis	  using	  the	  CardioCalipers	  program	  (Version	  3.3	  for	  Windows,	  
Iconico,	  New	  York,	  www.iconico.com),	  which	  enabled	  magnification	  for	  greater	  measurement	  
accuracy.	  	  	  
	  
QRS	  duration	  was	  averaged	  for	  each	  ECG	  following	  analysis	  of	  all	  12	  leads,	  and	  defined	  as	  the	  first	  
positive/negative	  deflection	  to	  the	  last	  sharp	  positive/negative	  deflection	  across	  the	  isoelectric	  line.	  	  
QRS	  dispersion	  (QRSd),	  QT	  dispersion	  (QTd)	  and	  JT	  dispersion	  (JTd)	  were	  calculated	  by	  subtracting	  
the	  narrowest	  interval	  from	  the	  longest	  across	  any	  12	  leads.	  	  The	  end	  of	  the	  T	  wave	  was	  defined	  as	  
the	  point	  of	  return	  to	  the	  isoelectric	  line.	  	  QT	  intervals	  were	  averaged	  across	  the	  12	  leads	  for	  each	  




Total	  number	  of	  pacing	  cycles	  –	  9	  –	  
with	   return	   to	   baseline	   between	  
each	  cycle.	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3.5	  	  Blood	  testing	  
Peripheral	  venous	  blood	  samples	  were	  obtained	  from	  all	  participants	  after	  they	  had	  rested	  for	  at	  
least	  20	  minutes.	  Blood	  was	  collected	  into	  tubes	  containing	  EDTA/aprotinin	  and	  lithium/heparin.	  NT-­‐
pro	  brain	  natriuretic	  peptide	  (NT-­‐pro	  BNP)	  samples	  were	  centrifuged	  at	  3000	  rpm	  for	  15	  minutes	  at	  
4°C	  and	  immediately	  analysed	  via	  sandwich	  immunoassay	  using	  electrochemiluminescence	  (E	  170	  
Module,	  Roche	  Diagnostics,	  Basel,	  Switzerland).	  	  For	  all	  subjects,	  renal	  function	  was	  determined	  
using	  routine	  laboratory	  methods.	  
	  
3.6	  	  Cardiopulmonary	  Exercise	  Testing	  
Cardiopulmonary	  exercise	  testing	  (CPEX)	  was	  performed	  on	  an	  electronically	  braked	  ergometer	  cycle	  
(Lode,	  Groningen,	  Holland)	  with	  computerised	  breath	  by	  breath	  ventilator	  gas	  analysis	  
(MedGraphics,	  Minnesota,	  USA).	  	  Prior	  to	  exercising,	  height	  and	  weight	  were	  measured	  and	  all	  
sensors	  calibrated.	  	  	  
	  
Patients	  wore	  a	  full	  face	  mask	  connected	  to	  an	  expiratory	  limb	  pneumotachograph,	  allowing	  
sampling	  of	  mouth	  tidal	  PCO2	  and	  PO2.	  	  12-­‐lead	  ECG	  was	  recorded	  at	  rest,	  continuously	  during	  
exercise	  and	  into	  recovery.	  	  	  
	  
Patients	  were	  encouraged	  to	  exercise	  to	  full	  capacity	  on	  an	  incremental	  bike	  protocol.	  	  Workload	  
increased	  at	  15-­‐25	  Watts	  depending	  on	  underlying	  fitness	  level;	  however,	  the	  ramping	  protocol	  
included	  an	  initial	  loadless	  three	  minutes	  of	  cycling	  to	  allow	  equilibration.	  	  Criteria	  for	  ending	  the	  
test	  included	  clinical	  need,	  or	  patient	  exhaustion	  having	  aimed	  for	  or	  achieved	  a	  respiratory	  
exchange	  rate	  >1.01.	  	  A	  period	  of	  active	  recovery	  (slow	  pedalling)	  followed	  maximal	  exertion.	  	  	  
Cuff	  blood	  pressure	  was	  checked	  every	  two	  minutes,	  and	  transvenous	  oxygen	  saturations	  were	  
measured	  continuously	  via	  a	  probe	  positioned	  over	  the	  right	  supraorbital	  artery.	  	  	  
	  
Peak	  oxygen	  uptake	  (VO2),	  anaerobic	  threshold	  (AT)	  and	  ventilatory	  response	  to	  CO2	  production	  
(VE/VCO2)	  were	  derived	  from	  the	  respiratory	  gas	  analysis	  during	  maximal	  exertion.	  	  VE/VCO2	  was	  
measured	  as	  the	  ratio	  at	  the	  AT.	  	  In	  turn,	  AT	  was	  determined	  by	  using	  the	  modified	  V-­‐slope	  method.	  	  
ChI	  was	  calculated	  as	  has	  been	  previously	  described:	  	  	  
(peak	  HR	  –	  resting	  HR)	  
(220-­‐age-­‐resting	  HR)	  
An	  ECG	  taken	  at	  peak	  exercise	  was	  also	  scanned	  for	  online	  analysis	  to	  determine	  QRS	  duration,	  
QRSd,	  QTd,	  JTd	  and	  QTc	  as	  stated	  above.	  	  	  
=	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3.7	  	  Cardiac	  Magnetic	  Resonance	  Imaging	  
Patients	  with	  devices	  or	  other	  metallic	  implants	  did	  not	  undergo	  this	  investigation.	  
Cardiac	  magnetic	  resonance	  (CMR)	  imaging	  was	  performed	  using	  a	  1.5Tesla	  scanner	  (Avanto,	  
Siemens	  Medical,	  Erlangen,	  Germany)	  at	  one	  institution	  (GOSH).	  	  All	  scans	  were	  analysed	  and	  
reported	  by	  one	  person	  experienced	  in	  this	  cohort	  of	  patients	  (MH)	  who	  followed	  a	  set	  protocol	  for	  
each	  scan.	  	  	  
	  
Patients	  were	  formally	  consented	  and	  underwent	  measurements	  for	  height	  and	  weight.	  	  Intravenous	  
cannulation	  at	  the	  left	  antecubital	  fossa	  enabled	  later	  injection	  of	  contrast	  agent	  (Dotarem®	  
279.32mg/ml,	  	  Gadoteric	  acid,	  Guerbet,	  France)	  during	  imaging.	  	  ECG	  monitoring	  took	  place	  
throughout	  the	  scan.	  	  	  
	  
3.7.1	  	  Assessment	  of	  Ventricular	  Volumes	  and	  Function	  Using	  Cine	  MRI	  
Retrospective	  gated	  steady-­‐state	  free	  precession	  cine	  MRI’s	  of	  the	  heart	  were	  acquired	  in	  the	  
vertical	  long-­‐axis,	  4-­‐chamber	  view	  and	  the	  short-­‐axis	  view	  covering	  the	  entirety	  of	  both	  ventricles	  (9	  
to	  12	  slices).	  Image	  parameters	  were	  TR=2.2	  ms;	  TE=1.1	  ms;	  flip	  angle=78°;	  slice	  thickness=6	  to	  8	  
mm;	  matrix=192×312;	  field	  of	  view=300	  to	  380	  mm;	  and	  temporal	  resolution=25	  phases	  acquired	  
during	  a	  single	  breath-­‐hold.	  Assessment	  of	  LV	  and	  RV	  volumes	  was	  performed	  by	  manual	  
segmentation	  of	  short-­‐axis	  cine	  images	  at	  end	  diastole	  and	  end	  systole	  (Argus;	  Siemens	  Medical	  
Systems).	  End	  diastolic	  and	  end	  systolic	  volumes	  were	  calculated	  by	  use	  of	  Simpson’s	  rule	  for	  each	  
ventricle,	  and	  from	  these	  volumes,	  stroke	  volume	  (SV)	  and	  ejection	  fraction	  (EF)	  were	  calculated.	  
Cardiac	  output	  (CO)	  was	  calculated	  by	  multiplying	  the	  effective	  arterial	  forward	  flow	  by	  the	  heart	  
rate.	  	  
	  
3.7.2	  	  MR	  Flow	  Quantification	  
Pulmonary	  artery	  and	  aortic	  flow	  data	  were	  acquired	  by	  use	  of	  a	  flow-­‐sensitive	  gradient-­‐echo	  
sequence	  (TR,	  27	  ms;	  TE,	  3.2	  ms;	  flip	  angle,	  30°;	  slice	  thickness,	  5	  mm;	  and	  matrix,	  256×240)	  during	  
free	  breathing.	  Image	  planes	  were	  located	  at	  the	  midpoint	  of	  the	  main	  PA	  and	  just	  above	  the	  sinus	  
level	  of	  the	  ascending	  aorta.	  	  Through-­‐plane	  flow	  data	  (30	  phases	  per	  cardiac	  cycle)	  were	  acquired	  
by	  use	  of	  retrospective	  cardiac	  gating.	  	  Arterial	  blood	  flow	  was	  calculated	  from	  phase	  contrast	  
images	  by	  use	  of	  a	  semiautomatic	  vessel	  edge-­‐detection	  algorithm	  (Argus;	  Siemens	  Medical	  
Systems)	  with	  operator	  correction.	  	  All	  volume	  and	  flow	  measurements	  were	  indexed	  for	  body	  
surface	  area	  and	  expressed	  in	  mL/beat/m2.	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CHAPTER	  4:	  	  Right	  Ventricular	  electrical	  remodelling	  	  
	  
4.1	  	  Introduction	  
Sudden	  cardiac	  death	  constitutes	  one	  of	  the	  leading	  causes	  of	  death	  in	  all	  patients	  with	  CHD,	  often	  
secondary	  to	  malignant	  cardiac	  arrhythmias4,5.	  	  A	  significant	  association	  between	  the	  risk	  of	  
arrhythmic	  death	  and	  a	  variety	  of	  surface	  ECG	  parameters,	  including	  QRS	  duration,	  QRS,	  QT,	  and	  JT	  
dispersion	  (d)	  has	  been	  shown	  in	  patients	  with	  repaired	  ToF38,51.	  	  In	  this	  subset	  of	  patients	  there	  is	  an	  
established	  correlation	  between	  increasing	  right	  ventricular	  (RV)	  end	  diastolic	  volume	  (EDV)	  and	  QRS	  
duration	  over	  time37,51,55	  secondary	  to	  progression	  of	  pulmonary	  regurgitation	  (PR).	  	  This	  finding	  is	  
not	  limited	  to	  those	  with	  a	  subpulmonary	  RV	  and	  has	  been	  found	  in	  patients	  with	  systemic	  RV	  and	  
chronically	  elevated	  RV	  pressures.	  In	  these	  patients,	  RV	  end	  diastolic	  volumes	  correlated	  with	  QRS	  
duration	  and	  both	  this	  and	  QRSd	  significantly	  increased	  during	  follow-­‐up36.	  	  	  
	  
Surgical	  pulmonary	  valve	  replacement	  (PVR)	  is	  associated	  with	  a	  reduction	  in	  RV	  EDV	  in	  adults	  with	  
severe	  PR39,40,169	  and	  research	  suggests	  that	  this	  leads	  to	  a	  reduction	  in	  QRS	  duration43.	  	  This	  implies	  
that	  reductions	  in	  RV	  volume,	  and	  presumably	  RV	  wall	  stress,	  lead	  to	  electrophysiological	  
remodelling	  when	  chronic	  RV	  dilatation	  is	  reversed.	  	  
	  
Percutaneous	  pulmonary	  valve	  implantation	  (PPVI)	  has	  been	  shown	  to	  be	  a	  safe	  and	  feasible	  
treatment	  option	  for	  RV	  to	  pulmonary	  artery	  conduit	  dysfunction46,	  and	  is	  not	  subject	  to	  the	  
confounding	  effects	  of	  open-­‐heart	  surgery,	  including	  cardiopulmonary	  bypass44,170.	  	  PPVI	  represents	  
a	  pure	  model	  for	  studying	  the	  haemodynamic	  consequences	  of	  RV	  stretch.	  It	  is	  associated	  with	  
positive	  outcomes	  and	  avoids	  incisions	  in	  the	  RV	  which	  could	  promote	  further	  conduction	  block	  and	  
re-­‐entrant	  ventricular	  tachycardia.	  	  Follow-­‐up	  of	  patients	  has	  revealed	  significant	  improvements	  in	  
RV	  EDV	  and	  RV	  systolic	  pressure	  in	  patients	  with	  either	  PR	  or	  outflow	  tract	  obstruction45.	  	  In	  this	  
study,	  I	  investigated	  changes	  in	  ECG	  parameters	  (QRS	  duration,	  QTc,	  QRS/QT/JT	  dispersions)	  
following	  PPVI,	  and	  their	  relationship,	  if	  any,	  to	  RV	  EDV	  and	  RV	  systolic	  pressure.	  
	  
4.2	  	  Methods	  
4.2.1	  	  Study	  population	  
Ninety	  nine	  patients	  were	  included	  in	  this	  prospective	  study.	  	  All	  had	  underlying	  CHD	  with	  
haemodynamically	  significant	  pulmonary	  valve	  lesions	  and	  underwent	  PPVI	  at	  Great	  Ormond	  Street	  
Carla	  Plymen	  MD	  (Res)	   Page	  54	  
	  
Hospital,	  The	  Heart	  Hospital	  or	  Harley	  Street	  Clinic	  (London).	  	  All	  had	  undergone	  previous	  surgical	  
palliation	  or	  repair.	  
	  
PPVI	  occurred	  between	  May	  2001	  and	  July	  2007	  enabling	  at	  least	  one	  year	  follow-­‐up	  in	  all	  subjects.	  	  
Clinical	  and	  morphologic	  inclusion	  criteria	  for	  PPVI	  include:	  RV	  systolic	  pressure	  >2/3	  systemic	  with	  
symptoms,	  RV	  systolic	  pressure	  >3/4	  without	  symptoms,	  moderate	  to	  severe	  PR	  with	  either,	  
symptoms,	  severe	  RV	  dysfunction	  or	  dilatation,	  or	  impaired	  exercise	  capacity171.	  	  RVOT	  diameter	  
measurements	  had	  to	  be	  less	  than	  22x22mm	  and	  greater	  than	  14x14mm.	  	  	  	  	  	  
	  
4.2.2	  Electrocardiogram	  
ECGs	  recorded	  24h	  pre-­‐,	  24h	  post	  and	  1	  year	  post	  PPVI	  were	  analysed.	  	  Electric	  intervals,	  including	  
QRS	  duration,	  QTc	  interval	  and	  QRS/QT	  and	  JT	  dispersion	  were	  calculated	  as	  set	  out	  in	  the	  earlier	  
methods	  section.	  	  Inter-­‐observer	  differences	  were	  compared	  with	  an	  independent	  observer	  who	  
was	  blinded	  in	  a	  similar	  manner	  to	  a	  series	  of	  20	  sample	  study	  ECG’s.	  	  Inter-­‐observer	  differences	  
between	  measured	  electrical	  parameters	  was	  <2.5%.	  	  	  
	  
4.2.3	  	  Echocardiography	  
Pre-­‐	  and	  1	  year	  post-­‐operative	  echocardiography	  reports	  were	  reviewed.	  	  Images	  were	  obtained	  
using	  a	  Vivid	  7	  (GE	  Vingmed,	  Milwaukee,	  Wis)	  by	  operators	  experienced	  in	  scanning	  CHD	  patients	  
who	  followed	  a	  set	  protocol	  for	  each	  patient.	  	  RV	  systolic	  pressure	  (RVSP)	  was	  calculated	  from	  
continuous	  wave	  Doppler	  analysis	  of	  the	  tricuspid	  regurgitant	  jet172.	  	  16%	  (n=16)	  had	  no	  discernable	  
TR	  jet	  and	  were	  not	  included	  in	  this	  analysis;	  89%	  of	  patients	  underwent	  1-­‐year	  follow-­‐up	  
echocardiography.	  	  	  	  
	  
4.2.4	  	  Cardiac	  magnetic	  resonance	  (CMR)	  imaging	  
CMR	  imaging	  was	  performed	  using	  a	  1.5T	  scanner	  (Symphony	  or	  Avanto,	  Siemens	  Medical	  System,	  
Erlangen,	  Germany).	  	  Patients	  underwent	  scans	  prior	  to	  the	  procedure	  and	  at	  1-­‐year	  post-­‐procedure.	  	  
In	  17	  patients	  (17%)	  CMR	  data	  were	  not	  acquired	  due	  to	  pacemaker	  or	  automated	  implantable	  
cardioverter	  defibrillator	  insertion	  (12%)	  or	  scan	  intolerance	  (5%).	  	  CMR	  assessment	  of	  ventricular	  
volumes	  and	  function	  has	  been	  previously	  described44,170.	  	  	  
	  
For	  the	  purpose	  of	  this	  study,	  PR	  was	  defined	  quantitatively	  via	  CMR	  as	  a	  regurgitant	  fraction	  of	  
more	  than	  25%,	  PS	  was	  defined	  as	  an	  RV	  outflow	  velocity	  of	  greater	  than	  3.8m/s	  with	  a	  regurgitant	  
fraction	  of	  less	  than	  25%,	  and	  mixed	  lesions	  comprised	  the	  remainder.	  	  	  The	  17	  patients	  not	  able	  to	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undergo	  MR	  imaging	  had	  valve	  lesion	  severity	  assessed	  qualitatively	  by	  echocardiography	  and/or	  
angiography.	  
	  
4.2.5	  	  Statistical	  analysis	  
Data	  are	  presented	  as	  mean	  ±	  standard	  deviation.	  	  Student’s	  paired	  or	  unpaired	  t-­‐test	  or	  repeated	  
measures	  ANOVA	  were	  used	  to	  analyse	  the	  data	  where	  appropriate.	  	  Repeated	  measures	  ANOVA	  
were	  followed	  by	  Fisher’s	  PLSD	  post-­‐hoc	  analysis,	  all	  t-­‐tests	  with	  Bonferroni	  correction	  as	  necessary.	  	  
Linear	  regression	  analysis	  was	  used	  to	  ascertain	  any	  relationship	  between	  ECG	  parameters	  and	  RV	  
volume.	  	  	  A	  p	  value	  <0.05	  was	  considered	  significant.	  	  Statistical	  analysis	  was	  performed	  using	  
StatView	  statistical	  software	  (SAS	  Institute	  Inc,	  North	  Carolina,	  USA)	  and	  all	  graphs	  produced	  using	  
GraphPad	  Prism	  (version	  5.00	  for	  Windows,	  GraphPad	  Software,	  San	  Diego,	  CA,	  USA,).	  	  	  
	  
Statistical	  analysis	  comprised	  examination	  of	  the	  group	  as	  a	  whole,	  and	  was	  then	  subdivided	  
according	  to	  the	  pulmonary	  valve	  lesion	  (PR,	  PS,	  mixed)	  and	  underlying	  structural	  pathology.	  	  
	  
	  
4.3	  	  Results	  
4.3.1.	  	  Patient	  characteristics	  
Ninety	  nine	  patients	  were	  identified	  for	  inclusion	  to	  this	  study.	  	  Mean	  age	  at	  time	  of	  procedure	  was	  
23.1+/-­‐10	  years,	  60%	  were	  male.	  	  The	  commonest	  pulmonary	  valvular	  lesion	  was	  predominantly	  
stenotic	  (43%),	  followed	  by	  mixed	  (29%)	  and	  then	  predominantly	  regurgitant	  (27%).	  	  The	  most	  
common	  congenital	  diagnosis	  within	  the	  group	  was	  pulmonary	  atresia	  with	  ventriculoseptal	  defect	  
(32%)	  followed	  by	  repaired	  ToF	  (28%).	  	  Others	  included	  transposition	  of	  the	  great	  arteries	  (11%),	  
common	  arterial	  trunk	  (12%),	  congenital	  aortic	  or	  pulmonary	  valve	  disease	  (13%)	  and	  double	  outlet	  
right	  ventricle	  (3%).	  	  No	  patients	  died	  during	  follow-­‐up.	  	  
	  
4.3.2	  	  Electrocardiographic	  data	  
Mean	  pre-­‐procedure	  QRS	  duration	  was	  prolonged	  at	  137±29	  ms	  with	  no	  significant	  change	  at	  any	  
time	  point	  in	  the	  total	  group	  (24	  hour	  133±28ms,	  1	  year	  134±29ms;	  p=0.7)	  (Figure	  15a).	  	  The	  
subgroup	  of	  patients	  with	  a	  pre-­‐procedure	  QRS	  duration	  ≥150ms	  also	  showed	  no	  significant	  change	  
in	  global	  or	  praecordial	  lead	  QRS	  duration	  either	  immediately,	  at	  24h	  or	  1	  year	  post	  PPVI	  (162±9ms,	  
159±12ms,	  160±12ms;	  	  p=0.28)	  (Figure	  15b).	  	  	  
	  
	  














Figure	  15:	  	  No	  significant	  change	  in	  either	  total	  group	  QRS	  duration	  (a)	  or	  in	  those	  with	  pre-­‐procedure	  
QRS>150ms	  (b)	  at	  any	  time	  point	  during	  follow-­‐up.	  	  
	  
When	  QRS	  duration	  was	  assessed	  by	  underlying	  pulmonary	  valvular	  lesion,	  there	  was	  a	  significant	  
reduction	  in	  the	  predominantly	  regurgitant	  group	  at	  one	  1	  year	  (135+/-­‐27	  to	  128+/-­‐29ms;	  p=0.007)	  
(Figure	  16).	  	  Patients	  with	  underlying	  PS	  or	  mixed	  valvular	  lesions	  showed	  no	  significant	  decrease	  in	  














Figure	  16:	  Changes	  in	  QRS	  duration	  with	  follow-­‐up	  within	  the	  pulmonary	  valve	  lesions.	  	  The	  PR	  group	  show	  a	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In	  the	  whole	  group,	  QTc,	  QTd,	  QRSd	  and	  JTd	  shortened	  significantly	  at	  1	  year	  (p≤	  0.001)	  (Figure	  17).	  	  
All	  4	  of	  these	  parameters	  were	  prolonged	  immediately	  post	  procedure	  (JTd	  and	  QTd	  achieving	  
statistical	  significance	  -­‐	  p=0.04;	  p=0.002)	  prior	  to	  shortening	  (Figure	  18).	  	  	  
	  
Figure	  17:	  Total	  mean	  values	  with	  standard	  error	  bars	  for	  QRS,	  JT	  and	  QT	  dispersions	  (left	  axis)	  and	  QTc	  (right	  
axis).	  	  Both	  JTd	  and	  QTd	  show	  significant	  increases	  immediately	  following	  PPVI.	  
	  
When	  comparing	  patients	  according	  to	  valve	  lesion,	  those	  with	  obstructive	  lesions	  had	  a	  significant	  
improvement	  in	  all	  dispersion	  values	  at	  one	  year	  compared	  to	  those	  with	  predominantly	  regurgitant	  
or	  mixed	  lesions	  (Figure	  18).	  	  QTc	  was	  significantly	  lower	  at	  1	  year	  in	  both	  the	  PR	  (450+/-­‐30	  to	  435+/-­‐
36ms)	  and	  PS	  (448+/-­‐31	  to	  433+/-­‐26	  ms)	  groups	  (p=0.02	  for	  both).	  	  
	  
	  
Figure	  18:	  	  Dispersion	  values	  in	  the	  obstructive	  and	  regurgitant	  groups.	  	  Obstructive	  lesions	  show	  significant	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PR:  QRSd p=0.03
       JTd p=0.50
       QTd p=0.10
PS:  QRSd p= 0.02
       JTd p=0.03
       QTd p=0.05
m
s
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There	  was	  no	  significant	  difference	  in	  any	  of	  the	  ECG	  parameters	  within	  the	  different	  underlying	  
congenital	  diagnoses.	  	  
	  
4.3.3	  	  Echocardiographic	  data	  
Echocardiographic	  determination	  of	  RV	  systolic	  pressure	  revealed	  significant	  reductions	  1-­‐year	  post	  
PPVI	  in	  all	  patients	  (66.3+/-­‐22.7	  mmHg	  to	  51.7+/-­‐18.6	  mmHg;	  p<0.0001,	  Table	  1).	  	  When	  this	  is	  
broken	  down	  to	  underlying	  lesion	  type,	  those	  with	  predominant	  stenosis	  had	  the	  greatest	  reduction	  
in	  pressure	  both	  acutely	  (76.2	  to	  54.4	  mmHg;	  p<0.0001)	  and	  at	  1	  year	  (76.2	  to	  57.8mmHg;	  
p=0.0004).	  	  
	  
4.3.4	  	  Cardiac	  magnetic	  resonance	  
Indexed	  RV	  EDV	  and	  RV	  end	  systolic	  volume	  (ESV)	  decreased	  significantly	  across	  the	  whole	  group	  at	  
1	  year	  (-­‐17.7%	  change,	  p<0.0001;	  -­‐12.8%,	  p=0.0005	  respectively,	  Table	  1).	  	  There	  was	  no	  significant	  
change	  in	  right	  ventricular	  ejection	  fraction	  (p=0.29).	  	  Patients	  with	  PR	  had	  a	  significantly	  higher	  
starting	  RV	  EDV	  than	  those	  with	  PS	  (111.8+/-­‐92.1	  and	  91+/-­‐26	  ml/m2;	  p=0.017);	  however,	  their	  one	  
year	  values	  were	  not	  significantly	  different	  (92.1+/-­‐31	  and	  82+/-­‐27ml/m2).	  
	  
	   Pre	   1	  year	   p	  value	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Table	  1:	  	  Showing	  pre-­‐	  and	  1	  year	  values	  for	  indexed	  right	  ventricular	  volumes,	  ejection	  fraction	  and	  systolic	  
pressure	  together	  with	  measured	  statistical	  significance.	  	  	  
	  
Pre-­‐procedure	  QRS	  correlated	  with	  pre	  procedure	  RV	  EDV	  (r=0.34;	  p=0.002).	  	  There	  was	  no	  such	  
correlation	  at	  one	  year;	  however,	  RV	  EDV	  at	  one	  year	  did	  correlate	  with	  QTc	  at	  one	  year	  (r=0.4;	  
p=0.007).	  	  When	  analysed	  by	  valvular	  lesion	  there	  was	  a	  significant	  correlation	  at	  1	  year	  with	  change	  
in	  (∆)	  RV	  EDV	  and	  ∆QTd	  in	  the	  PS	  group	  (r=0.4,	  p=0.03).	  Similarly,	  ∆RV	  EDV	  correlated	  with	  ∆QTc	  
(r=0.6,	  p=0.04)	  and	  ∆JTd	  (r=0.6,	  p=0.03)	  respectively	  in	  the	  PR	  group.	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4.4	  	  Discussion	  
Sudden	  cardiac	  death	  is	  a	  leading	  mode	  of	  death	  in	  patients	  with	  CHD.	  	  Arrhythmic	  death	  in	  repaired	  
ToF	  has	  been	  associated	  with	  a	  QRS	  duration	  >180ms,	  and	  the	  addition	  of	  further	  electrical	  
measurements	  (QRSd,	  QTd,	  JTd)	  has	  further	  refined	  this	  risk38,51.	  	  QRS	  prolongation	  has	  been	  
associated	  with	  increasing	  RV	  EDV36,37,55,	  and	  patients	  undergoing	  surgical	  PVR	  demonstrate	  
significant	  subsequent	  improvements	  in	  RV	  EDV.	  	  PPVI	  is	  an	  established	  minimally	  invasive	  
procedure	  that	  may	  provide	  an	  alternative	  to	  surgery	  in	  selected	  patients.	  	  This	  procedure	  is	  unique	  
in	  that	  it	  permits	  the	  study	  of	  the	  effect	  of	  reduction	  in	  RV	  volume	  on	  electrical	  remodelling,	  
independent	  of	  surgical	  incision	  in	  the	  ventricular	  myocardium,	  additional	  surgical	  intervention	  at	  
the	  time	  of	  valve	  replacement	  or	  cardiopulmonary	  bypass.	  	  	  
	  
Previous	  publications	  have	  confirmed	  that	  this	  mode	  of	  relief	  of	  pulmonary	  outflow	  obstruction	  and	  
regurgitation,	  as	  with	  its	  surgical	  counterpart,	  leads	  to	  reductions	  in	  RV	  EDV,	  RV	  ESV	  and	  RV	  systolic	  
pressure44,45,170.	  	  This	  study	  therefore	  aimed	  to	  assess	  the	  1	  year	  changes	  in	  QRS	  duration,	  QTc	  and	  
QRS,	  JT	  and	  QT	  dispersion	  following	  isolated	  (percutaneous)	  pulmonary	  valve	  implantation	  in	  a	  
cohort	  of	  patients	  with	  CHD.	  	  Given	  that	  these	  electrical	  parameters	  can	  be	  viewed	  as	  a	  marker	  of	  
arrhythmia	  propensity	  and	  burden,	  electrical	  remodelling	  could	  impact	  positively	  on	  these	  outcomes	  
over	  the	  long	  term.	  	  	  
	  
This	  study	  confirms	  a	  significant	  reduction	  in	  RV	  EDV,	  RVESV	  and	  RV	  systolic	  pressure	  following	  PPVI.	  	  
	  
4.4.1	  	  QRS	  duration	  
In	  patients	  with	  pulmonary	  valve	  pathology	  who	  do	  not	  undergo	  PVR,	  the	  QRS	  duration	  is	  normally	  
noted	  to	  increase	  yearly	  by	  approximately	  2-­‐4ms36,52.	  	  Several	  studies	  have	  examined	  the	  effect	  of	  
surgical	  PVR	  on	  surface	  ECG	  parameters,	  mainly	  QRS	  duration,	  with	  inconsistent	  results:	  some	  
studies	  show	  post	  procedure	  shortening43,173,	  others	  stabilisation41,	  and	  yet	  others	  initial	  stabilisation	  
followed	  by	  subsequent	  prolongation	  over	  time120.	  	  My	  study	  includes	  a	  cohort	  with	  a	  number	  of	  
underlying	  congenital	  cardiac	  diagnoses	  and	  either	  obstructive,	  regurgitant	  or	  mixed	  pulmonary	  
valvular	  pathologies.	  	  I	  found	  that	  the	  group	  as	  a	  whole	  shows	  no	  significant	  decrease	  in	  QRS	  
duration	  at	  one	  year	  of	  follow-­‐up	  after	  PPVI.	  	  However,	  when	  selecting	  those	  patients	  with	  
predominantly	  regurgitant	  physiology,	  there	  is	  a	  significant	  reduction	  in	  QRS	  width	  at	  one	  year.	  	  This	  
sub-­‐group	  is	  comparable	  to	  the	  surgical	  cohorts	  since	  these	  latter	  include	  patients	  in	  whom	  the	  vast	  
majority	  have	  pulmonary	  regurgitation.	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The	  follow	  up	  period	  of	  1	  year	  compares	  favourably	  with	  the	  surgical	  cohorts,	  which	  vary	  between	  a	  
mean	  of	  8	  months173,	  14.3	  months43	  and	  >4	  years41,120,169.	  	  It	  is	  important	  to	  note	  that	  all	  of	  the	  above	  
studies	  included	  patients	  who	  underwent	  additional	  surgical	  intervention	  at	  the	  time	  of	  PVR,	  a	  valid	  
confounding	  factor.	  	  Some	  of	  these	  studies	  found	  that	  the	  greatest	  degree	  of	  QRS	  length	  reduction	  
occurred	  in	  those	  in	  whom	  the	  pre-­‐procedure	  duration	  was	  >150ms41,173	  –	  I	  did	  not	  find	  this	  to	  be	  
the	  case	  in	  my	  study.	  	  
	  
None	  of	  the	  patients	  died	  during	  the	  1	  year	  follow	  up	  period.	  	  A	  reduction	  in	  QRS	  duration	  would	  be	  
expected	  to	  effect	  a	  longer-­‐term	  decrease	  in	  arrhythmia	  propensity	  and	  associated	  mortality174,175;	  
however,	  very	  few	  studies	  have	  examined	  the	  long-­‐term	  outcomes	  in	  patients	  undergoing	  PVR.	  	  
Harrild	  and	  colleagues	  observed	  that	  in	  55	  of	  98	  patients	  with	  repaired	  ToF	  undergoing	  PVR	  with	  
available	  pre-­‐	  and	  post-­‐procedure	  ECG	  data,	  not	  only	  was	  there	  no	  significant	  change	  in	  QRS	  
duration	  at	  a	  mean	  of	  3	  years	  follow-­‐up,	  but	  that	  there	  was	  no	  survival	  benefit	  in	  terms	  of	  death	  or	  
ventricular	  tachycardia42.	  	  Their	  study	  cohort	  attempted	  to	  match	  these	  patients	  to	  a	  control	  
population	  with	  repaired	  ToF	  of	  similar	  ages	  and	  similar	  QRS	  durations,	  although	  this	  latter	  allowed	  
an	  overlap	  of	  30ms.	  	  Such	  a	  range	  of	  30ms	  in	  paired	  QRS	  durations	  may	  be	  misrepresentative,	  since	  
a	  difference	  of	  such	  magnitude	  would	  represent	  significant	  changes	  in	  the	  conduction	  properties	  of	  
the	  ventricular	  myocardium.	  	  It	  is	  also	  relevant	  to	  note	  again	  that	  surgical	  myocardial	  incisions	  during	  
PVR	  could	  confound	  the	  interpretation	  of	  any	  outcome	  data	  in	  these	  patients.	  	  
	  
This	  study	  suggests	  that	  isolated	  intervention	  in	  patients	  with	  pulmonary	  regurgitation	  does	  lead	  to	  
a	  reduction	  in	  QRS	  duration	  at	  1	  year.	  	  It	  would	  appear	  that	  the	  underlying	  physiological	  process	  of	  
pulmonary	  regurgitation,	  as	  compared	  to	  the	  high-­‐pressure	  environment	  of	  obstructive	  lesions,	  
allows	  for	  remodelling	  of	  depolarisation	  as	  manifest	  on	  the	  surface	  ECG.	  	  Longer	  term	  follow	  up	  will	  
determine	  whether	  this	  change	  stabilises,	  continues	  to	  reduce	  or	  indeed	  prolongs	  over	  time.	  	  
Assessment	  of	  parallel	  arrhythmic	  burden	  will	  further	  define	  the	  impact	  of	  this	  outcome.	  
	  
4.4.2	  	  QTc,	  QRSd,	  QTd,	  JTd	  
This	  study	  shows	  a	  significant	  decrease	  in	  all	  the	  above	  ECG	  parameters	  at	  one	  year.	  	  Interestingly,	  
there	  was	  a	  trend,	  statistically	  significant	  in	  the	  case	  of	  JTd	  and	  QTd,	  towards	  immediate	  post-­‐
procedure	  lengthening	  followed	  by	  gradual	  improvement	  over	  the	  course	  of	  the	  year	  which	  could	  
not	  be	  accounted	  for	  by	  the	  anaesthetic	  agents	  used.	  	  Other	  authors	  have	  not	  found	  any	  significant	  
positive	  changes	  at	  follow	  up	  when	  measuring	  QRSd	  or	  QTd	  following	  surgical	  PVR43,	  indeed	  Therrien	  
et	  al	  document	  a	  non-­‐significant	  increase	  in	  QTd	  at	  one	  year120.	  	  It	  should	  be	  noted	  however,	  that	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these	  studies	  included	  patients	  in	  whom	  pulmonary	  regurgitation	  was	  the	  predominant	  lesion.	  	  
These	  differing	  findings	  may	  be	  explained	  by	  comparison	  of	  pulmonary	  lesions	  which	  found	  superior	  
electrical	  (dispersion)	  outcome	  in	  those	  with	  obstructive	  physiology,	  suggesting	  that	  this	  high	  
pressure	  physiology	  is	  associated	  with	  greater	  reversibility	  in	  returning	  to	  a	  more	  homogeneous	  
form	  of	  ventricular	  repolarisation	  following	  its	  relief.	  	  Despite	  this,	  and	  importantly,	  QTc	  duration	  
reduces	  regardless	  of	  lesion	  type.	  	  	  
	  
4.4.3	  	  Cellular	  correlates	  of	  surface	  ECG	  measures	  
QTc,	  QTd	  and	  JTd	  are	  all	  parameters	  of	  repolarisation	  and	  surrogate	  measures	  of	  regional	  dispersion	  
action	  potential	  duration	  (APD).	  	  It	  is	  well	  recognised	  that	  myocardial	  stretch	  increases	  monophasic	  
APD-­‐mechano-­‐electric	  feedback	  (MEF).	  MEF	  has	  been	  demonstrated	  in	  a	  wide	  variety	  of	  
experimental	  preparations	  and	  species	  to	  cause	  delayed	  after	  depolarisations	  and	  either	  shortening	  
or	  lengthening	  of	  the	  APD	  depending	  on	  the	  nature	  of	  the	  intervention.	  	  Therefore,	  MEF	  can	  cause	  
triggered	  activity	  and	  generate	  the	  appropriate	  conditions	  for	  re-­‐entrant	  arrhythmias.	  	  Gatzoulis	  et	  
al	  have	  suggested	  that	  the	  RV	  distension,	  secondary	  to	  chronic	  PR,	  creates	  an	  optimal	  
electrophysiologic	  milieu	  in	  which	  arrhythmias	  may	  develop38,51.	  	  Penny’s	  group	  has	  demonstrated	  
that	  after	  only	  3	  months	  of	  PR	  in	  the	  lamb,	  the	  RV	  shows	  enhanced	  susceptibility	  to	  stretch-­‐induced	  
arrhythmias	  and	  increased	  inhomogeneity	  of	  activation176.	  	  Myocardium	  from	  these	  ventricles	  
showed	  impaired	  mechanical	  restitution,	  increased	  intracellular	  resistivity,	  reduced	  conduction	  
velocity,	  increased	  dispersion	  of	  activation,	  and	  prolonged	  endocardial	  APD.	  	  This	  would	  create	  ideal	  
conditions	  for	  re-­‐entrant	  VT,	  and	  provide	  the	  mechanistic	  basis	  for	  the	  clinical	  observation	  of	  an	  
increase	  in	  QRS	  dispersion36	  and	  QRS	  duration52	  in	  patients	  after	  TOF	  repair.	  These	  changes	  are	  
thought	  to	  accompany	  progressive	  ventricular	  dilation	  secondary	  to	  PR;	  the	  rate	  of	  which	  is	  one	  of	  
the	  most	  sensitive	  markers	  for	  ventricular	  arrhythmia	  and	  sudden	  death51.	  An	  in	  vitro	  study	  
comparing	  dilated	  and	  hypertrophied	  human	  myocardium	  demonstrated	  significantly	  longer	  steady-­‐
state	  APD	  in	  dilated	  versus	  hypertrophied	  hearts	  and	  steeper	  APD	  restitution	  slopes	  in	  the	  latter177.	  	  
Therefore,	  measurable	  changes	  in	  electrophysiological	  parameters	  occur	  in	  response	  to	  volume	  and	  
pressure	  overload	  which	  may	  have	  important	  clinical	  implications.	  	  The	  fact	  that	  these	  surface	  ECG	  
markers	  of	  APD	  are	  reduced	  post	  PPVI	  suggests	  that	  correction	  of	  the	  haemodynamic	  lesion	  in	  this	  
patient	  cohort	  results	  in	  increased	  homogeneity	  of	  repolarisation	  which	  would	  theoretically	  
translate	  into	  a	  reduced	  susceptibility	  to	  ventricular	  arrhythmia.	  	  This	  reduced	  risk	  of	  arrhythmia	  
would	  be	  further	  enhanced	  particularly	  in	  the	  PR	  group	  as	  QRS	  duration	  here	  was	  significantly	  
reduced,	  reflecting	  more	  homogenous	  myocardial	  conduction	  and	  less	  opportunity	  for	  conduction	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block	  and	  re-­‐entry.	  The	  advantage	  that	  PPVI	  avoids	  incisional	  scars	  would	  further	  serve	  to	  reduce	  the	  
arrhythmogenicity	  of	  the	  RV	  in	  these	  patients.	  
	  
4.5	  	  Limitations	  
RV	  EDV	  measured	  in	  this	  cohort	  pre-­‐	  PPVI	  is	  less	  than	  that	  described	  for	  other	  surgical	  cohorts43;	  
however,	  my	  population	  comprised	  both	  children	  and	  adults.	  	  It	  should	  be	  noted	  that	  only	  those	  
patients	  with	  a	  valve	  orifice	  area	  of	  22mm	  or	  less	  are	  amenable	  to	  percutaneous	  intervention,	  and	  
this	  may	  have	  some	  bearing	  on	  outcome	  –	  it	  is	  possible	  that	  those	  with	  PR	  and	  a	  larger	  valve	  orifice	  
area	  have	  greater	  haemodynamic	  compromise,	  although	  all	  patients	  are	  referred	  for	  either	  
intervention	  when	  similar	  degrees	  of	  RV	  volume	  overload	  are	  reached.	  This	  is	  unlikely	  to	  have	  been	  a	  
significant	  issue	  in	  the	  younger	  patients.	  	  This	  study	  was	  not	  able	  to	  examine	  changes	  in	  arrhythmia	  
propensity,	  either	  inducible	  or	  spontaneous,	  and	  this	  is	  an	  important	  area	  for	  further	  study.	  	  
	  
Finally,	  the	  PPVI	  procedure	  is	  a	  relatively	  recent	  interventional	  strategy.	  	  As	  yet,	  numbers	  of	  patients	  
are	  small;	  however,	  with	  increasing	  availability	  and	  larger	  numbers,	  statistical	  strength	  will	  be	  
increased.	  	  
	  
4.6	  	  Conclusions	  
This	  study	  shows	  that	  electrical	  remodelling	  occurs	  following	  PPVI	  in	  patients	  with	  CHD,	  with	  
significant	  haemodynamic	  and	  electrocardiographic	  improvements	  at	  1	  year	  of	  follow-­‐up.	  Patients	  
with	  predominant	  regurgitant	  physiology	  show	  most	  marked	  improvements	  in	  the	  surface	  ECG	  
parameters	  of	  depolarisation,	  whilst	  for	  those	  with	  stenotic	  physiology	  improvements	  are	  most	  
marked	  in	  surface	  ECG	  parameters	  of	  repolarisation.	  	  It	  remains	  to	  be	  seen	  whether	  these	  
improvements	  translate	  into	  decreased	  long-­‐term	  arrhythmia	  burden	  and	  risk	  of	  sudden	  cardiac	  
death.	  	  
	  
Surgical	  (open)	  pulmonary	  valve	  replacement	  (PVR)	  currently	  remains	  the	  commonest	  means	  of	  
intervention	  for	  pulmonary	  valve	  disease	  in	  CHD	  however.	  	  This	  mode	  of	  therapy	  facilitates	  direct	  
examination	  of	  the	  electrical	  activating	  system	  on	  the	  surface	  of	  the	  RV	  at	  the	  time	  of	  surgery:	  
Identifying	  the	  latest	  area	  of	  activation	  on	  the	  RV	  surface	  may	  provide	  therapeutic	  insight	  into	  sites	  
for	  targeted	  resynchronisation	  therapy	  in	  these	  complex	  patients	  with	  the	  potential	  for	  direct	  
electrical	  remodelling.	  	  The	  next	  Chapter	  will	  examine	  this	  in	  greater	  detail.	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CHAPTER	  5:	  	  Targeted	  single	  and	  dual	  site	  right	  
ventricular	  pacing	  	  
	  
5.1	  Introduction	  
Adults	  with	  ToF	  or	  significant	  congenital	  pulmonary	  stenosis	  (PS)	  therefore	  often	  have	  a	  RBBB	  
pattern	  on	  the	  surface	  ECG	  resulting	  from	  earlier	  corrective	  surgery33,34,35;	  QRS	  duration	  often	  
prolongs	  during	  follow-­‐up	  in	  association	  with	  progressive	  PR	  and	  consequent	  increases	  in	  RV	  size37.	  	  
In	  such	  adults,	  QRS	  duration	  and	  other	  ECG	  parameters	  are	  linked	  with	  increased	  risk	  of	  malignant	  
arrhythmias	  and	  sudden	  cardiac	  death38,51.	  	  Further,	  long-­‐term	  problems	  with	  resulting	  RV	  
dysfunction	  also	  contribute	  to	  morbidity	  and	  early	  mortality55,178,179	  in	  this	  group.	  	  	  
	  
Surgical	  intervention	  to	  implant	  a	  competent	  pulmonary	  valve	  can	  cause	  acute	  RV	  dysfunction	  
leading	  to	  increased	  morbidity	  and	  mortality	  in	  the	  short	  term:	  	  Studies	  show	  that	  across	  all	  patient	  
groups	  with	  CHD,	  including	  those	  with	  ToF,	  surgery	  is	  linked	  to	  a	  decrease	  in	  ventricular	  contractile	  
function,	  most	  marked	  on	  the	  second	  post-­‐operative	  day93.	  	  A	  sub-­‐group	  of	  patients	  with	  ToF	  have	  a	  
significantly	  poorer	  post-­‐operative	  course,	  linked	  to	  a	  restrictive	  cardiac	  physiology,	  requiring	  longer	  
intensive	  care	  recovery	  with	  prolonged	  inotropic	  support94.	  	  	  
	  
These	  patients	  with	  RBBB	  might	  therefore	  benefit	  from	  targeted	  pacing	  resynchronisation,	  in	  both	  
the	  acute	  and	  longer-­‐term	  setting,	  provided	  optimal	  sites	  within	  the	  RV	  are	  identified.	  	  Since	  the	  
outflow	  tract	  and	  free	  wall	  of	  the	  RV	  show	  latest	  activation	  in	  patients	  with	  repaired	  ToF54	  these	  
sites	  should	  theoretically	  constitute	  targets	  for	  lead	  placement	  when	  delivering	  cardiac	  
resynchronisation	  therapy	  (CRT).	  However,	  this	  has	  not	  been	  formally	  evaluated	  –	  preliminary	  
evidence	  has	  raised	  the	  tantalising	  prospect	  of	  using	  “sub-­‐pulmonary	  RV	  CRT”	  to	  improve	  RV	  
performance	  and	  clinical	  endpoints	  in	  outpatient	  populations89.	  	  This	  is	  likely	  to	  be	  of	  particular	  
importance	  in	  the	  early	  post-­‐operative	  period	  when	  RV	  demand	  increases	  under	  haemodynamic	  
stress.	  	  Further,	  optimisation	  of	  atrioventricular	  delays	  also	  appears	  to	  be	  important90.	  	  At	  present,	  
relatively	  little	  is	  known	  about	  the	  electrical	  activation	  sequence,	  underlying	  mechanical	  
dyssynchrony	  and	  subsequent	  potential	  benefits	  of	  CRT	  in	  this	  cohort.	  	  	  
	  
This	  study	  therefore	  sought	  to	  define	  the	  electrical	  activation	  pattern	  of	  the	  RV	  in	  patients	  
undergoing	  surgical	  pulmonary	  valve	  replacement	  using	  intra-­‐operative	  mapping	  techniques	  and	  
assess	  the	  haemodynamic	  and	  echocardiographic	  effects	  of	  targeted	  epicardial	  pacing	  to	  the	  site	  of	  
latest	  activation.	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5.2	  Methods	  
Following	  local	  ethical	  approval,	  all	  adults	  with	  repaired	  ToF	  or	  early	  surgical	  intervention	  of	  
congenital	  PS	  referred	  for	  surgical	  pulmonary	  valve	  replacement	  (PVR)	  during	  March	  2010	  to	  June	  
2011	  were	  approached	  for	  inclusion	  to	  this	  study.	  	  All	  had	  significant	  pulmonary	  regurgitation,	  as	  
defined	  by	  moderate	  to	  severe	  PR	  on	  cardiac	  magnetic	  resonance	  imaging	  (regurgitant	  fraction	  >	  
25%)	  with	  symptoms,	  severe	  RV	  dysfunction	  or	  dilatation,	  and/or	  impaired	  exercise	  capacity.	  	  	  
Participants	  underwent	  surgical	  PVR	  at	  my	  Institution	  (The	  Heart	  Hospital,	  London)	  by	  one	  of	  two	  
surgeons	  experienced	  with	  this	  anatomy.	  	  The	  surgical	  procedure	  has	  been	  described	  in	  the	  
Appendices	  section.	  	  	  
	  
5.2.1	  Electroanatomic	  Mapping	  
Electroanatomic	  mapping	  was	  undertaken	  following	  completion	  of	  the	  surgical	  procedure,	  whilst	  the	  
heart	  was	  still	  exposed.	  	  All	  patients	  had	  been	  rewarmed	  and	  were	  off	  cardiopulmonary	  bypass.	  	  All	  
were	  haemodynamically	  stable,	  in	  sinus	  rhythm,	  and	  remained	  under	  general	  anaesthesia.	  	  	  The	  
method	  for	  electroanatomic	  mapping	  has	  been	  described	  in	  the	  Materials	  &	  Methods	  section.	  
	  
5.2.2	  Acute	  haemodynamic	  study	  	  
Baseline	  and	  study	  measurements	  of	  cardiac	  parameters	  were	  derived	  using	  the	  Edwards	  Flotrac	  
System	  as	  previously	  described.	  	  	  
	  
Once	  a	  patient	  was	  clinically	  stable	  on	  the	  intensive	  care	  unit	  (normally	  within	  3	  hours	  of	  undergoing	  
electroanatomic	  mapping)	  and	  whilst	  still	  fully	  sedated,	  pacing	  was	  undertaken.	  	  Atrial	  and	  
ventricular	  epicardial	  pacing	  wires	  were	  connected	  as	  necessary	  so	  as	  to	  generate	  DDD	  RVA	  (apical),	  
DDD	  RValt	  or	  DDD	  BiRV	  pacing.	  	  Pacing	  was	  performed	  in	  all	  three	  modes	  at	  two	  different	  
atrioventricular	  delays	  (intrinsic	  PR	  -­‐20ms;	  intrinsic	  PR	  -­‐40ms)	  at	  10%	  above	  the	  patients’	  own	  
intrinsic	  heart	  rate.	  	  Each	  patient	  also	  underwent	  AAI	  pacing	  -­‐	  to	  serve	  as	  a	  baseline	  with	  which	  to	  
compare	  all	  other	  modalities.	  	  Each	  pacing	  burst	  was	  programmed	  for	  one	  minute	  and	  was	  followed	  
by	  a	  return	  to	  intrinsic	  rhythm	  (no	  pacing)	  between	  bursts.	  	  Pacing	  order	  was	  determined	  using	  an	  
online	  random	  sequence	  generator	  and	  all	  modes	  repeated	  three	  times	  to	  take	  into	  account	  normal	  
physiologic	  changes	  that	  might	  occur	  during	  the	  study	  period.	  	  A	  total	  of	  21	  pacing	  bursts	  were	  
therefore	  delivered,	  all	  in	  random	  order.	  	  	  
	  
ECG	  recordings	  were	  taken	  at	  baseline	  and	  at	  each	  pacing	  mode	  for	  later	  analysis.	  	  These	  were	  
scanned	  and	  analysed	  in	  the	  usual	  fashion.	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5.2.3	  Sub-­‐acute	  echocardiographic	  study	  
A	  subset	  of	  patients	  underwent	  further	  echocardiographic	  evaluation	  during	  pacing	  three	  to	  four	  
days	  post	  procedure.	  	  Images	  were	  obtained	  using	  a	  Vivid	  7	  (GE	  Vingmed,	  Milwaukee,	  Wis)	  by	  an	  
operator	  experienced	  in	  scanning	  CHD	  patients	  (JO’L).	  	  Exactly	  the	  same	  randomised	  pacing	  protocol	  
was	  performed	  as	  in	  theatre	  except	  more	  prolonged	  pacing	  was	  undertaken	  for	  two	  to	  three	  
minutes	  to	  allow	  acquisition	  of	  the	  necessary	  images	  following	  a	  preceding,	  and	  full,	  baseline	  study.	  	  
Each	  pacing	  mode	  was	  followed	  by	  a	  return	  to	  intrinsic	  rhythm	  (no	  pacing)	  between	  modes.	  	  Pacing	  
order	  was	  determined	  using	  an	  online	  random	  sequence	  generator	  but	  only	  repeated	  once	  giving	  a	  
total	  of	  seven	  pacing	  modes.	  	  	  
	  
Echocardiographic	  images	  were	  imported	  and	  subsequently	  analysed	  offline	  by	  one	  experienced	  
operator	  using	  a	  dedicated	  GE	  workstation	  (GE	  Vingmed,	  Milwaukee,	  Wis).	  	  Quantitative	  profiles	  (Q	  
analysis	  software;	  GE	  Vingmed,	  Milwaukee,	  Wis)	  allowed	  for	  specific	  raw	  Dicom	  data	  to	  be	  analysed	  
for	  any	  degree	  of	  interventricular	  dyssynchrony	  with	  Tissue	  Doppler	  Imaging,	  by	  determination	  of	  
significant	  (greater	  than	  65msec)	  difference	  between	  the	  LV	  septal/lateral	  walls	  and	  the	  RV	  lateral	  
wall	  during	  peak	  strain.	  	  Global	  RV	  function	  was	  assessed	  by	  measuring	  the	  tricuspid	  annular	  plane	  
systolic	  excursion	  (TAPSE)	  as	  measured	  by	  M-­‐mode	  echocardiography	  by	  the	  maximum	  
displacement	  of	  the	  lateral	  tricuspid	  annulus.	  	  For	  LV	  function	  determination,	  a	  single	  four	  chamber	  
method	  of	  disk	  equation	  was	  used	  for	  a	  measurement	  of	  LV	  global	  function.	  	  
	  
5.2.4	  	  Statistical	  analysis	  
Data	  are	  presented	  as	  mean	  ±	  standard	  deviation	  or	  median	  (range)	  as	  necessary.	  	  Student’s	  paired	  
or	  unpaired	  t-­‐test	  or	  repeated	  measures	  ANOVA	  were	  used	  to	  analyse	  the	  data	  where	  appropriate.	  	  
Repeated	  measures	  ANOVA	  were	  followed	  by	  Fisher’s	  PLSD	  post-­‐hoc	  analysis,	  all	  t-­‐tests	  with	  
Bonferroni	  correction	  as	  necessary.	  	  A	  p	  value	  <0.05	  was	  considered	  significant.	  	  Statistical	  analysis	  
was	  performed	  using	  StatView	  statistical	  software	  (SAS	  Institute	  Inc,	  North	  Carolina,	  USA)	  and	  all	  
graphs	  produced	  using	  GraphPad	  Prism	  (version	  5.00	  for	  Windows,	  GraphPad	  Software,	  San	  Diego,	  




5.3.1	  Patient	  characteristics	  
Sixteen	  adults	  were	  included	  in	  this	  study,	  50%	  (n=8)	  had	  ToF;	  63%	  (n=10)	  were	  female.	  	  All	  had	  
significant	  PR	  with	  mean	  CMR	  regurgitant	  fraction	  of	  47±10%.	  	  All	  were	  in	  sinus	  rhythm	  with	  RBBB	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pattern	  on	  surface	  ECG.	  	  Clinical	  characteristics	  of	  the	  study	  cohort	  are	  shown	  in	  Table	  2.	  	  Mean	  age	  
was	  32±11	  years;	  mean	  pre-­‐procedure	  QRS	  duration	  136±26ms,	  mean	  pre-­‐operative	  RV	  end	  diastolic	  
volume	  (RVEDV)	  183±76ml/m2.	  	  Ten	  (63%)	  of	  those	  included	  had	  undergone	  previous	  transannular	  
patch	  (TAP)	  repair,	  seven	  at	  the	  time	  of	  original	  ToF	  repair.	  	  
	  
	   Total	   ToF	   Congenital	  PS	   p	  value	  
Number	  n(%)	   16	   8(50)	   8(50)	   -­‐/-­‐	  
Female	  n(%)	   10	  (63)	   5	   5	   -­‐/-­‐	  
Age	  at	  PVR	   32±11	   30±8	   36±14	   0.34	  
Age	  at	  original	  repair	   3.3±2.3	   4±1	   2±3	   0.14	  
TAP	  (at	  original	  repair)	  n(%)	   10(63)	   7	   3	   -­‐/-­‐	  
Pre-­‐procedure	  QRS	  duration	  (ms)	   136±26	   137±26	   120±4	   0.20	  
RVEDV	  (ml/m2)	   183±76	   166±40	   205±81	   0.26	  
RVESV	  (ml/m2)	   89±47	   80±30	   103±65	   0.43	  
RVEF	  (%)	   51±8	   53±7	   49±10	   0.40	  
LVEF	  (%)	   57±10	   53±12	   60±9	   0.27	  
PR	  RF	  (%)	   47±10	   45±10	   50±10	   0.28	  
	  
Table	  2:	  Clinical	  characteristics	  of	  the	  study	  cohort.	  	  No	  factor	  was	  significantly	  different	  between	  the	  two	  




Mapping	  was	  undertaken	  without	  adverse	  incident	  in	  all	  patients.	  	  In	  two	  participants	  (both	  with	  
ToF),	  electrogram	  analysis	  was	  not	  possible	  at	  the	  RV	  anterior	  wall	  due	  to	  significant	  scarring.	  	  
A	  highly	  significant	  difference	  in	  electrical	  activation	  times	  was	  found	  in	  the	  whole	  group	  (p=0.0013).	  	  
Post	  hoc	  analysis	  identified	  the	  RV	  free	  wall	  as	  the	  area	  most	  likely	  to	  be	  subject	  to	  delay,	  and	  
electrical	  activation	  here	  occurred,	  on	  average,	  37ms	  after	  the	  earliest	  activation	  time.	  	  The	  RV	  
outflow	  tract	  was	  also	  subject	  to	  activation	  delay;	  on	  average	  activation	  started	  27ms	  after	  the	  
earliest	  activation	  time.	  	  Figure	  19	  shows	  a	  basic	  colour	  map	  representation	  of	  activation	  across	  the	  
RV	  in	  both	  ToF	  and	  congenital	  PS,	  with	  and	  without	  TAP	  repair.	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Figure	  19:	  	  Basic	  activation	  maps	  of	  the	  RV	  surface	  for	  each	  anatomy	  studied.	  	  Although	  the	  RV	  free	  wall	  had	  
the	  greatest	  delay	  in	  activation	  in	  whole	  cohort,	  the	  RVOT	  was	  subject	  to	  the	  greatest	  variation	  in	  activation,	  
being	  latest	  in	  those	  with	  TAP	  repair	  and/or	  ToF.	  
	  
Table	  3	  presents	  the	  activation	  delays	  at	  both	  these	  locations	  in	  the	  cohort	  as	  a	  whole,	  and	  per	  
diagnosis.	  	  Interestingly,	  those	  with	  repaired	  ToF	  and	  those	  with	  previous	  TAP	  repair	  had	  significantly	  
greater	  delay	  at	  the	  RVOT	  than	  those	  with	  either	  congenital	  PS	  or	  no	  TAP	  repair	  (p=0.01;	  p=0.02.	  	  
Table	  3,	  Figure	  19).	  	  Those	  with	  TAP	  repair	  had	  greatest	  activation	  delay	  at	  the	  RVOT,	  though	  this	  did	  
not	  reach	  statistical	  significance.	  
	  
	   Free	  wall	   RVOT	   p	  value	  
Total	   37±33	   27±25	   -­‐/-­‐	  
ToF	   48±31	   41±17*	   0.5	  
Cong	  PS	   23±32	   13±25*	   0.4	  
TAP	  repair	   37±23	   39±16†	   0.8	  
No	  TAP	  repair	   25±37	   6±25†	   0.2	  
Table	  3:	  	  Activation	  delay	  compared	  to	  earliest	  activation	  time	  (time	  0).	  	  All	  times	  are	  in	  ms.	  	  	  
†	  p=0.01;	  *p=0.02	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Acute	  post-­‐operative	  pacing	  
All	  recruited	  patients	  were	  paced,	  and	  there	  were	  no	  pacing-­‐related	  adverse	  events.	  	  Further,	  all	  
patients	  were	  haemodynamically	  stable	  throughout	  recovery	  and	  none	  required	  formal	  temporary	  
pacing	  during	  this	  time.	  	  	  
	  
All	  modes	  of	  pacing,	  including	  AAI	  pacing,	  generated	  increases	  of	  CO,	  CI	  and	  SV	  significantly	  above	  
baseline	  (Table	  4).	  	  MAP	  did	  not	  change	  significantly	  with	  any	  mode	  of	  pacing	  (p=0.49).	  	  DDD	  RV	  alt	  
pacing	  with	  AV	  delay	  minus	  20ms	  of	  intrinsic	  was	  associated	  with	  the	  greatest	  overall	  increase	  in	  
central	  haemodynamics	  (Table	  4),	  and	  this	  significance	  was	  maintained	  when	  directly	  compared	  to	  
DDD	  RV	  apical	  pacing	  at	  the	  same	  AV	  delay:	  	  CO	  (5.8±1.3	  to	  6.4±1.7;	  p=0.018),	  CI	  (3.4±0.8	  to	  3.7±1.0;	  
p=0.02)	  and	  SV	  (63±13	  to	  68±17;	  p=0.007)	  (Figure	  20).	  
	  
	   Baseline	  
(intrinsic)	  




















CO	  (L/min)	   4.7±1.2†	   5.5±0.9	   5.8±1.3*	   5.9±1.3	   6.4±1.7*	   6.1±1.4	   5.9±1.5	   5.9±1.3	   0.003	  
CI	  
(L/min/m2)	  
2.7±0.7†	   3.2±0.5	   3.4±0.8	   3.5±0.9	   3.7±1	   3.6±0.9	   3.5±0.9	   3.5±0.8	   0.004	  
SV	  (ml)	   58±16†	   61±10	   63±13	   64±13	   68±17	   66±14	   65±15	   65±13	   0.01	  
MAP	  
(mmHg)	  
70±11†	   74±10	   72±10	   73±9	   72±10	   73±10	   74±9	   74±10	   0.49	  
	  
*Direct	  paired	  t	  test	  p=0.018	  
†	  not	  included	  in	  repeated	  measures	  ANOVA	  
Table	  4:	  	  All	  forms	  of	  pacing,	  including	  AAI	  pacing,	  generated	  increases	  of	  CO,	  CI	  and	  SV	  significantly	  above	  
baseline	  however	  DDD	  RV	  alternate	  site	  pacing	  was	  found	  to	  generate	  the	  greatest	  increase	  in	  all	  measured	  
parameters.	  	  MAP	  did	  not	  change	  significantly	  with	  any	  form	  of	  pacing	  (p=0.49).	  	  	  
	  
	  
5.3.3	  QRS	  duration	  	  
Mean	  QRS	  duration	  for	  the	  whole	  cohort	  pre	  procedure	  was	  136±26ms.	  	  Although	  a	  visible	  trend	  is	  
seen,	  there	  was	  no	  significant	  difference	  in	  QRS	  duration	  between	  those	  with	  a	  diagnosis	  to	  ToF	  or	  
congenital	  PS	  (137±27	  vs	  120±26;	  p=0.20)	  or	  those	  with	  and	  without	  a	  history	  of	  TAP	  repair	  (134±23	  
vs	  116±8;	  p=0.16).	  	  	  
	  
Both	  forms	  of	  RV	  apical	  pacing	  were	  associated	  with	  a	  significantly	  wider	  QRS	  duration	  than	  
occurred	  during	  AAI	  pacing,	  though	  there	  was	  no	  significant	  difference	  in	  QRS	  duration	  when	  
comparing	  the	  alternate	  pacing	  sites	  (RVA	  to	  RValt	  -­‐20ms	  p=0.11;	  RVA	  to	  RValt	  -­‐40ms	  p=0.07).	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Figure	  21	  presents	  the	  mean	  data	  for	  each	  pacing	  programme.	  	  Full	  QRS	  data	  on	  two	  patients	  (one	  




















Figure	  20:	  Direct	  comparison	  of	  DDD	  RV	  apical	  pacing	  with	  DDD	  RV	  alternate	  site	  pacing	  shows	  that	  the	  latter	  
is	  associated	  with	  significantly	  increased	  haemodynamic	  variables.	  All	  AV	  delays	  at	  intrinsic	  minus	  20ms.	  
	  
	  
Figure	  21:	  	  Mean	  QRS	  durations	  with	  each	  pacing	  mode	  and	  sinus	  rhythm	  (SR).	  	  RV	  apical	  pacing	  generated	  the	  
widest	  complexes.	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5.3.4	  Sub	  acute	  echocardiographic	  study	  
A	  subset	  of	  seven	  patients	  underwent	  echocardiographic	  study.	  	  Four	  opted	  not	  to	  take	  part	  in	  this	  
second	  stage,	  one	  patient	  with	  ToF	  had	  unfortunately	  already	  had	  her	  pacing	  wires	  removed	  on	  the	  
ward	  earlier,	  and	  in	  the	  remaining	  four	  electrical	  capture	  via	  one	  or	  more	  pacing	  wires	  was	  
technically	  difficult,	  probably	  due	  to	  movement.	  	  	  
	  
Of	  the	  seven	  patients,	  three	  had	  ToF	  and	  four	  had	  congenital	  PS.	  	  All	  patients	  with	  ToF	  had	  
undergone	  TAP	  repair	  as	  had	  one	  additional	  PS	  patient.	  	  Five	  were	  female	  (71%).	  	  All	  had	  LV	  ejection	  
fractions	  greater	  than	  50%	  and	  none	  showed	  interventricular	  dyssynchrony	  prior	  to	  pacing,	  nor	  at	  
any	  time	  with	  any	  modality	  of	  pacing.	  
	  
Assessment	  of	  RV	  and	  LV	  contraction	  by	  both	  tissue	  Doppler	  analysis	  and	  M-­‐mode	  echocardiography	  
confirms	  that	  RV	  apical	  pacing	  at	  any	  AV	  delay	  is	  significantly	  worse	  than	  that	  measured	  at	  baseline	  –	  
ie,	  with	  no	  pacing	  (Figure	  22).	  	  No	  pacing	  mode	  was	  found	  to	  improve	  on	  baseline	  measurements.	  	  	  
	  
Figure	  22:	  RV	  apical	  pacing	  was	  associated	  with	  deterioration	  of	  both	  RV	  and	  LV	  longitudinal	  contractility	  but	  
no	  other	  form	  of	  pacing	  was	  found	  to	  be	  superior	  to	  no	  pacing.	  
	  
	  
5.4	  	  Discussion	  
This	  is	  the	  largest	  study	  examining	  targeted	  single	  and	  dual	  site	  pacing	  in	  the	  RV	  of	  adults	  with	  
repaired	  ToF	  or	  pulmonary	  stenosis.	  	  Electroanatomic	  mapping	  confirmed	  that	  whilst	  there	  is	  no	  
uniform	  pattern	  to	  activation	  of	  the	  RV,	  the	  latest	  area	  of	  electrical	  activation	  in	  these	  adults	  is	  often	  
the	  RV	  free	  wall;	  however,	  the	  RVOT	  is	  subject	  to	  the	  greatest	  variation	  in	  activation,	  being	  latest	  in	  
those	  with	  TAP	  repair	  and/or	  ToF.	  	  This	  study	  confirms	  that	  targeted	  (alternate)	  single	  site	  RV	  pacing	  
significantly	  improves	  cardiac	  haemodynamics	  acutely,	  more	  so	  than	  RV	  apical	  pacing	  or	  dual	  site	  RV	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pacing.	  RV	  apical	  pacing	  either	  exerted	  a	  minimal	  or	  detrimental	  effect	  on	  haemodynamics	  and	  RV	  
echocardiographic	  function.	  	  
	  
5.4.1	  	  Electrical	  activation	  of	  the	  right	  ventricle	  
Analogous	  to	  LBBB,	  RBBB	  is	  a	  complex	  electrical	  disease.	  	  Findings	  in	  this	  study	  of	  a	  lack	  of	  uniformity	  
to	  activation	  across	  the	  cohort	  and	  are	  in	  keeping	  with	  the	  knowledge	  that	  block	  to	  the	  right	  bundle	  
can	  occur	  at	  different	  levels,	  proximal,	  distal	  and	  terminal,	  depending	  on	  the	  location	  and	  extent	  of	  
original	  (surgical)	  insult33,34,35.	  	  Further,	  although	  all	  these	  levels	  of	  block	  manifest	  different	  electrical	  
activation	  sequences	  on	  electrophysiological	  mapping,	  all	  are	  represented	  by	  a	  similar	  RBBB	  pattern	  
on	  the	  surface	  ECG.	  	  When	  directly	  comparing,	  therefore,	  those	  patients	  who	  had	  a	  transannular	  
patch	  repair	  with	  those	  that	  had	  not,	  it	  is	  perhaps	  unsurprising	  to	  note	  that	  the	  former	  had	  
significant	  delays	  in	  electrical	  activation	  compared	  to	  the	  latter.	  	  Thus,	  although	  both	  the	  RV	  free	  
wall	  and	  RV	  outflow	  tract	  had	  similar	  levels	  of	  activation	  delay	  in	  the	  whole	  cohort,	  the	  RV	  outflow	  
tract	  was	  subject	  to	  the	  greatest	  variation,	  depending	  on	  anatomy	  and	  mechanism	  of	  original	  repair.	  	  	  
	  
These	  results	  correspond	  to	  a	  high	  density	  epi-­‐	  and	  endocardial	  mapping	  study	  of	  Fallot’s	  patients	  
which	  demonstrated	  that	  the	  RVOT	  and	  infundibular	  area	  was	  the	  latest	  site	  of	  activation	  in	  73%	  of	  
the	  15	  cases	  studied	  –	  indeed,	  the	  degree	  of	  delay	  between	  apex	  and	  RVOT	  was	  equivalent	  to	  the	  
finding	  of	  approximately	  50ms	  when	  the	  RVOT	  was	  the	  latest	  activating	  region181.	  	  Furthermore,	  
significant	  LV	  epicardial	  activation	  delays	  were	  also	  identified,	  indicating	  that	  RBBB	  in	  ToF	  is	  linked	  to	  
left	  ventricular	  electrical	  dyssynchrony.	  Importantly	  that	  study	  did	  not	  examine	  the	  effects	  of	  pacing	  
on	  haemodynamics.	  However,	  in	  a	  limited	  combined	  body	  surface	  mapping	  and	  biventricular	  pacing	  
study	  of	  ToF	  patients	  the	  infundibulum	  was	  found	  to	  be	  the	  latest	  site	  of	  activation	  and	  BiV	  (ie;	  RV-­‐
LV)	  pacing	  improved	  exercise	  capacity	  and	  dyssynchrony	  parameters180.	  	  Interestingly	  targeted	  latest	  
site	  RV	  pacing	  was	  not	  performed	  only	  conventional	  RV	  apical	  pacing	  and	  BiV	  stimulation.	  
	  
This	  current	  study	  did	  not	  find	  the	  RV	  apex	  was	  subject	  to	  significant	  delay,	  in	  keeping	  with	  
previously	  published	  studies54,181.	  	  Further,	  the	  degree	  of	  RV	  volume	  overload	  and	  PR	  was	  similar	  in	  
the	  whole	  cohort,	  as	  was	  LV	  function,	  suggesting	  that	  haemodynamic	  factors	  were	  not	  related	  to	  the	  
electrical	  findings.	  	  	  
	  
5.4.2	  	  Resynchronisation	  pacing	  
Regardless	  of	  the	  underlying	  cause,	  the	  level	  of	  functional	  block	  and	  its	  consequent	  effect	  on	  local	  
mechanical	  response	  are	  of	  paramount	  importance	  when	  considering	  the	  delivery,	  and	  thus	  efficacy,	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of	  cardiac	  resynchronisation	  therapy.	  	  My	  study	  finds	  that	  targeted,	  alternate	  site,	  RV	  pacing	  leads	  to	  
superior	  improvements	  in	  CO,	  CI	  and	  SV	  when	  compared	  to	  AAI	  pacing	  alone	  or	  DDD	  RV	  apical	  
pacing	  in	  adults	  late	  after	  repair	  of	  ToF	  or	  congenital	  PS.	  	  I	  show	  that	  RV	  pacing	  alone	  does	  not	  
confer	  significant	  advantages	  over	  AAI	  pacing,	  and	  in	  fact	  is	  associated	  with	  prolongation	  of	  the	  QRS	  
duration	  and	  decrease	  in	  longitudinal	  contractility	  of	  the	  RV	  and	  LV.	  	  Interestingly,	  the	  combination	  
of	  targeted	  alternate	  site	  RV	  pacing	  and	  RV	  apical	  pacing	  (DDD	  BiRV)	  does	  not	  lead	  to	  a	  further	  
improvement	  in	  haemodynamics,	  and	  indeed	  also	  appears	  inferior	  to	  alternate	  site	  RV	  pacing	  alone.	  	  	  
	  
This	  is	  the	  first	  study	  in	  this	  population	  to	  directly	  compare	  DDD	  RV	  apical	  pacing	  and	  best	  alternate	  
site	  RV	  pacing.	  	  Although	  it	  supports	  the	  concept	  of	  ‘sub-­‐pulmonary	  RV	  CRT’	  in	  this	  cohort,	  long-­‐term	  
effects	  in	  terms	  of	  iatrogenic	  dyssynchrony	  need	  to	  be	  established.	  	  Thambo	  and	  colleagues	  
reported	  that	  such	  therapy	  was	  associated	  with	  marked	  dyssynchrony	  of	  both	  the	  LV	  and	  the	  RV	  in	  a	  
small	  cohort,	  though	  RV	  pacing	  sites	  were	  not	  directly	  targeted	  and	  dyssynchrony	  was	  most	  marked	  
with	  RV	  apical	  pacing92.	  	  The	  fact	  that	  considerable	  epicardial	  conduction	  delays	  also	  affect	  the	  left	  
ventricle	  in	  ToF	  has	  important	  implications	  for	  lead	  placement.	  	  
	  
Although	  RV	  disease	  is	  predominant	  in	  this	  congenital	  population,	  it	  does	  not	  occur	  in	  isolation	  and	  
the	  possibility	  of	  iatrogenic	  dyssynchrony	  in	  the	  long-­‐term	  should	  be	  considered	  in	  the	  sub-­‐aortic	  LV,	  
especially	  if	  the	  systolic	  function	  of	  this	  chamber	  is	  already	  impaired.	  	  	  Abd	  El	  Rahman	  et	  al	  describe	  
delayed	  activation	  of	  the	  LV	  in	  around	  half	  of	  patients	  with	  repaired	  ToF	  and	  RBBB55.	  	  The	  pattern	  
differed	  from	  that	  seen	  in	  patients	  with	  dilated	  cardiomyopathy	  and	  RBBB,	  affecting	  the	  ventricular	  
septum	  and	  not	  the	  lateral	  LV	  wall.	  	  In	  a	  retrospective	  analysis	  of	  75	  patients	  with	  repaired	  ToF,	  
Tzemos	  and	  co-­‐workers	  noted	  a	  significant	  association	  between	  QRS	  duration	  and	  adverse	  LV	  
volume,	  activation	  delay	  and	  septal	  strain56,	  and	  recently,	  the	  Toronto	  group	  published	  their	  finding	  
of	  significant	  delays	  in	  LV	  activation	  in	  their	  study	  group	  of	  adults	  with	  repaired	  ToF.	  	  It	  is	  already	  
well	  established	  that	  RV	  apical	  pacing,	  both	  acutely	  and	  in	  the	  long	  term	  in	  the	  general	  population,	  is	  
associated	  with	  LV	  dyssynchrony	  and	  functional	  impairment.	  	  My	  current	  findings	  indicate	  that	  such	  
dyssynchrony	  as	  may	  be	  induced	  by	  additional	  RV	  apical	  pacing	  (ie	  with	  dual	  site	  RV	  pacing)	  may	  be	  
sufficient	  to	  abrogate	  the	  benefits	  of	  targeted	  single	  site	  resynchronisation.	  	  	  
	  
The	  acute	  nature	  of	  this	  study	  needs	  to	  be	  considered	  also:	  The	  phenomenon	  of	  ventricular	  
interdependence	  explains	  how	  early	  surgical	  intervention	  on	  the	  RV	  and	  the	  subsequent	  effects	  of	  
progressive	  haemodynamic	  lesions	  may	  negatively	  impact	  LV	  function	  by	  electromechanical	  
uncoupling.	  	  A	  recent	  study	  looked	  at	  the	  degree	  of	  excursion	  of	  the	  intraventricular	  septum,	  the	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main	  mediator	  of	  this	  phenomenon,	  in	  patients	  with	  repaired	  ToF.	  	  The	  group	  determined	  that	  in	  
those	  with	  abnormal	  excursion	  there	  was	  a	  reduction	  in	  global	  and	  septal	  LV	  systolic	  function182.	  	  A	  
study	  by	  Tobler	  et	  al	  determined	  that	  LV	  function	  improved	  in	  adults	  with	  ToF	  several	  years	  
following	  surgical	  PVR,	  supporting	  the	  recovery	  of	  adverse	  electromechanical	  interactions	  between	  
the	  two	  chambers58.	  	  This	  finding	  has	  been	  documented	  elsewhere	  also183;	  however,	  in	  both	  studies	  
patients	  did	  better	  when	  there	  was	  already	  LV	  functional	  impairment.	  	  This	  was	  not	  the	  case	  in	  this	  
current	  study.	  
	  
5.4.3	  	  Clinical	  Implications	  
Single	  site,	  targeted	  RV	  pacing	  led	  to	  significant	  improvements	  in	  global	  cardiac	  haemodynamics.	  	  In	  
the	  acute	  setting,	  in	  those	  who	  suffer	  more	  protracted	  post	  operative	  courses	  linked	  to	  adverse	  RV	  
function,	  targeted	  resynchronisation	  pacing	  would	  be	  of	  significant	  benefit	  in	  the	  immediate	  
recovery	  period	  especially	  since	  it	  is	  clear	  that	  RV	  apical	  pacing	  is	  deleterious	  at	  worst,	  and	  at	  best	  
neutral	  in	  effect.	  	  In	  terms	  of	  routine	  temporary	  pacing	  wire	  placement,	  these	  data	  indicate	  that	  
epicardial	  RV	  leads	  should	  be	  placed	  in	  the	  outflow	  tract/free	  wall	  area	  of	  the	  RV	  as	  opposed	  to	  the	  
apex.	  
	  
5.4.4	  	  Limitations	  
This	  was	  an	  acute	  study	  in	  a	  small	  population	  of	  patients.	  	  Invasive	  assessment	  of	  RV	  dP/dt	  may	  have	  
provided	  more	  specific	  RV	  data	  acutely.	  	  Further,	  due	  to	  the	  early	  post-­‐operative	  stage,	  
echocardiographic	  imaging	  windows	  were	  not	  always	  optimal	  so	  assessment	  was	  sometimes	  limited.	  	  
Echocardiographic	  assessment	  of	  the	  RV	  is	  more	  qualitative	  than	  cardiac	  magnetic	  resonance	  
imaging	  (CMR)	  -­‐	  the	  gold	  standard	  tool.	  	  However,	  several	  parameters	  of	  RV	  function,	  specifically	  
TAPSE,	  have	  been	  shown	  to	  correlate	  well	  with	  RV	  ejection	  fraction	  as	  determined	  by	  CMR184	  and	  
also	  corresponds	  to	  functional	  capacity.	  	  The	  complex	  interplay	  between	  changes	  in	  loading	  
conditions	  and	  ventricular	  contractility	  associated	  with	  cardiac	  surgery	  dictates	  that	  haemodynamic	  
measurements	  on	  day	  one	  may	  not	  be	  compared	  to	  non	  invasive	  measurements	  on	  day	  three	  post	  
operatively.	  	  Longer	  term	  studies	  are	  necessary	  to	  determine	  the	  impact	  of	  alternate	  site	  pacing	  in	  a	  
population	  of	  ToF	  patients	  with	  RBBB	  and	  RV	  impairment.	  	  
	  
5.4.5	  	  Conclusion	  
Single	  site	  RV	  pacing	  targeted	  to	  the	  region	  of	  latest	  intrinsic	  activation	  in	  patients	  with	  RBBB	  
undergoing	  PVR	  induces	  acute	  improvements	  in	  central	  haemodynamics	  and	  supports	  the	  concept	  
Carla	  Plymen	  MD	  (Res)	   Page	  74	  
	  
of	  subpulmonary	  “RV	  CRT”.	  	  Targeted	  pacing	  in	  such	  patients	  has	  therapeutic	  potential	  both	  in	  the	  
post-­‐operative	  and	  chronic	  setting	  and	  is	  superior	  to	  RV	  apical	  pacing,	  which	  may	  be	  detrimental.	  	  
	  
This	  Thesis	  has	  thus	  set	  out	  that	  electrical	  parameters	  can	  foretell	  risk	  in	  those	  with	  a	  subpulmonary	  
RV.	  	  Strategies	  to	  alleviate	  and	  accommodate	  this	  risk	  are	  on-­‐going,	  as	  highlighted	  in	  these	  last	  
chapters.	  	  In	  those	  patients	  with	  a	  systemic	  (subaortic)	  RV	  however,	  very	  little	  is	  known	  regarding	  
the	  association	  between	  surface	  ECG	  parameters	  and	  risk	  -­‐	  this	  population	  experiences	  a	  high	  
incidence	  of	  morbidity	  and	  mortality	  as	  a	  result	  of	  arrhythmia,	  HF	  and/or	  SCD4,5	  -­‐	  survival	  rates	  of	  
76%	  at	  20	  years	  have	  been	  reported13,	  with	  a	  mean	  age	  at	  death	  of	  27±7	  years4.	  	  	  In	  my	  next	  chapter	  
therefore,	  I	  chose	  to	  examine	  the	  association	  between	  surface	  ECG	  parameters	  and	  mortality	  in	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CHAPTER	  6:	  	  Relationship	  between	  ECG	  parameters	  
and	  mortality	  in	  adults	  with	  a	  systemic	  right	  ventricle	  
	  
6.1	  	  	  Introduction	  
In	  TGA	  palliated	  by	  atrial	  switch	  redirection	  (Mustard	  or	  Senning	  procedure),	  impairment	  of	  systemic	  
RV	  function	  relates	  to	  long-­‐term	  outcome16;	  however,	  no	  easily	  accessible	  or	  widely	  applicable	  
clinical	  marker	  has	  been	  identified	  to	  quantify	  risk	  and	  predict	  outcome	  for	  this	  complex	  congenital	  
cohort.	  	  	  	  
	  
Early	  research	  in	  patients	  with	  a	  systemic	  RV	  has	  found	  that	  abnormalities	  on	  the	  surface	  ECG	  may	  
be	  relevant104,104,105;	  however,	  data	  is	  somewhat	  contradictory	  and	  span	  different	  age	  and	  palliation	  
cohorts:	  Sun	  et	  al	  found	  that	  QT	  dispersion	  (QTd)	  was	  an	  independent	  risk	  factor	  for	  SCD,	  being	  
significantly	  greater	  in	  this	  group	  than	  in	  those	  who	  survived;	  however,	  the	  study	  cohort	  comprised	  
patients	  immediately	  post	  atrial	  switch	  repair	  to	  a	  maximum	  of	  five	  years	  follow	  up106.	  	  Kammeraad	  
and	  colleagues	  also	  studied	  children	  and	  younger	  adults	  post	  repair	  where	  the	  mean	  age	  of	  SCD	  or	  
‘near	  miss’	  event	  was	  12.3	  years107.	  	  They	  report	  no	  significant	  disparity	  between	  measured	  QRS	  
duration,	  QTd	  or	  QTc	  intervals	  between	  their	  study	  and	  control	  groups.	  	  Both	  Gatzoulis	  et	  al	  and	  
Schwerzmann	  and	  co	  workers	  examined	  adults.	  	  The	  former	  determined	  that	  whilst	  both	  QRS	  
duration	  and	  QTd	  were	  significantly	  increased	  in	  adults	  with	  a	  history	  of	  ventricular	  tachyarrhythmia,	  
only	  the	  latter	  was	  predictive	  of	  such	  late	  events104.	  	  Schwerzmann	  et	  al	  reported	  that	  when	  QRS	  
duration	  was	  >140ms	  there	  was	  a	  10	  fold	  increased	  risk	  for	  SCD	  or	  sustained	  VT	  compared	  to	  
<140ms105.	  
	  
This	  study	  therefore	  sought	  to	  examine	  the	  relationship	  between	  surface	  ECG	  parameters	  and	  




6.2	  	  Methods	  
6.2	  1	  	  Study	  population	  
Case	  notes	  for	  all	  adults	  (>18	  years)	  with	  atrial	  redirection	  surgery	  for	  TGA	  under	  regular	  follow	  up	  
since	  2000	  at	  the	  Heart	  Hospital	  (London)	  were	  reviewed.	  	  Those	  with	  good	  quality	  ECG	  obtained	  at	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the	  time	  of	  most	  recent	  follow-­‐up	  were	  included	  for	  analysis.	  	  82	  patients	  fulfilled	  criteria	  and	  were	  
thus	  included	  in	  this	  study.	  	  ECG’s	  were	  analysed	  as	  previously	  documented.	  
	  
Patients	  were	  divided	  into	  3	  subgroups	  according	  to	  arrhythmic	  history	  as	  evidenced	  either	  on	  
ECG/during	  admission	  or	  routine	  Holter	  monitor;	  those	  with	  no	  documented	  arrhythmias,	  those	  with	  
prior	  supraventricular	  arrhythmias	  (SVT	  –	  symptomatic	  or	  >30	  beats),	  and	  those	  with	  prior	  
ventricular	  tachyarrhythmias	  (VT;	  sustained	  or	  non-­‐sustained	  (≥4	  beats)).	  	  The	  fourth	  group	  
comprised	  deceased	  patients	  and	  those	  undergoing	  cardiac	  transplant,	  irrespective	  of	  arrhythmic	  
history.	  	  For	  the	  purposes	  of	  this	  study	  only	  patients	  dying	  from	  cardiac	  causes	  (heart	  failure,	  sudden	  
cardiac	  death)	  were	  included	  in	  the	  analysis.	  	  Mode	  of	  death	  was	  obtained	  from	  the	  case	  notes	  
and/or	  death	  certificates,	  as	  necessary.	  	  	  
	  
6.2.2	  	  Statistical	  analysis	  
The	  Kolmogorov-­‐Smirnov	  test	  was	  used	  to	  evaluate	  whether	  each	  parameter	  followed	  a	  Gaussian	  
distribution.	  Values	  are	  expressed	  as	  mean	  ±	  standard	  deviation	  (SD),	  median	  (25-­‐75th	  percentile	  
values)	  or	  percentages,	  as	  appropriate.	  	  Univariate	  comparisons	  were	  performed	  by	  Student’s	  t-­‐test,	  
Mann	  Whitney	  U	  test,	  and	  Chi-­‐square	  test	  for	  normally	  distributed,	  non-­‐normally	  distributed	  and	  
categorical	  variables	  respectively.	  Pearson’s	  or	  Spearman’s	  correlation	  coefficients	  were	  used	  as	  
appropriate	  to	  look	  for	  univariate	  associations	  between	  several	  continuous	  variables.	  	  
	  
Cox	  proportional	  hazard	  analysis	  and	  receiver	  operator	  characteristic	  (ROC)	  curves	  were	  used	  to	  
determine	  the	  relationship	  between	  QRS	  and	  QTc	  and	  mortality.	  	  	  Kaplan-­‐Meier	  plots	  were	  
generated	  from	  these	  results.	  
Differences	  were	  considered	  to	  be	  significant	  at	  a	  p	  value	  of	  <0.05	  (two-­‐tailed).	  
	  
	  
6.3	  	  Results	  
There	  have	  been	  15	  (9%)	  TGA	  deaths	  at	  my	  Institution	  since	  the	  year	  2000.	  	  Two	  were	  non	  cardiac	  
(teratoma;	  primary	  hepatoma)	  and	  these	  were	  excluded	  from	  further	  analysis.	  	  The	  remainder	  
comprised	  5	  SCD	  (33.3%)	  and	  8	  HF	  related	  deaths	  (53%)	  including	  one	  peri	  heart-­‐lung	  
transplantation.	  	  Excluding	  the	  non-­‐cardiac	  modes	  of	  demise,	  mean	  age	  at	  death	  was	  29±10	  years,	  
median	  age	  at	  palliation	  was	  36	  months	  (range	  0.5-­‐144)	  and	  62%	  (n=8)	  had	  undergone	  Senning	  
procedure	  (Table	  5).	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Sixty	  nine	  patients	  (84%)	  are	  currently	  under	  continued	  follow-­‐up	  at	  my	  Institution.	  	  Mean	  age	  of	  
this	  cohort	  was	  28±6	  years	  and	  median	  age	  at	  palliation	  7	  months	  (range1-­‐96).	  	  Thirty-­‐two	  percent	  
(n=21)	  were	  female,	  and	  51%	  (n=35)	  had	  undergone	  Senning	  palliation	  (Table	  5).	  	  Sixty-­‐six	  percent	  
(n=46)	  had	  no	  documented	  arrhythmias,	  25%	  (n=17)	  had	  documented	  episodes	  of	  SVT,	  and	  9%	  (n=7)	  
had	  documented	  VT.	  	  	  	  
	  
	   Alive	   Dead	   p	  value	  
N	   69	   13	   -­‐/-­‐	  
Age	  (yrs)	   28±6	   29±10	   0.74	  
Age	  at	  palliation	  (mths)	   7	  (1-­‐96)	   36	  (0.5-­‐144)	   <0.0001	  
Senning,	  n	  (%)	   35	  (51)	   8	  (62)	   0.74	  
Female,	  n	  (%)	  















CRT	   0	   1	  (8)	   -­‐/-­‐	  
ICD	   2	  (3)	   1	  (8)	   0.40	  








ACEi/ARB	   21	  (30)	   7	  (47)	   0.31	  
Diuretics	   6	  (9)	   8	  (53)	   <0.0001	  
Table	  5:	  Patient	  characteristics	  in	  each	  of	  the	  two	  major	  study	  groups.	  	  	  
Key:	  	  PPM	  permanent	  pacemaker,	  CRT	  cardiac	  resynchronisation	  device,	  ICD	  implantable	  cardioverter	  
defibrillator,	  ACEi	  angiotensin	  converting	  enzyme	  inhibitor,	  ARB	  angiotensin	  receptor	  blocker	  
	  
Of	  the	  total	  cohort	  (n=82)	  71%	  had	  ‘simple’	  TGA	  with	  the	  remainder	  (29%)	  having	  either	  required	  
later	  surgical	  revision	  of	  the	  atrial	  pathways	  or	  having	  associated	  ventricular	  septal	  defect	  (‘complex’	  
TGA).	  	  	  
	  
	  
6.3.1	  	  Arrhythmic	  type	  
Table	  6	  presents	  mean	  and	  median	  values	  as	  necessary	  for	  all	  measured	  ECG	  parameters	  within	  each	  
of	  the	  subgroups.	  	  QRS	  duration	  increases	  significantly	  with	  changing	  arrhythmia	  malignancy	  and	  is	  
greatest	  within	  the	  deceased	  subgroup	  (p=0.0003).	  	  QTc	  interval	  is	  also	  significantly	  different	  
(p=0.0009).	  	  Of	  note,	  neither	  QRSd	  nor	  QTd	  show	  any	  significant	  changes	  within	  any	  of	  the	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   No	  arrhythmias	   Supraventricular	   Ventricular	   Deceased	   P	  value†	  
ECG	  parameters	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  n=46	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  n=17	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  n=7	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  n=13	  
QRS	  *(ms)	   86	  (79-­‐96)	   91	  (80-­‐103)	   107	  (87-­‐153)	   113	  (104-­‐142)	   <0.0001	  
QRSd	  (ms)	   30±10	   37±13	   34±11	   34±7	   0.168	  
QTc	  *(ms)	   394	  (318-­‐405)	   390	  (382-­‐443)	   385	  (373-­‐454)	   443	  (410-­‐465)	   0.0006	  
QTd	  (ms)	   51±17	   58±25	   59±12	   60±13	   0.31	  
JTd	  (ms)	   48±14	   53±15	   64±17	   59±19	   0.016	  
CMR	  imaging	  parameters	  	  	  	  	  	  	  n=30	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  n=9	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  n=5	  
RVEDV	  (ml/m2)	   103±22	   109±32	   124±31	   N/A	   0.237	  
RVESV	  (ml/m2)	   48±17	   54±32	   68±25	   N/A	   0.181	  
RVEF	  (%)	   54±9.	   49±10	   47±9	   N/A	   0.230	  
LVEF	  (%)	   63±7	   57±16	   69±14	   N/A	   0.079	  
Biochemical	  parameters	  
BNP	  *	  (pmol/L)	   17	  (11	  to	  28)	   54	  (25	  to	  121)	   72	  (26	  to	  98)	   N/A	   0.001	  
Table	  6:	  RV	  -­‐right	  ventricular,	  EDV	  end	  diastolic	  volume,	  ESV	  end	  systolic	  volume,	  EF	  ejection	  fraction,	  LV	  left	  ventricular,	  BNP	  
NT-­‐pro	  brain	  natriuretic	  peptide.	  	  




Analysis	  of	  the	  study	  cohort	  as	  two	  independent	  groups	  –	  those	  alive	  at	  the	  time	  of	  investigation	  
(n=69),	  and	  those	  deceased	  (n=13)	  –	  found	  that	  both	  QRS	  duration	  and	  QTc	  interval	  are	  significantly	  
different:	  mean	  QRS	  duration	  94ms	  vs	  118ms	  and	  mean	  QTc	  interval	  400ms	  vs	  445ms	  in	  living	  and	  
deceased	  patients	  respectively	  (p=0.002	  for	  both;	  Figure	  23).	  	  In	  univariate	  analysis	  both	  QRS	  
duration	  and	  QTc	  interval	  were	  associated	  with	  increased	  risk	  of	  death	  (p<0.0001	  for	  both):	  QRS	  
hazard	  ratio	  15	  [95%	  confidence	  interval	  3.3-­‐68.6]	  and	  for	  QTc	  interval	  hazard	  ratio	  10.7	  [95%	  
confidence	  interval	  2.3-­‐49].	  	  A	  QRS	  duration	  cut	  off	  of	  >104ms	  had	  a	  sensitivity	  and	  specificity	  of	  96%	  
and	  66%	  in	  predicting	  death	  whilst	  a	  QTc	  interval	  >406ms	  had	  a	  sensitivity	  and	  specificity	  of	  96%	  and	  
56%	  for	  predicting	  death	  (Figure	  24).	  	  Two	  year	  mortality	  was	  36%	  when	  QRS	  duration	  <	  104ms	  and	  
88%	  when	  >104ms	  (p<0.0001	  for	  difference).	  	  Multivariate	  analysis	  was	  not	  possible	  due	  to	  the	  
strength	  of	  association	  of	  these	  two	  factors.	  	  No	  marker	  of	  dispersion	  was	  associated	  with	  outcome	  
when	  analysed	  independently.	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Figure	  23:	  Comparison	  of	  values	  for	  QRS	  duration	  (left)	  and	  QTc	  interval	  (right)	  in	  the	  cohort	  remaining	  under	  












Figure	  24:	  Kaplan	  Meier	  survival	  curves	  for	  QRS	  (left)	  and	  QTc	  (right):	  	  QRS>103ms	  has	  an	  OR	  13.26	  (CI	  3.60	  to	  
48.85,	  p<0.001)	  compared	  to	  QRS	  <103ms,	  and	  those	  with	  QTc>406ms	  have	  13.27	  (CI	  2.97	  to	  59.36,	  p=0.001)	  
greater	  odds	  of	  mortality	  compared	  to	  those	  below	  406ms.	  
	  
6.4	  	  Discussion	  
This	  study	  finds	  that	  both	  QRS	  duration	  and	  QTc	  interval	  are	  independently	  associated	  with	  mortality	  
in	  adults	  late	  after	  atrial	  switch	  redirection	  surgery	  for	  TGA.	  	  Further;	  cut-­‐off	  values	  for	  these	  two	  
parameters	  are	  within	  the	  perceived	  ‘normal’	  range.	  	  I	  find	  no	  relationship	  between	  QTd	  and	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Morbidity	  and	  mortality	  is	  prevalent	  in	  young	  adults	  with	  atrial	  switch	  TGA4.	  	  Systemic	  RV	  systolic	  
function	  deteriorates	  with	  time	  from	  palliative	  surgery	  and	  this	  in	  turn	  is	  linked	  to	  risk	  of	  arrhythmia	  
and	  outcome16,17	  ,104.	  	  Easily	  applied	  predictive	  risk	  markers	  are	  currently	  not	  available,	  though	  
research	  in	  this	  area	  is	  growing.	  	  The	  establishment	  of	  ubiquitous	  markers	  predictive	  of	  outcome	  
would	  be	  of	  immense	  value	  in	  this	  complex	  cohort	  of	  congenital	  patients.	  
	  
The	  bulk	  of	  evidence	  purporting	  QRS	  duration	  and	  QTc	  interval	  as	  valuable	  risk	  and	  outcome	  
parameters	  is	  found	  in	  adults	  with	  acquired	  or	  cardiomyopathic	  heart	  disease	  -­‐	  prolongation	  of	  
either	  variable	  prompts	  further	  investigation	  of	  possible	  underlying	  cause	  and/or	  instigation	  of	  
prophylactic	  or	  therapeutic	  measures,	  including	  device	  therapy119,	  ,185,186,187,188,189.	  
	  
Increasing	  evidence	  is	  being	  obtained	  to	  show	  a	  similar	  association	  between	  ECG	  parameters	  and	  
outcome	  in	  those	  adults	  with	  CHD	  and	  a	  subpulmonary	  RV;	  however,	  the	  underlying	  
electromechanical	  conditions	  cannot	  be	  translated	  to	  those	  patients	  with	  a	  systemic	  RV,	  and	  in	  this	  
population,	  the	  evidence	  is	  less	  clear	  cut.	  	  
	  
In	  adults	  with	  Mustard	  palliation	  of	  TGA,	  QRS	  duration	  has	  been	  noted	  to	  increase	  with	  follow-­‐up16.	  	  
Gatzoulis	  and	  colleagues	  reported	  that	  those	  with	  previous	  arrhythmia	  (SVT	  or	  VT)	  had	  a	  significantly	  
longer	  duration	  of	  QRS	  than	  those	  without51;	  however,	  in	  this	  cohort	  QRS	  duration	  did	  not	  relate	  to	  
outcome.	  	  Kammeraad	  and	  co-­‐workers	  studied	  patients	  palliated	  by	  Mustard	  and	  Senning	  
techniques	  and	  found	  no	  significant	  differences	  in	  QRS	  duration	  when	  comparing	  patients	  who	  had	  
suffered	  sudden	  death	  with	  those	  that	  had	  not107.	  	  This	  cohort	  constituted	  younger	  patients	  
however,	  whereas	  Schwerzmann	  et	  al	  determined	  that	  a	  QRS	  duration	  >140ms	  was	  associated	  with	  
risk	  of	  malignant	  arrhythmia	  and	  sudden	  death	  adults	  with	  Mustard	  repair105.	  	  	  
	  
QTc	  interval	  has	  been	  the	  subject	  of	  less	  investigation:	  Roos-­‐Hesselink	  did	  document	  that	  this	  did	  
not	  increase	  with	  follow-­‐up16.	  	  Kammeraad	  et	  al	  found	  no	  significant	  difference	  in	  QTc	  interval	  when	  
comparing	  sudden	  death	  events	  with	  a	  matched	  cohort107.	  	  	  
	  
6.4.1	  	  Implications	  
The	  finding	  of	  relatively	  narrow	  measures	  for	  both	  QRS	  duration	  and	  QTc	  interval	  in	  relation	  to	  risk	  
and	  outcome	  will	  demand	  regular	  scrutiny	  of	  the	  12	  lead	  ECG	  in	  this	  population.	  	  If	  identified,	  such	  
patients	  should	  be	  regarded	  as	  ‘high	  risk’	  and	  subsequent	  investigations	  undertaken	  as	  necessary	  to	  
help	  further	  delineate	  this	  risk.	  	  Anti-­‐heart	  failure	  medications	  should	  be	  considered	  as	  required;	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however,	  in	  the	  absence	  of	  clear	  compromising	  haemodynamic	  lesions	  or	  other	  reversible	  cause,	  
this	  study	  would	  suggest	  a	  low	  threshold	  for	  consideration	  of	  prophylactic	  implantable	  cardioverter-­‐
defibrillator	  insertion.	  	  	  
	  
The	  establishment	  of	  a	  QRS	  duration	  >104ms	  as	  being	  independently	  linked	  with	  risk	  of	  death	  
demands	  reconsideration	  of	  ‘normal’	  definitions	  in	  a	  population	  of	  patients	  who,	  by	  necessity,	  are	  
subject	  to	  lifelong	  abnormal	  cardiac	  physiology99.	  	  My	  findings	  carry	  implications	  for	  cardiac	  
resynchronisation	  therapy	  given	  the	  increased	  risk	  at	  such	  a	  ‘narrow’	  QRS	  duration.	  	  Further,	  the	  
question	  of	  earlier,	  unseen,	  compromise	  to	  RV	  systolic	  function	  reflected	  by	  this	  increased	  risk,	  with	  
long-­‐term	  bradyarrhythmia	  pacing	  also	  merits	  consideration.	  	  	  
	  
6.4.2	  	  Conclusion	  
QRS	  duration	  >104ms	  and/or	  QTc	  interval	  >406ms	  are	  related	  to	  increased	  risk	  of	  death	  in	  adults	  
late	  after	  atrial	  redirection	  surgery	  for	  TGA.	  	  I	  propose	  that	  serial	  monitoring	  of	  the	  surface	  ECG	  for	  
these	  parameters	  form	  a	  routine	  assessment	  in	  all	  patients	  with	  atrial	  redirection	  surgery	  for	  TGA.	  	  
In	  association	  with	  proven	  or	  clinical	  suspicion	  of	  arrhythmia,	  a	  QRS	  duration	  >104ms	  and/or	  QTc	  
interval	  >406ms	  should	  prompt	  full	  investigation	  and	  consideration,	  as	  necessary,	  of	  early	  initiation	  
of	  antifailure	  and/or	  anti	  arrhythmia	  therapies.	  	  	  	  
	  
This	  chapter	  therefore	  supports	  the	  theory	  that	  electrical	  parameters	  can	  be	  linked	  to	  outcome	  in	  
those	  with	  a	  systemic	  RV,	  as	  they	  are	  known	  to	  be	  in	  those	  with	  a	  subpulmonary	  RV.	  	  In	  this	  latter	  
group,	  electrical	  remodelling,	  either	  positive	  or	  negative,	  is	  associated	  with	  haemodynamic	  
remodelling.	  	  There	  is	  a	  paucity	  of	  data	  examining	  any	  similar	  relationship	  between	  RV	  volumes	  and	  
function	  and	  electrical	  parameters	  in	  the	  systemic	  RV	  and	  my	  next	  Chapter	  will	  therefore	  study	  this	  
in	  closer	  detail.	  	  I	  have	  also	  chosen	  to	  include	  study	  of	  the	  neurohormonal	  biomarker	  NT-­‐proBNP	  in	  
this	  cohort	  of	  patients,	  examining	  its	  relationship	  in	  this	  complex	  congenital	  population	  to	  both	  RV	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CHAPTER	  7:	  	  Relationship	  of	  systemic	  right	  ventricular	  
function	  to	  ECG	  parameters	  and	  NT-­‐proBNP	  levels	  in	  
adults	  with	  transposition	  of	  the	  great	  arteries	  late	  
after	  Senning	  or	  Mustard	  surgery	  
	  
	  
7.1	  	  Introduction	  
Outcome	  in	  the	  population	  of	  young	  adults	  with	  atrial	  switch	  palliation	  of	  TGA	  is	  related	  to	  the	  
function	  of	  the	  systemic	  RV190.	  	  Cardiac	  magnetic	  resonance	  (CMR)	  imaging	  is	  the	  most	  accurate	  and	  
reproducible	  tool	  for	  assessing	  this112,113;	  however,	  this	  method	  is	  time	  consuming	  and	  availability	  
often	  restricted	  to	  specialist	  centres.	  	  The	  high	  prevalence	  of	  implanted	  pacing/defibrillator	  devices	  
in	  this	  population	  and	  the	  small	  but	  significant	  proportion	  of	  patients	  with	  claustrophobia	  also	  limit	  
its	  use.	  	  CMR	  imaging	  may	  be	  prompted	  following	  clinical	  assessment,	  yet	  patients	  notoriously	  under	  
report	  functional	  ability	  and	  symptoms	  despite	  marked	  impairment	  on	  objective	  testing191.	  Cost	  
effective	  and	  more	  readily	  available	  surrogate	  clinical	  markers	  that	  closely	  relate	  to	  ventricular	  
function	  would	  therefore	  be	  highly	  desirable.	  	  
	  
Elevated	  circulating	  brain	  natriuretic	  peptide	  (BNP)	  levels	  help	  identify	  patients	  with	  impaired	  
systemic	  ventricular	  function96	  and	  relate	  to	  outcome	  in	  those	  with	  acquired	  heart	  disease192.	  	  In	  
mixed	  cohorts	  of	  patients	  with	  congenital	  cardiac	  disease,	  BNP	  has	  been	  shown	  to	  relate	  to	  systemic	  
ventricular	  function	  as	  determined	  by	  echocardiography147	  and	  to	  function	  of	  the	  pressure	  
overloaded	  systemic	  and	  sub-­‐pulmonary	  RV	  as	  determined	  by	  CMR148.	  	  Surface	  ECG	  measures,	  
including	  QRS	  width,	  have	  also	  been	  found	  to	  relate	  to	  RV	  size	  and	  function	  in	  the	  setting	  of	  pressure	  
overload36.	  The	  inter-­‐relationship	  of	  systemic	  RV	  size	  and	  function	  with	  circulating	  BNP	  levels	  and	  
surface	  ECG	  measures	  in	  adults	  with	  transposition	  of	  the	  great	  arteries	  late	  after	  atrial	  switch	  repair	  
is	  unknown.	  
	  
7.1	  	  Methods	  
7.1.1	  	  Study	  population	  	  
Data	  was	  routinely	  collected	  prospectively	  from	  consecutive	  adults	  with	  previous	  Senning	  or	  
Mustard	  surgery	  for	  TGA	  attending	  a	  dedicated	  CHD	  heart	  failure	  clinic	  at	  my	  Institution	  between	  
January	  2008	  and	  March	  2009.	  	  Some	  of	  these	  patients	  had	  been	  included	  for	  study	  in	  the	  previous	  
Chapter,	  however	  all	  current	  patients	  had	  undergone	  assessment	  of	  symptoms	  by	  NYHA	  functional	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class,	  measurement	  of	  circulating	  N-­‐terminal	  pro	  Brain	  Natriuretic	  Peptide	  (NT-­‐proBNP)	  levels	  and	  
surface	  ECG	  as	  part	  of	  their	  routine	  clinic	  work-­‐up.	  	  CMR	  imaging	  was	  performed	  within	  3	  months	  of	  
clinic	  attendance	  in	  accordance	  with	  clinic	  protocols.	  	  	  
	  
7.1.2	  	  Electrocardiography	  	  
Standard	  original	  hard	  copies	  were	  scanned	  and	  analysed	  as	  previously	  explained.	  	  ECG’s	  were	  
analysed	  by	  one	  observer	  (CP)	  who	  was	  blinded	  to	  NT-­‐proBNP	  and	  CMR	  findings.	  	  Average	  QRS	  
duration,	  	  QTc,	  QRS,	  QT	  and	  JT	  dispersions	  (d)	  were	  determined	  across	  the	  12	  leads	  as	  described	  in	  
the	  Materials	  &	  Methods	  section.	  
	  
7.1.3	  	  NT-­‐pro	  Brain	  Natriuretic	  Peptide	  
Peripheral	  venous	  blood	  was	  collected	  from	  each	  patient	  after	  they	  had	  rested	  for	  a	  minimum	  of	  20	  
minutes.	  	  Samples	  were	  centrifuged	  and	  immediately	  analysed	  via	  sandwich	  immunoassay	  using	  
electrochemiluminescence	  (E	  170	  Module,	  Roche	  Diagnostics,	  Basel,	  Switzerland).	  	  
	  
7.1.4	  	  Cardiac	  Magnetic	  Resonance	  Imaging	  
CMR	  imaging	  was	  performed	  using	  a	  1.5T	  scanner	  (Avanto,	  Siemens	  Medical	  Systems,	  Erlangen,	  
Germany),	  with	  assessment	  of	  ventricular	  volumes	  as	  previously	  described.	  	  Manual	  segmentation	  of	  
the	  ventricles	  with	  exclusion	  of	  the	  major	  RV	  trabeculae	  from	  the	  blood	  pool	  volume	  was	  
undertaken.	  	  Quantification	  of	  aortic	  forward	  flow	  volume	  using	  phase	  contrast	  volumetry	  provided	  
an	  internal	  quantitative	  guide	  to	  the	  RV	  stroke	  volume	  and	  improves	  the	  accuracy	  of	  volumetric	  
quantification	  in	  the	  presence	  of	  tricuspid	  valve	  regurgitation193.	  Volumes	  were	  indexed	  to	  body	  
surface	  area.	  
	  
7.1.5	  	  Statistical	  Analysis	  
The	  Kolmogorov-­‐Smirnov	  test	  was	  used	  to	  confirm	  or	  exclude	  normal	  distribution	  for	  each	  variable.	  
Values	  are	  expressed	  as	  mean	  ±	  standard	  deviation	  (SD),	  median	  (25-­‐75th	  percentile	  values)	  or	  
percentages,	  as	  appropriate.	  	  Univariate	  comparisons	  were	  performed	  by	  Student’s	  t-­‐test,	  Mann	  
Whitney	  U	  test,	  and	  Chi-­‐square	  test	  for	  normally	  distributed,	  non-­‐normally	  distributed	  and	  
categorical	  variables	  respectively.	  Pearson’s	  or	  Spearman’s	  correlation	  coefficients	  were	  used	  as	  
appropriate	  to	  look	  for	  univariate	  associations	  between	  continuous	  variables	  (SPSS	  Inc.,	  Chicago,	  
USA	  and	  GraphPad	  Software	  Inc,	  La	  Jolla,	  USA).	  Differences	  were	  considered	  to	  be	  significant	  at	  a	  P	  
value	  of	  <0.05.	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7.3	  	  Results	  
7.3.1	  	  Patient	  characteristics	  
Thirty-­‐five	  adults	  were	  included	  in	  the	  study.	  	  None	  suffered	  decompensated	  heart	  failure	  or	  
compromising	  arrhythmia	  between	  time	  of	  clinic	  attendance	  and	  CMR	  imaging.	  Mean	  age	  was	  
29±6.5	  years	  at	  the	  time	  of	  clinic	  attendance	  and	  14±13.6	  months	  at	  the	  time	  of	  surgery	  (54%	  a	  
Mustard	  operation).	  	  Five	  (14%)	  patients	  had	  associated	  ventricular	  septal	  defects	  repaired	  at	  
original	  palliation	  –	  ‘complex’	  anatomy.	  	  Seven	  further	  patients	  (20%)	  underwent	  later	  surgical	  
revision	  of	  atrial	  pathways.	  For	  the	  purpose	  of	  statistical	  analysis	  these	  12	  patients	  comprised	  the	  
‘complex	  surgical’	  group.	  The	  remaining	  23	  patients	  had	  simple	  TGA	  and	  single	  stage	  surgery.	  	  Ten	  
patients	  were	  taking	  beta-­‐blockers	  (29%),	  18	  angiotensin	  converting	  enzyme	  inhibitors/angiotensin	  
receptor	  blockers	  (51%),	  and	  2	  were	  on	  diuretic	  therapy	  (6%).	  	  Table7	  summarises	  baseline	  
measurements	  of	  all	  investigations.	  	  
	  
Twelve	  patients	  were	  in	  NYHA	  class	  II	  (34%)	  with	  the	  remainder	  in	  functional	  class	  I.	  	  	  	  Patients	  in	  
NYHA	  class	  II	  had	  significantly	  longer	  QRS	  duration	  (90±3	  vs	  113±8ms;	  p=0.003),	  QRSd	  (30±2	  vs	  
39±4ms	  p=0.03)	  and	  QTc	  interval	  (390±8	  vs	  426±17ms;	  P=0.03)	  compared	  to	  those	  in	  functional	  class	  
I.	  	  RV	  end	  systolic	  indexed	  volume	  (RVESVI)	  (48±3	  vs	  64±8ml/m2;	  P=0.04)	  and	  NT-­‐proBNP	  (29±6	  vs	  
56±10pmol/L;	  p=0.02)	  were	  also	  higher	  in	  patients	  in	  NYHA	  class	  II.	  There	  was	  no	  statistical	  
difference	  between	  functional	  classes	  with	  respect	  to	  palliation	  method,	  age	  at	  follow-­‐up,	  age	  at	  
repair	  or	  RVEF.	  	  
	  
7.3.2	  	  Complex	  vs	  Simple	  Surgical	  Course	  
Compared	  to	  those	  with	  uncomplicated	  surgery,	  patients	  with	  complex	  anatomical	  and	  surgical	  
history	  had	  higher	  NT-­‐proBNP	  levels	  (55±26	  vs	  20±35pmol/L;	  P=0.002)	  and	  longer	  QRS	  duration	  
(116±28ms	  vs	  89±11ms;	  P=0.0004;	  Table	  7)	  whilst	  showing	  no	  difference	  in	  NYHA	  class,	  RV	  volumes	  
or	  RV	  function.	  	  Four	  of	  those	  with	  ‘complex’	  history	  had	  undergone	  Senning	  palliation	  as	  compared	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   All	  (n=35	   Surgery	  type	   P	  
value	  










Age,	  median	  (range),	  years	   29	  (18-­‐40)	   33	  (22-­‐40)	   25	  (18-­‐39)	   0.0003	   28	  (18-­‐38)	   34	  (19-­‐40)	   0.17	  
Age	  at	  surgery,	  median	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  (range),	  months	  
9	  (1-­‐52)	   12	  (3-­‐52)	   6	  (1-­‐48)	   0.01	   9	  (4-­‐36)	   13	  (1-­‐52)	   0.02	  
Male/female	   24/11	   11/8	   13/3	   -­‐-­‐-­‐	   15/8	   9/3	   -­‐-­‐-­‐	  

















RVESVI,	  mL/m2	   53±21	   55±23	   50±19	   0.44	   50±7	   60±31	   0.16	  
RVEF,	  %	   51±8	   50±8	   52±8	   0.65	   52±7	   49±10	   0.25	  

















QTc,	  ms	   402±47	   414±57	   388±26	   0.10	   395±39	   420±59	   0.15	  
	  
Table	  7.	  Patient	  characteristics	  and	  results	  for	  Cardiac	  Magnetic	  Resonance,	  NT-­‐pro	  BNP	  and	  ECG	  measures	  in	  all	  
patients	  and	  according	  to	  surgical	  history.	  	  Values	  are	  mean±SD	  unless	  stated	  otherwise.	  	  RVEDVI	  and	  RVESVI	  refer	  to	  
indexed	  right	  ventricular	  volumes	  during	  diastole	  and	  systole	  respectively.	  Definitions	  of	  simple	  and	  complex	  surgical	  
course	  are	  given	  in	  the	  text.	  *P	  value	  becomes	  NS	  when	  corrected	  for	  age.	  §Encompasses	  those	  with	  complex	  anatomy	  
and	  those	  with	  further	  surgical	  reintervention. 	  
	  
	  
7.3.3	  	  Cardiac	  Magnetic	  Resonance	  Imaging	  
For	  the	  cohort	  as	  a	  whole,	  mean	  RV	  end	  diastolic	  indexed	  volume	  (RVEDVI)	  was	  108±27ml/m2,	  mean	  
RVESVI	  53±21ml/m2	  and	  mean	  RVEF	  51±8%.	  	  RVEDVI	  did	  not	  relate	  to	  age	  at	  follow	  up	  (P=0.8)	  or	  age	  
at	  palliative	  surgery	  (P=0.5).	  There	  was	  also	  no	  statistical	  difference	  when	  comparing	  CMR	  measures	  
between	  those	  with	  Mustard	  and	  Senning	  palliation.	  
	  
7.3.4	  	  NT-­‐proBNP	  measurements	  
Mean	  plasma	  NT-­‐proBNP	  concentration	  was	  38±34	  pmol/L.	  There	  was	  no	  relationship	  between	  NT-­‐
proBNP	  and	  age	  at	  clinic	  attendance	  or	  age	  at	  palliation.	  There	  was	  a	  trend	  towards	  higher	  NT-­‐
proBNP	  levels	  in	  females	  (p=0.054)	  but	  values	  were	  unrelated	  to	  renal	  function	  (creatinine	  p=0.6).	  	  
NT-­‐proBNP	  levels	  were	  significantly	  higher	  in	  those	  with	  Mustard	  palliation	  compared	  to	  those	  who	  
underwent	  Senning	  surgery	  (50±38	  vs	  23±22;	  p=0.01),	  but	  this	  significance	  was	  lost	  when	  adjusting	  
for	  age	  (p=0.09).	  	  	  
	  
NT-­‐proBNP	  and	  CMR	  
There	  was	  a	  significant	  negative	  correlation	  between	  NT-­‐proBNP	  levels	  and	  RV	  ejection	  fraction	  (r=	  -­‐
0.54,	  p=0.0007;	  Figure	  25)	  corresponding	  with	  significant	  positive	  correlations	  between	  NT-­‐proBNP	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levels	  and	  both	  indexed	  end	  diastolic	  and	  systolic	  volumes	  (r=0.43,	  p=0.01	  and	  r=0.53,	  p=0.001	  
respectively;	  Table	  8).	  	  No	  association	  was	  found	  between	  NT-­‐proBNP	  levels	  and	  LV	  ejection	  fraction	  
or	  LV	  volume	  measurements.	  	  	  
	  
Figure	  25:	  	  Correlations	  between	  right	  ventricular	  ejection	  fraction	  (panel	  a),	  or	  indexed	  right	  ventricular	  
volumes	  (panel	  b),	  and	  NT-­‐proBNP.	  
	  
	   RVEDVI	   RVESVI	   RVEF	  






























Table	  8:	  Correlation	  coefficients	  of	  Cardiac	  Magnetic	  Resonance	  measurements	  with	  NT-­‐proBNP	  and	  ECG	  
parameters.	  	  RVEDVI	  and	  RVESVI	  refer	  to	  indexed	  right	  ventricular	  volumes	  during	  diastole	  and	  systole	  
respectively.	  
	  
7.3.5	  	  ECG	  measurements	  
Mean	  QRS	  duration	  was	  98±23ms,	  QTc	  interval	  402±47ms,	  QRSd	  33±12ms,	  JTd	  53±18ms	  and	  QTd	  
57±22ms.	  	  No	  ECG	  parameter	  related	  to	  age	  at	  follow-­‐up,	  age	  at	  palliation	  or	  the	  palliative	  subtypes.	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ECG	  and	  CMR	  
QRS	  duration,	  QRSd,	  QTc	  and	  QTd	  all	  correlated	  significantly	  with	  both	  RVEDVI	  and	  RVESVI	  (Table	  8),	  
the	  most	  significant	  correlation	  being	  between	  QRSd	  and	  RVEDVI	  (r=0.60,	  P≤0.0001;	  Figure	  26).	  	  QRS	  
duration,	  QRSd	  and	  QTc	  all	  had	  inverse	  relationships	  to	  RVEF.	  	  Only	  QTd	  showed	  no	  relation	  with	  
RVEF	  and	  it	  was	  the	  only	  ECG	  parameter	  to	  show	  a	  correlation	  with	  LVEF	  (r=	  -­‐0.39,	  P=0.02).	  
	  
Figure	  26:	  	  Correlations	  between	  right	  ventricular	  ejection	  fraction	  and	  QTc	  (panel	  a),	  and	  indexed	  right	  
ventricular	  volumes	  and	  QRS	  dispersion	  (panel	  b).	  
	   	  
	  
7.4	  	  Discussion	  
This	  is	  the	  largest	  prospective	  study	  examining	  the	  inter-­‐relationship	  between	  NT-­‐proBNP,	  ECG	  
parameters	  and	  systemic	  RV	  function	  in	  a	  homogenous	  cohort	  of	  adults	  late	  after	  atrial	  switch	  
redirection	  surgery	  for	  TGA.	  	  It	  demonstrates	  that	  larger	  systemic	  RV	  volumes	  and	  lower	  ejection	  
fractions	  are	  associated	  with	  higher	  circulating	  levels	  of	  NT-­‐proBNP	  and	  longer	  ECG	  measures	  of	  
ventricular	  depolarisation	  and	  repolarisation.	  This	  pattern	  of	  falling	  systemic	  ventricular	  function,	  
increasing	  circulating	  natriuretic	  peptide	  levels	  and	  prolongation	  of	  ECG	  measures	  characterises	  the	  
heart	  failure	  syndrome	  in	  acquired	  heart	  disease	  and	  adds	  further	  support	  to	  the	  view	  that	  many	  
congenital	  heart	  diseases	  are,	  in	  essence,	  heart	  failure	  syndromes99.	  
	  
It	  is	  interesting	  to	  note	  that	  NT-­‐proBNP	  levels	  were	  higher	  and	  QRS	  width	  longer	  in	  the	  group	  with	  
complex	  anatomical	  and	  surgical	  history	  compared	  to	  those	  without,	  whilst	  at	  the	  same	  time	  NYHA	  
class	  and	  CMR	  measures	  of	  RV	  volumes	  and	  function	  showed	  no	  difference	  between	  these	  groups.	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These	  findings	  suggest	  that	  NT-­‐proBNP	  levels	  and	  ECG	  parameters	  provide	  information	  about	  heart	  
failure	  status	  over	  and	  above	  that	  determined	  by	  symptom	  assessment	  and	  CMR.	  
	  
The	  subjective	  nature	  of	  symptom	  scores	  and	  the	  poor	  correlation	  between	  symptoms	  and	  
cardiopulmonary	  exercise	  capacity,	  a	  powerful	  predictor	  of	  prognosis191,	  is	  well	  known.	  The	  relatively	  
poor	  prognostic	  power	  of	  left	  ventricular	  ejection	  fraction	  in	  patients	  with	  acquired	  heart	  failure	  
compared	  to	  ventilatory	  efficiency	  and	  natriuretic	  peptide	  levels	  is	  also	  well	  documented194.	  Taken	  
together	  with	  these	  findings,	  this	  suggests	  that	  symptom	  assessment	  and	  measurement	  of	  RV	  
volumes	  and	  function	  alone	  may	  not	  provide	  the	  optimum	  description	  of	  pathological	  processes	  in	  a	  
particular	  patient	  and	  may	  not	  be	  the	  best	  measures	  to	  use	  when	  determining	  future	  risk.	  It	  would	  
be	  helpful	  to	  clarify	  the	  relative	  prognostic	  power	  of	  these	  various	  measures	  in	  futures	  studies.	  
	  
7.4.1	  	  Natriuretic	  peptides	  and	  systemic	  right	  ventricular	  function	  
NT-­‐proBNP	  levels	  were	  higher	  in	  the	  Mustard	  cohort	  compared	  to	  the	  Senning	  cohort.	  	  This	  perhaps	  
reflects	  developing	  surgical	  practice,	  with	  earlier	  age	  at	  palliation	  using	  the	  Senning	  technique	  
superseding	  the	  relatively	  later	  palliation	  age	  with	  the	  former	  technique.	  The	  trend	  towards	  
significantly	  higher	  levels	  after	  adjusting	  for	  these	  variables;	  however,	  implies	  that	  an	  intrinsic	  
disadvantage	  of	  Mustard	  surgery	  over	  the	  Senning	  operation	  cannot	  be	  excluded	  with	  confidence	  on	  
these	  data.	  
	  
NT-­‐proBNP	  levels	  correlated	  significantly	  with	  RVEDVi	  and	  RVESVi.	  	  BNP	  levels	  have	  also	  been	  shown	  
by	  others	  to	  relate	  to	  the	  severity	  of	  tricuspid	  regurgitation	  and	  RV	  volume	  overload	  following	  
Mustard	  and	  Senning	  surgery146,195.	  Tulevski	  and	  colleagues	  included	  9	  patients	  with	  TGA	  palliated	  by	  
Mustard	  or	  Senning	  procedure	  in	  a	  heterogenous	  group	  and	  found	  that	  RVEF,	  measured	  by	  CMR,	  
correlated	  negatively	  to	  BNP	  levels	  (r=	  -­‐0.65)148.	  	  Garg	  and	  co-­‐workers	  found	  no	  correlation	  between	  
RVEF	  and	  BNP	  in	  patients	  with	  systemic	  RV	  physiology,	  although	  there	  was	  a	  strong	  correlation	  with	  
atrial	  natriuretic	  peptide	  (ANP)153;	  a	  somewhat	  surprising	  result	  as	  both	  ANP	  and	  BNP	  correlate	  
exceptionally	  closely	  (r=0.91,	  P<0.0001)	  in	  adults	  with	  CHD147.	  	  
	  
Although	  similar	  relationships	  between	  BNP	  levels	  and	  RV	  volumes	  have	  also	  been	  described	  in	  the	  
context	  of	  sub-­‐pulmonary	  RV	  anatomy196	  Neffke	  et	  al	  found	  only	  a	  weak	  correlation	  between	  BNP	  
and	  RVEDV36	  in	  a	  heterogeneous	  cohort	  with	  systemic	  or	  subpulmonary	  RV	  physiology.	  	  This	  suggests	  
that	  pathophysiological	  responses	  differ	  between	  various	  anatomic	  substrates,	  reflected	  in	  the	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mechanism	  of	  neurohormone	  production,	  and	  that	  these	  substrates	  might	  be	  better	  investigated	  in	  
isolation.	  
	  
7.4.2	  	  Electrocardiographic	  markers	  and	  systemic	  right	  ventricular	  function	  
In	  patients	  with	  acquired	  heart	  disease,	  QRS	  duration	  is	  a	  measure	  of	  myocardial	  electromechanical	  
dissociation,	  helps	  guide	  the	  prescription	  of	  resynchronisation	  therapy	  and	  is	  useful	  in	  assessing	  the	  
risk	  of	  malignant	  arrhythmias98.	  	  Prolongation	  of	  QRS	  duration	  and	  dispersion	  are	  likely	  to	  reflect	  the	  
effects	  of	  chronic	  pressure	  overload	  and	  myocardial	  stretch	  on	  the	  systemic	  RV	  and	  indicate	  
electromechanical	  uncoupling	  here	  also.	  This	  study	  demonstrates	  the	  close	  relationship	  between	  
measures	  of	  ventricular	  depolarisation	  and	  repolarisation	  with	  volume	  and	  function	  of	  the	  systemic	  
RV	  and	  indeed,	  Gatzoulis	  and	  colleagues	  reported	  similar	  associations	  with	  respect	  to	  QRS	  duration	  
in	  a	  comparable	  cohort104.	  	  Neffke	  et	  al	  found	  that	  QRS	  dispersion	  manifested	  a	  greater	  rate	  of	  
change	  over	  time	  than	  QRS	  duration	  in	  this	  context36,	  describing	  that	  the	  latter	  measure	  did	  not	  
significantly	  increase	  over	  5	  years	  follow-­‐up.	  	  This	  is	  in	  contrast	  to	  Roos-­‐Hesselink	  and	  colleagues	  
who	  confirm	  significant	  increases	  in	  QRS	  duration	  over	  long-­‐term	  follow	  up	  in	  a	  large	  cohort	  
accompanying	  deterioration	  in	  systemic	  RV	  function	  as	  measured	  by	  echocardiographyError!	  
Bookmark	  not	  defined..	  
	  
Prolonged	  QTd	  has	  been	  shown	  to	  be	  an	  independent	  predictor	  of	  late	  arrhythmia	  in	  patients	  with	  
Mustard	  palliation	  and,	  in	  combination	  with	  loss	  of	  sinus	  rhythm	  on	  the	  surface	  ECG,	  it	  has	  been	  
associated	  with	  sudden	  cardiac	  death	  in	  adults	  with	  either	  Mustard	  or	  Senning	  palliation106.	  	  
Recently,	  Schwerzmann	  and	  colleagues	  suggested	  that	  a	  cut-­‐off	  QRS	  duration	  of	  >140ms	  defines	  a	  
group	  of	  adults	  after	  Mustard	  palliation	  at	  increased	  risk	  of	  malignant	  arrhythmia	  or	  sudden	  
death105.	  	  By	  contrast,	  Kammeraad	  and	  co-­‐workers	  were	  unable	  to	  find	  differences	  in	  QRS	  duration,	  
QTc	  or	  QTd	  between	  patients	  with	  TGA	  that	  had	  died	  suddenly	  and	  those	  that	  had	  not107.	  
	  
The	  relationships	  of	  these	  various	  ECG	  parameters	  to	  electromechanical	  dyssynchrony	  in	  the	  
systemic	  RV	  and	  to	  prognosis	  in	  palliated	  TGA	  therefore	  need	  further	  clarification.	  They	  may	  yet	  
provide	  useful	  insight	  into	  the	  mechanisms	  that	  drive	  outcome	  and	  could	  help	  guide	  
resynchronisation	  therapy	  in	  a	  group	  where	  the	  evidence	  base	  for	  this	  therapy	  remains	  narrow.	  
	  
7.4.3	  	  Limitations	  
Although	  this	  cohort	  represents	  a	  large	  sample	  size	  in	  this	  congenital	  population,	  these	  patients	  
were	  only	  investigated	  at	  a	  single	  time	  point.	  	  Serial	  investigation	  will	  provide	  more	  data	  with	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regards	  to	  prognostic	  value	  of	  NT-­‐proBNP.	  	  Furthermore,	  and	  as	  previously	  stated,	  NT-­‐proBNP	  
measurements	  were	  undertaken	  within	  three	  months	  of	  CMR	  imaging,	  and	  are	  thus	  not	  concurrent.	  	  
However,	  no	  patient	  suffered	  symptomatic	  decline	  necessitating	  admission	  in	  the	  interim.	  
	  
7.4.4	  	  Conclusion	  
This	  study	  of	  patients	  late	  after	  surgical	  palliation	  of	  TGA	  describes	  the	  close	  relationships	  between	  
NT-­‐proBNP,	  ECG	  parameters	  and	  measures	  of	  systemic	  RV	  function.	  Circulating	  peptide	  levels	  and	  
surface	  ECG	  parameters	  constitute	  safe,	  cost	  effective	  and	  widely	  available	  surrogate	  markers	  of	  
systemic	  RV	  function	  and	  provide	  useful	  additional	  information	  on	  heart	  failure	  status.	  Both	  
measures	  hold	  promise	  as	  prognostic	  markers	  and	  their	  association	  with	  long-­‐term	  outcome	  should	  
be	  determined.	  
	  
The	  next	  Chapter	  sought	  to	  further	  study	  the	  role	  of	  CMR	  imaging	  in	  evaluating	  the	  systemic	  RV.	  	  
Diffuse	  fibrosis	  has	  been	  described	  in	  adults	  with	  LV	  disease	  and,	  in	  combination	  with	  
neurohormonal	  markers,	  is	  considered	  a	  marker	  of	  cardiac	  disease	  severity.	  	  It’s	  presence,	  and	  
relation	  to	  other	  disease	  parameters	  in	  the	  systemic	  RV	  has	  not	  previously	  been	  investigated.	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CHAPTER	  8:	  	  Diffuse	  Myocardial	  Fibrosis	  in	  the	  




8.1	  	  Introduction	  
As	  previously	  stated,	  though	  intra-­‐atrial	  repair	  (Mustard	  and	  Senning	  operations)	  of	  TGA	  has	  been	  
largely	  been	  superseded	  by	  the	  arterial	  switch	  operation,	  there	  remains	  a	  sizeable	  population	  of	  
adults	  under	  regular	  follow-­‐up	  who	  underwent	  such	  early	  palliative	  surgery.	  	  With	  the	  morphologic	  
RV	  supporting	  the	  systemic	  circulation,	  there	  is	  a	  high	  burden	  of	  early	  morbidity	  and	  mortality	  from	  
heart	  failure	  and	  sudden	  cardiac	  death5.	  Long-­‐term	  outcome	  in	  this	  cohort	  relates	  to	  the	  function	  of	  
the	  systemic	  RVError!	  Bookmark	  not	  defined.	  and	  CMR	  imaging	  is	  widely	  regarded	  as	  the	  best	  
available	  imaging	  modality	  for	  this	  purpose112,112.	  	  
	  
Other	  markers	  of	  heart	  failure	  severity,	  including	  high	  circulating	  brain	  natriuretic	  peptide	  (NT-­‐
proBNP)	  levels	  and	  impaired	  cardiopulmonary	  exercise	  (CPEX)	  performance,	  have	  also	  been	  
described	  in	  adults	  with	  CHD96,147,147.	  Both	  measures	  have	  been	  shown	  to	  relate	  to	  long-­‐term	  
prognosis	  in	  mixed	  cohorts	  with	  CHD	  and	  in	  those	  with	  a	  systemic	  RV158,158,159,160,197,198.	  
	  
Myocardial	  fibrosis	  is	  considered	  to	  be	  a	  marker	  of	  disease	  severity	  and	  its	  presence	  is	  used	  to	  
monitor	  disease	  progression	  and	  regression199.	  	  In	  those	  with	  previous	  Mustard	  or	  Senning	  surgery,	  
focal	  fibrosis,	  assessed	  using	  the	  late	  gadolinium	  enhancement	  (LGE)	  technique,	  has	  been	  found	  to	  
correlate	  with	  systolic	  function	  of	  the	  systemic	  RV	  and	  with	  documented	  arrhythmia200.	  	  However,	  
the	  LGE	  method	  does	  not	  allow	  evaluation	  of	  diffuse	  fibrosis	  and	  this	  latter	  has	  been	  found	  to	  
correlate	  with	  systemic	  RV	  end-­‐diastolic	  volume	  and	  ejection	  fraction	  in	  a	  small	  cohort	  described	  by	  
Broberg	  et	  al201.	  	  Equilibrium	  contrast	  CMR	  (EQ-­‐CMR)	  has	  previously	  been	  validated	  against	  cardiac	  
biopsy	  determination	  of	  diffuse	  fibrosis	  for	  assessment	  of	  left	  ventricular	  interstitial	  expansion	  (a	  
surrogate	  marker	  of	  diffuse	  fibrosis	  in	  most	  disease	  states)	  in	  patients	  with	  severe	  aortic	  stenosis	  
and	  hypertrophic	  cardiomyopathy	  202.	  The	  technique	  is	  similar	  to	  that	  of	  Broberg,	  but	  the	  use	  of	  
equilibrium	  contrast	  removes	  uncertainties	  regarding	  contrast	  kinetics	  in	  heart	  failure	  or	  renal	  
impairment	  and	  does	  not	  require	  an	  assumption	  of	  pseudoequilibrium.	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In	  this	  prospective	  study	  EQ-­‐CMR	  was	  used	  to	  evaluate	  diffuse	  fibrosis	  in	  adults	  late	  after	  atrial	  
redirection	  surgery	  for	  TGA,	  comparing	  the	  results	  to	  both	  normal	  subjects	  and	  also	  other	  heart	  
failure	  parameters	  to	  determine	  its	  usefulness	  as	  a	  measure	  of	  disease	  severity.	  	  	  
	  
	  
8.2	  	  Methods:	  
8.2.1	  	  Study	  population	  
Fourteen	  adult	  patients	  with	  previous	  Senning	  or	  Mustard	  surgery	  for	  TGA,	  followed	  up	  in	  a	  
dedicated	  CHD	  heart	  failure	  clinic	  at	  my	  Institution,	  were	  thus	  prospectively	  recruited	  between	  June	  
2009	  and	  June	  2010.	  	  These	  patients	  were	  of	  similar	  characteristics	  to	  their	  peers	  in	  the	  previous	  
studies,	  but	  all	  patients	  underwent	  measurement	  of	  NT-­‐pro	  BNP,	  CPEX	  testing	  and	  CMR	  imaging	  
within	  a	  three-­‐month	  period.	  	  This	  was	  a	  prospective	  study.	  	  None	  required	  admission	  for	  
decompensated	  heart	  failure	  during	  this	  time.	  	  These	  patients	  were	  compared	  to	  14	  age	  and	  gender-­‐
matched	  normal	  subjects,	  as	  there	  is	  some	  evidence	  to	  suggest	  an	  increase	  in	  ECV	  with	  age203.	  All	  
normal	  subjects	  underwent	  cardiac	  history	  and	  examination,	  12	  lead	  ECG	  and	  CMR	  to	  ensure	  they	  
did	  not	  have	  any	  underlying	  cardiovascular	  disease.	  	  The	  study	  had	  Institutional	  approval	  and	  all	  
patients	  and	  normal	  subjects	  gave	  informed	  consent	  to	  participate	  in	  the	  study.	  
	  
8.2.2	  	  NT-­‐pro	  brain	  natriuretic	  peptide	  
Peripheral	  venous	  blood	  was	  collected	  from	  each	  patient	  after	  they	  had	  rested	  for	  a	  minimum	  of	  20	  
minutes.	  	  Samples	  were	  centrifuged	  and	  immediately	  analysed	  via	  sandwich	  immunoassay,	  using	  
electrochemiluminescence	  (E	  170	  Module,	  Roche	  Diagnostics,	  Basel,	  Switzerland).	  	  
	  
8.2.3	  CMR	  
CMR	  was	  performed	  using	  a	  1.5T	  Siemens	  Avanto	  scanner	  (Siemens	  Medical	  Systems,	  Erlangen,	  
Germany),	  with	  assessment	  of	  ventricular	  volumes	  as	  previously	  described.	  	  Manual	  segmentation	  of	  
the	  ventricles,	  with	  exclusion	  of	  the	  major	  RV	  trabeculae	  from	  the	  blood	  pool	  volume,	  was	  
undertaken.	  	  Quantification	  of	  aortic	  forward	  flow	  volume,	  using	  phase	  contrast	  volumetry,	  provided	  
an	  internal	  quantitative	  guide	  to	  the	  RV	  stroke	  volume	  and	  improved	  the	  accuracy	  of	  volumetric	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Equilibrium	  contrast	  CMR	  	  
EQ-­‐CMR,	  as	  previously	  validated	  against	  histology	  in	  aortic	  stenosis	  and	  hypertrophic	  
cardiomyopathy202,	  is	  an	  add-­‐on	  to	  a	  standard	  clinical	  scan.	  We	  quantified	  the	  tissue	  volume	  of	  
distribution,	  a	  marker	  of	  the	  extracellular	  volume	  (ECV),	  of	  the	  routine	  clinical	  contrast	  agent,	  
Gadoteratemeglumine,	  (gadolinium-­‐DOTA,	  marketed	  as	  Dotarem	  ©	  Guerbet	  S.A.	  France)	  which	  
partitions	  freely	  between	  the	  plasma	  and	  interstitial	  space	  but	  does	  not	  enter	  cells.	  Interstitial	  tissue	  
volume	  is	  primarily	  determined	  by	  the	  amount	  of	  extracellular	  matrix.	  EQ-­‐CMR	  involves	  three	  steps:	  
1)	  a	  standard	  gadolinium	  bolus	  followed	  by	  constant	  infusion	  to	  eliminate	  contrast	  kinetic	  effects	  
and	  achieve	  an	  equilibrium	  contrast	  state	  throughout	  the	  body;	  2)	  signal	  intensity	  (T1)	  measurement	  
pre-­‐	  and	  post-­‐contrast	  equilibrium	  using	  CMR;	  and	  3)	  a	  direct	  measure	  of	  blood	  volume	  of	  contrast	  
distribution,	  by	  taking	  a	  complete	  blood	  count,	  and	  equating	  the	  blood	  volume	  of	  contrast	  
distribution	  to	  one	  minus	  the	  haematocrit.	  The	  ECV	  is	  then	  calculated	  as204:	  
	  
ECV	  	  =	  	  (1-­‐hematocrit)	  x	  (1/T1	  myocardium	  post	  contrast	  -­‐	  1/T1	  myocardium	  pre	  contrast)	  
(1/T1	  blood	  post	  contrast	  -­‐	  1/T1	  blood	  pre	  contrast)	  
	  
In	  this	  study,	  T1	  mapping	  was	  performed	  using	  the	  same	  method	  as	  previously	  described,	  fast	  low	  
angle	  single	  shot	  inversion	  recovery	  (FLASH	  IR)	  at	  increasing	  inversion	  times,	  in	  a	  mid-­‐short	  axis	  
slice.17	  The	  blood	  T1	  was	  assessed	  using	  a	  region	  of	  interest	  within	  the	  LV	  cavity.	  The	  myocardial	  T1	  
was	  assessed	  using	  a	  region	  of	  interest	  within	  the	  interventricular	  septum	  and	  also	  within	  the	  RV	  
free	  wall.	  	  
	  
8.2.4	  	  Cardiopulmonary	  exercise	  testing	  
CPEX	  was	  performed	  on	  an	  electronically	  braked	  ergometer	  cycle	  (Lode,	  Groningen,	  Holland)	  with	  
computerised	  breath-­‐by-­‐breath	  ventilator	  gas	  analysis	  (MedGraphics,	  Minnesota,	  USA).	  	  The	  CPEX	  
protocol	  has	  been	  described	  in	  the	  Materials	  &	  Methods	  section.	  
	  
8.2.5	  	  Statistical	  Analysis	  
The	  Kolmogorov-­‐Smirnov	  test	  was	  used	  to	  assess	  normality.	  Values	  are	  expressed	  as	  mean	  ±	  
standard	  deviation	  (SD),	  median	  (25-­‐75th	  percentile	  values)	  or	  percentages,	  as	  appropriate.	  	  
Univariate	  comparisons	  were	  performed	  by	  Student’s	  t-­‐test,	  Mann	  Whitney	  U	  test,	  and	  Chi-­‐square	  
test	  for	  normally	  distributed,	  non-­‐normally	  distributed	  and	  categorical	  variables	  respectively.	  
Pearson’s	  or	  Spearman’s	  correlation	  coefficients	  were	  used	  as	  appropriate	  to	  look	  for	  univariate	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associations	  between	  continuous	  variables	  (SPSS	  Inc.,	  Chicago,	  USA	  and	  GraphPad	  Software	  Inc,	  La	  




8.3.1	  	  Patient	  and	  control	  subject	  characteristics	  
The	  fourteen	  patients	  (6	  female)	  had	  a	  mean	  age	  of	  33.7±6.5	  years	  and	  median	  age	  at	  palliation	  of	  
9.7(7-­‐20)	  months	  (Table	  9).	  	  Six	  (43%)	  had	  Senning	  palliation.	  Details	  of	  the	  fourteen	  normal	  subjects	  
(6	  female,	  median	  age	  32,	  range	  24-­‐49)	  are	  also	  in	  table	  9.	  
	  
	   TGA	  (n=14)	   Controls	  (n-­‐14)	   p	  value	  
Age,	  years	   34±7	   32(24-­‐49)	   0.64	  
Age	  at	  surgery,	  median	  (range),	  months	   10(7-­‐20)	   -­‐/-­‐	   -­‐/-­‐	  
Male/female	   8/6	   8/6	   -­‐/-­‐	  
NYHA	  functional	  class	  I/II	   12/2	   14/-­‐0	   -­‐/-­‐	  

















Table	  9:	  	  Table	  comparing	  controls	  to	  those	  with	  a	  systemic	  RV.	  	  EDVi	  and	  ESVi	  refer	  to	  indexed	  ventricular	  volumes	  during	  
diastole	  and	  systole	  respectively.	  	  	  
	  
8.3.2	  CMR	  
Mean	  indexed	  RV	  end	  diastolic	  volume	  (RVEDVi)	  was	  79±13ml/min2,	  mean	  indexed	  RV	  end	  systolic	  
volume	  (RVESVi)	  35±4ml/min2	  and	  mean	  RV	  ejection	  fraction	  (RVEF)	  59±5%	  (Table	  9).	  	  No	  patients	  
had	  any	  focal,	  macroscopic	  areas	  of	  LGE.	  	  	  Mean	  septal	  ECV	  in	  patients	  was	  0.254±0.036,	  which	  was	  
significantly	  higher	  than	  that	  of	  normal	  subjects	  (0.230±0.032;	  p=	  0.03).	  	  There	  was	  no	  correlation	  
between	  CMR	  measures	  of	  systemic	  RV	  volume	  or	  systolic	  function	  to	  septal	  ECV.	  
	  
Right	  Ventricular	  Free	  Wall	  ECV	  
It	  was	  not	  possible	  to	  accurately	  assess	  the	  ECV	  in	  the	  right	  ventricular	  free	  wall	  (or	  any	  other	  right	  
ventricular	  segment	  away	  from	  the	  septum)	  using	  the	  current	  method.	  This	  was	  mainly	  due	  to	  
trabeculation	  which	  resulted	  in	  myocardial	  regions	  of	  interest	  partial	  voluming	  with	  blood.	  The	  
presence	  of	  blood	  in	  the	  region	  of	  interest	  will	  falsely	  elevate	  the	  ECV.	  	  	  The	  problem	  is	  illustrated	  in	  
Figure	  27.	  	  This	  assessment	  was	  therefore	  abandoned	  and	  only	  septal	  ECV	  is	  reported.	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Figure	  27:	  FLASH	  IR	  short	  axis	  images	  from	  a	  patient	  with	  a	  systemic	  right	  ventricle	  taken	  at	  an	  inversion	  time	  
of	  700ms	  on	  contrast	  infusion	  is	  shown.	  In	  pane	  a)	  the	  anatomy	  is	  depicted	  (RV	  =	  right	  ventricle	  and	  LV	  =	  left	  
ventricle).	  In	  pane	  b)	  the	  problems	  in	  assessing	  right	  ventricular	  free	  wall	  T1	  are	  shown.	  The	  region	  of	  interest	  
drawn	  partial	  volumes	  both	  blood	  and	  myocardium	  due	  to	  trabeculation.	  Although	  less	  important,	  artefact	  
from	  sternal	  wires	  is	  also	  present	  (arrowed).	  Partial	  voluming	  with	  myocardium	  and	  blood	  was	  a	  problem	  in	  
nearly	  all	  patients	  in	  all	  right	  ventricular	  segments.	  
	  
EQ-­‐CMR	  and	  NT-­‐proBNP	  
Median	  NT-­‐proBNP	  was	  19.5	  (14-­‐45)	  pmol/L.	  	  NT-­‐proBNP	  showed	  a	  positive	  relationship	  with	  septal	  






















Figure	  28:	  Graph	  shows	  positive	  relationship	  between	  increasing	  NT-­‐proBNP	  and	  Septal	  ECV	  
	  
EQ-­‐CMR	  and	  CPEX	  testing	  
CPEX	  testing	  provided	  the	  following	  data:	  mean	  ChI	  0.69±0.21,	  mean	  pVO2	  22±8ml/kg/min	  and	  mean	  
VE/VCO2	  slope	  28±5	  (Table	  9).	  	  There	  was	  no	  association	  between	  Septal	  ECV	  and	  either	  pVO2	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(p=0.24;	  r=0.38)	  or	  VE/VCO2	  slope	  (p=0.60;	  r=0.18).	  	  There	  was;	  however,	  a	  significant	  negative	  
correlation	  between	  septal	  ECV	  and	  chronotropic	  index	  (p=0.04;	  r=0.58.	  	  (Figure	  29).	  
	  
Figure	  29:	  	  Significant	  negative	  relationship	  between	  ChI	  and	  septal	  ECV.	  	  	  
	  
	  
8.4	  	  Discussion	  	  
This	  study	  suggests	  that	  diffuse	  fibrosis	  is	  more	  pronounced	  in	  the	  myocardium	  of	  the	  systemic	  RV	  of	  
adults	  late	  after	  palliation	  of	  TGA	  compared	  to	  controls.	  The	  extent	  of	  interstitial	  expansion	  was	  
related	  to	  known	  markers	  of	  disease	  severity	  and	  outcome	  parameters	  (NT-­‐proBNP	  and	  ChI)	  
suggesting	  a	  potential	  causative	  role.	  	  	  	  
	  
Lifelong	  maintenance	  of	  the	  systemic	  circulation	  by	  the	  morphologic	  RV	  results	  in	  a	  heart	  failure	  
phenotype	  that	  is	  associated	  with	  significant	  early	  morbidity	  and	  premature	  mortality4,13.	  Evidence	  is	  
emerging	  that	  myocardial	  fibrosis,	  determined	  histologically	  or	  by	  CMR,	  is	  a	  key	  factor	  in	  the	  
development	  of	  ventricular	  dysfunction	  in	  patients	  with	  both	  acquired	  and	  CHD	  where	  pressure	  
overload	  is	  the	  principal	  insult200,201.	  	  	  Further,	  LGE	  on	  CMR	  has	  been	  linked	  to	  prolongation	  of	  ECG	  
parameters	  associated	  with	  inhomogeneous	  electrical	  activation	  associated	  with	  sudden	  cardiac	  
death200.	  	  Quantifying	  myocardial	  fibrosis	  in	  patients	  with	  systemic	  RVs	  also	  provides	  an	  additional	  
measure	  of	  disease	  severity.	  Further	  studies	  are	  needed	  to	  investigate	  the	  clinical	  usefulness	  of	  EQ-­‐
CMR	  in	  predicting	  outcome	  in	  this	  group.	  	  
	  
EQ-­‐CMR	  has	  been	  previously	  validated	  as	  a	  novel	  non-­‐invasive	  technique	  to	  quantify	  diffuse	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similar	  method	  to	  identify	  and	  quantify	  diffuse	  myocardial	  fibrosis	  in	  adults	  with	  atrial	  switch	  
palliation	  of	  TGA.	  	  The	  results	  are	  similar	  to	  those	  of	  Broberg	  et	  al201,	  who	  used	  a	  bolus	  technique	  as	  
opposed	  to	  EQ-­‐CMR.	  	  There	  are	  a	  number	  of	  T1	  mapping	  based	  techniques	  in	  development	  by	  CMR	  
currently205.	  	  The	  use	  here	  of	  an	  infusion	  of	  gadolinium,	  to	  reach	  contrast	  equilibrium,	  eliminates	  
contrast	  kinetics,	  which	  can	  alter	  in	  an	  individual	  over	  time	  (for	  example	  due	  to	  changes	  in	  body	  
weight	  or	  renal	  function)	  which	  may	  permit	  more	  precise	  evaluation	  of	  changes	  over	  time	  in	  any	  
individual,	  	  important	  both	  in	  the	  clinical	  and	  research	  settings.	  The	  technique	  has	  been	  validated	  
against	  histology	  in	  aortic	  stenosis	  and	  hypertrophic	  cardiomyopathy202.	  Although	  the	  bolus	  
gadolinium	  technique	  is	  perhaps	  simpler,	  the	  total	  CMR	  scan	  time	  in	  the	  cohort	  remained	  at	  around	  
1	  hour	  for	  all	  patients,	  as	  the	  bolus	  and	  infusion	  was	  given	  early	  in	  the	  protocol	  whilst	  continuing	  to	  
scan	  other	  parameters	  during	  equilibration.	  Despite	  the	  differences	  in	  study	  method,	  the	  results	  
obtained	  in	  both	  small	  studies	  are	  similar,	  and	  suggest	  that	  CMR	  diffuse	  fibrosis	  assessment	  is	  a	  
useful	  biomarker	  in	  this	  cohort	  of	  patients.	  
	  
Earlier	  work	  has	  confirmed	  that	  focal	  myocardial	  scar,	  as	  represented	  by	  localised	  late	  gadolinium	  
enhancement	  of	  the	  myocardium	  on	  CMR	  imaging,	  can	  be	  present	  in	  patients	  with	  atrial	  switch	  
palliated	  TGA,	  and	  relates	  to	  the	  systolic	  function	  of	  the	  systemic	  RV200.	  	  This	  finding	  most	  likely	  
reflects	  localised	  surgical	  insult	  or	  coronary	  insufficiency	  (due	  to	  RV	  hypertrophy	  or	  abnormal	  
coronary	  circulation).	  	  My	  study	  did	  not	  find	  that	  the	  ECV	  related	  to	  measures	  of	  RV	  size	  or	  systolic	  
function.	  	  This	  may	  reflect	  the	  small	  cohort	  size	  involved,	  or	  may	  suggest	  early	  pathophysiological	  
detection	  of	  disease	  such	  that	  diffuse	  fibrosis	  is	  a	  precursor	  to	  measurable	  RV	  dysfunction.	  It	  is	  
worth	  noting	  that	  the	  mean	  RV	  ejection	  fraction	  of	  this	  study	  cohort	  was	  within	  the	  perceived	  
normal	  range.	  	  It	  is	  possible	  that	  such	  diffuse	  fibrosis	  may	  relate	  to	  diastolic	  dysfunction	  in	  the	  
systemic	  RV;	  however,	  this	  is	  not	  straightforward	  issue	  in	  this	  cohort.	  	  Interestingly,	  diffuse	  fibrosis	  
was	  found	  to	  relate	  to	  NT-­‐proBNP.	  	  This	  is	  an	  established	  neurohormonal	  marker	  of	  disease	  in	  the	  
general	  cardiology	  population96.	  	  It	  is	  also	  increasingly	  being	  recognised	  as	  a	  valuable	  tool	  in	  CHD,	  
and	  specifically	  in	  TGA,	  where	  it	  correlates	  to	  systemic	  RV	  function	  as	  determined	  by	  CMR206.	  	  In	  the	  
general	  cardiology	  population	  NT-­‐proBNP	  has	  an	  established	  role	  in	  detecting	  asymptomatic	  left	  
ventricular	  dysfunction	  in	  high-­‐risk	  populations140	  and	  in	  predicting	  cardiovascular	  events	  in	  those	  
with	  preserved	  ventricular	  function141.	  	  The	  finding	  of	  diffuse	  fibrosis	  on	  CMR	  imaging	  in	  the	  setting	  
of	  preserved	  RV	  systolic	  function	  may	  represent	  a	  similar	  early	  warning	  sign.	  	  	  
	  
Septal	  ECV	  also	  showed	  a	  negative	  correlation	  to	  ChI,	  but	  no	  relation	  to	  pVO2	  or	  VE/VCO2	  –	  both	  
established	  independent	  markers	  of	  outcome	  in	  CHD.	  	  Giardini	  and	  colleagues	  studied	  adults	  with	  a	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systemic	  RV	  and	  previous	  Mustard	  or	  Senning	  palliation	  and	  proposed	  a	  VE/VCO2	  slope	  cut-­‐off	  >35.4	  
as	  being	  predictive	  of	  four-­‐year	  mortality	  or	  cardiac	  related	  admission162	  –	  the	  majority	  of	  patients	  
involved	  in	  this	  study	  had	  cut-­‐off	  values	  lower	  than	  this.	  	  Similarly,	  values	  for	  pVO2	  in	  this	  cohort	  
were	  above	  the	  levels	  previously	  published	  as	  predictors	  of	  adverse	  events	  in	  congenital	  cohorts159.	  	  
Adults	  with	  a	  systemic	  RV	  often	  describe	  themselves	  as	  well	  and	  asymptomatic,	  despite	  objective	  
evidence	  to	  the	  contrary.	  	  Formal	  exercise	  testing	  has	  however	  found	  that	  the	  majority	  with	  a	  
systemic	  RV	  have	  chronotropic	  incompetence	  and	  furthermore,	  that	  in	  a	  proportion	  of	  those	  
studied,	  such	  inability	  to	  increase	  heart	  rate	  was	  unrelated	  to	  metabolic	  parameters,	  suggesting	  that	  
this	  alone	  may	  be	  causing	  exercise	  intolerance161.	  	  Whether	  these	  findings	  represents	  early	  detection	  
of	  ensuing	  RV	  dysfunction	  remains	  to	  be	  determined;	  however,	  it	  is	  likely	  that	  any	  underlying	  cause	  
is	  multifactorial.	  	  It	  is	  of	  interest	  to	  note	  that	  a	  study	  of	  adults	  with	  hypertrophic	  cardiomyopathy	  
also	  found	  a	  relationship	  between	  delayed	  Gadolinium	  enhancement	  on	  CMR	  and	  blunted	  heart	  rate	  
response	  on	  exercise207.	  	  Such	  late	  Gadolinium	  enhancement	  has	  been	  found	  to	  be	  an	  independent	  
predictor	  of	  deficient	  exercise	  capacity	  in	  such	  cohorts208;	  however,	  relationship	  to	  outcome	  and	  
underlying	  mechanism	  is	  not	  yet	  established.	  
	  
It	  is	  important	  to	  note	  here	  the	  small	  but	  significant	  annual	  incidence	  of	  bradyarrhythmias	  and	  
complete	  heart	  block	  that	  occur	  in	  this	  population.	  	  Such	  arrhythmias	  increase	  with	  time	  during	  
follow	  up13,	  and	  published	  frequency	  of	  pacemaker	  insertions	  vary	  from	  5-­‐11%13,209.	  	  It	  is	  well	  
recognised	  that	  sick	  sinus	  syndrome	  is	  associated	  with	  a	  diffuse	  fibrotic	  process	  in	  the	  sinoatrial	  
node	  and	  indeed	  a	  recent	  murine	  model	  has	  recapitulated	  this210.	  Furthermore,	  the	  patients	  
presented	  in	  this	  paper	  develop	  increased	  atrial	  wall	  stress	  and	  stretch,	  which	  will	  promote	  local	  
hypertrophy	  and	  fibrosis	  in	  conjunction	  with	  the	  effects	  of	  corrective	  surgery.	  	  Marouche	  et	  al	  has	  
recently	  demonstrated	  significant	  correlations	  between	  atrial	  fibrosis	  using	  gadolinium	  
enhancement	  and	  sinus	  node	  disease	  supporting	  pathological	  studies	  and	  recent	  murine	  models	  of	  
the	  process211.	  Therefore,	  although	  this	  study	  did	  not	  seek	  to	  identify	  diffuse	  fibrosis	  at	  the	  sinus	  
node,	  given	  the	  early	  palliative	  intervention	  and	  subsequent	  lifelong	  adverse	  physiology,	  it	  is	  likely	  
that	  the	  septal	  hypertrophy	  identified	  is	  not	  an	  isolated	  process	  and	  similar	  changes	  are	  occurring	  in	  
the	  atria	  and	  SA	  node	  leading	  to	  chronotropic	  incompetence	  which	  could	  be	  explored	  as	  CMR	  
resolution	  of	  fibrosis	  improves.	  	  	  
	  
The	  septal	  fibrosis	  seen	  on	  EQ-­‐CMR	  may	  therefore	  underlie	  the	  conduction	  pathway	  problems	  that	  
develop	  in	  such	  patients,	  possibly	  due	  to	  myocardial	  disarray.	  	  It	  will	  be	  interesting	  to	  see	  whether	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the	  degree	  of	  abnormality	  can	  predict	  future	  development	  of	  conduction	  block	  and	  the	  need	  for	  
pacing.	  	  
	  
8.4.1	  	  Limitations	  
This	  study	  is	  limited	  in	  size	  and	  further	  larger	  scale	  investigation	  is	  needed.	  Although	  the	  results	  
show	  the	  potential	  for	  the	  technique	  to	  be	  useful,	  newer	  methods	  for	  T1	  mapping	  have	  recently	  
become	  available	  and	  show	  the	  potential	  for	  higher	  resolution	  whole	  heart	  mapping	  in	  3	  breath	  
holds212.	  These	  could	  allow	  more	  accurate	  assessment	  of	  the	  RV	  free	  wall,	  which	  were	  not	  possible	  
to	  assess	  in	  this	  study.	  	  
	  
Despite	  the	  presence	  of	  RV	  hypertrophy	  in	  the	  patient	  cohort,	  the	  assessment	  of	  diffuse	  fibrosis	  in	  
the	  anterior	  free	  wall	  of	  the	  RV	  was	  technically	  problematic.	  The	  ubiquitous	  presence	  of	  
trabeculation	  within	  the	  systemic	  RV	  free	  wall,	  leaves	  very	  few	  areas	  of	  compacted	  RV	  myocardium	  
during	  diastole	  that	  are	  without	  blood	  pool	  contamination.	  	  If	  zones	  of	  blood	  pool	  are	  included	  in	  the	  
myocardial	  analysed	  region	  of	  interest,	  the	  ECV	  would	  be	  falsely	  elevated.	  	  Metal	  artefact	  from	  
sternal	  wires	  also	  contributed	  to	  artefact	  in	  this	  zone	  in	  many	  patients.	  	  
	  
8.4.2	  	  Conclusion	  
There	  is	  an	  increased	  amount	  of	  diffuse	  fibrosis	  in	  the	  septum	  of	  adults	  with	  a	  systemic	  RV,	  late	  after	  
Senning	  or	  Mustard	  palliation	  for	  TGA	  that	  can	  be	  quantified	  non-­‐invasively.	  	  The	  extent	  of	  diffuse	  
fibrosis	  showed	  significant	  association	  with	  NT-­‐proBNP	  measurement	  and	  may	  aid	  in	  the	  
identification	  of	  patients	  at	  risk	  of	  developing	  bradyarrhythmia.	  	  Larger	  and	  longer-­‐term	  studies	  are	  
needed	  to	  determine	  whether	  such	  diffuse	  fibrosis	  is	  of	  prognostic	  significance	  and	  whether	  its	  
extent	  can	  be	  modified	  with	  therapeutic	  intervention.	  
	  
My	  final	  Chapter	  sought	  to	  take	  a	  closer	  look	  at	  the	  functional	  status	  of	  adults	  under	  routine	  
surveillance	  at	  my	  Institution	  with	  atrial	  palliation	  of	  TGA.	  	  Disease	  characterisation	  and	  relationship	  
to	  functional	  ability	  is	  not	  established	  in	  this	  complex	  cohort	  and	  with	  the	  information	  made	  
available	  from	  the	  previous	  Chapters	  I	  wanted	  to	  further	  understand	  the	  relationship	  between	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CHAPTER	  9:	  	  Quality	  of	  life	  in	  adults	  after	  Mustard	  or	  
Senning	  palliation	  and	  relationship	  to	  other	  
measurements	  of	  systemic	  right	  ventricular	  function.	  
	  
9.1	  	  Introduction	  
Patients	  with	  CHD	  notoriously	  underreport	  their	  symptoms	  and	  physical	  limitations115,191,213.	  	  In	  
clinical	  practice	  we	  often	  rely	  on	  these	  symptoms	  to	  select	  patients	  at	  high	  risk	  for	  adverse	  events,	  
and	  hence	  may	  neglect	  a	  significant	  group	  of	  patients	  who	  would	  benefit	  from	  early	  and	  targeted	  
therapeutic	  intervention.	  	  Such	  adverse	  events	  are	  particularly	  high	  in	  substrates	  where	  the	  RV	  is	  the	  
systemic	  ventricle.	  This	  is	  particularly	  true	  in	  the	  setting	  of	  TGA	  repaired	  by	  the	  Mustard	  or	  Senning	  
procedure,	  with	  significant	  morbidity	  and	  premature	  mortality4,13.	  
	  
In	  the	  general	  population	  with	  heart	  failure	  several	  validated	  self-­‐assessment	  tools	  exist,	  including	  
the	  Minnesota	  Living	  With	  Heart	  Failure	  Questionnaire	  (MLWHFQ),	  which	  provide	  a	  numerical	  
estimation	  of	  quality	  of	  life.	  	  These	  tools	  measure	  the	  impact	  of	  disease	  on	  many	  activities	  of	  daily	  
living	  and	  mental	  health	  and	  are	  useful	  to	  follow	  progress	  of	  disease	  and	  efficacy	  of	  treatment.	  	  
None	  have	  been	  tested	  in	  the	  population	  with	  a	  systemic	  RV	  however.	  	  In	  this	  population	  several	  
objective	  measures	  of	  RV	  function	  are	  emerging,	  including	  NT-­‐proBNP206	  and	  certain	  ECG	  
parameters52,105,105.	  	  CMR	  imaging	  evaluation	  of	  the	  systemic	  RV	  and	  atrial	  pathways	  is	  an	  excellent	  
tool	  in	  this	  population,	  though	  this	  investigation	  can	  be	  time	  consuming,	  expensive	  and	  is	  not	  
available	  to	  all.	  	  CPEX	  testing	  has	  recently	  given	  rise	  to	  an	  early	  evidence	  base	  for	  all	  cause	  mortality	  
among	  adults	  with	  CHD,	  including	  measurements	  of	  peak	  VO2	  and	  VE/VCO2	  slope158,158,159,160,.	  	  In	  
adults	  with	  a	  systemic	  RV	  and	  previous	  Mustard	  or	  Senning	  palliation,	  a	  VE/VCO2	  slope	  cut-­‐off	  >35.4	  
has	  been	  proposed	  as	  being	  predictive	  of	  four-­‐year	  mortality	  or	  cardiac	  related	  admission,	  though	  
this	  was	  related	  to	  the	  age	  at	  time	  of	  exercise	  and	  also	  age	  at	  original	  palliation162.	  	  Both	  heart	  rate	  
reserve	  and	  ChI	  have	  also	  been	  found	  to	  provide	  prognostic	  and	  predictive	  outcome	  data	  in	  general	  
cohorts	  with	  CHD	  and	  in	  those	  with	  a	  systemic	  RV161,163.	  	  	  
	  
The	  inter-­‐relationship	  between	  all	  these	  measures	  in	  adults	  late	  after	  Mustard	  or	  Senning	  palliation	  
is	  not	  established.	  	  The	  relationship	  between	  these	  measures	  and	  subjective	  symptom	  scoring	  has	  
also	  not	  been	  studied	  in	  detail.	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9.2	  Methods	  
9.2.1	  Study	  population	  	  
This	  was	  a	  prospective	  study.	  	  Data	  was	  routinely	  collected	  from	  adults	  with	  previous	  Senning	  or	  
Mustard	  surgery	  for	  TGA	  attending	  a	  dedicated	  CHD	  clinic	  at	  The	  Heart	  Hospital	  (London)	  between	  
January	  2010	  and	  July	  2011.	  	  These	  adults	  were	  included	  from	  the	  same	  pool	  of	  patients	  as	  that	  
previously	  studied.	  	  Data	  included	  assessment	  of	  symptoms	  by	  NYHA	  functional	  class,	  measurement	  
of	  circulating	  N-­‐terminal	  pro	  Brain	  Natriuretic	  Peptide	  (NT-­‐proBNP)	  levels	  and	  renal	  function,	  and	  
surface	  electrocardiogram	  (ECG).	  Patients	  were	  also	  invited	  to	  fill	  out	  a	  MLWHFQ.	  	  CMR	  imaging	  and	  
CPEX	  were	  performed	  within	  3	  months	  of	  clinic	  attendance	  in	  accordance	  with	  clinic	  protocols	  in	  
those	  also	  willing	  to	  participate	  in	  this	  part	  of	  the	  study.	  	  	  Protocols	  for	  ECG,	  CPEX	  and	  CMR	  have	  
been	  previously	  in	  this	  Thesis.	  The	  study	  had	  Institutional	  approval	  and	  all	  patients	  gave	  informed	  
consent	  to	  participate	  in	  the	  study.	  
	  
9.2.2	  Quality	  of	  Life	  Questionnaire	  
Each	  patient	  was	  invited	  to	  complete	  a	  MLWHFQ166.	  	  This	  is	  6-­‐point	  (zero	  to	  5)	  Likert	  scale,	  21	  item	  
self-­‐assessment	  questionnaire	  that	  was	  undertaken	  at	  the	  time	  of	  clinic	  attendance.	  	  	  Scored	  out	  of	  
105,	  the	  lower	  the	  score,	  the	  less	  the	  impact	  of	  disease.	  	  The	  MLWHFQ	  contains	  questions	  on	  
functional	  ability,	  symptoms	  and	  mental	  health,	  as	  well	  as	  activities	  of	  daily	  living	  including	  work,	  
chores	  and	  leisure	  time.	  	  	  
	  
9.2.3	  	  Statistical	  Analysis	  
The	  Kolmogorov-­‐Smirnov	  test	  was	  used	  to	  confirm	  or	  exclude	  normal	  distribution	  for	  each	  variable.	  
Values	  are	  expressed	  as	  mean	  ±	  standard	  deviation	  (SD),	  median	  (25-­‐75th	  percentile	  values)	  or	  
percentages,	  as	  appropriate.	  	  Univariate	  comparisons	  were	  performed	  by	  Student’s	  t-­‐test,	  Mann	  
Whitney	  U	  test,	  and	  Chi-­‐square	  test	  for	  normally	  distributed,	  non-­‐normally	  distributed	  and	  
categorical	  variables	  respectively.	  Pearson’s	  or	  Spearman’s	  correlation	  coefficients	  were	  used	  as	  
appropriate	  to	  look	  for	  univariate	  associations	  between	  continuous	  variables	  (SPSS	  Inc.,	  Chicago,	  
USA	  and	  GraphPad	  Software	  Inc,	  La	  Jolla,	  USA).	  Differences	  were	  considered	  to	  be	  significant	  at	  a	  P	  
value	  of	  <0.05.	  
	  
9.3	  	  Results	  
9.3.1	  	  Patient	  characteristics	  
Ninety-­‐two	  adults	  were	  included	  in	  the	  study.	  	  No	  patient	  died	  or	  was	  admitted	  with	  decompensated	  
heart	  failure	  between	  clinic	  attendance	  or	  subsequent	  CMR	  or	  CPEX.	  	  Mean	  age	  at	  time	  of	  clinic	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attendance	  for	  the	  whole	  cohort	  was	  31±6.5	  years.	  	  	  Median	  age	  at	  initial	  surgical	  repair	  was	  8	  (0.1-­‐
96)	  months.	  	  51%	  (n=47)	  underwent	  Mustard	  palliation;	  60%	  (n=55)	  were	  male.	  	  Sixteen	  (17%)	  
patients	  had	  associated	  ventricular	  septal	  defects	  repaired	  at	  original	  palliation	  –	  ‘complex’	  
anatomy.	  	  Seven	  further	  patients	  (8%)	  underwent	  later	  surgical	  revision	  of	  atrial	  pathways.	  For	  the	  
purpose	  of	  statistical	  analysis	  these	  23	  patients	  comprised	  the	  ‘complex	  surgical’	  group.	  The	  
remaining	  69	  patients	  had	  simple	  TGA	  and	  single	  stage	  surgery.	  	  Table	  10	  summarises	  baseline	  
measurements	  of	  all	  investigations.	  	  
	  
Twenty-­‐nine	  patients	  were	  taking	  beta-­‐blockers	  (32%),	  33	  angiotensin	  converting	  enzyme	  
inhibitors/angiotensin	  receptor	  blockers	  (36%),	  and	  10	  were	  on	  diuretic	  therapy	  (11%).	  	  Sixteen	  
(17%)	  had	  permanent	  pacemakers	  in-­‐situ	  and	  four	  (4%)	  had	  ICD’s.	  	  No	  patient	  had	  CRT	  in-­‐situ.	  
	  
9.3.2	  	  Quality	  of	  Life	  Assessment	  
Ninety-­‐two	  patients	  completed	  a	  MLWHFQ	  and	  also	  had	  NT-­‐proBNP	  testing,	  renal	  function	  and	  
resting	  ECG	  analysis	  (Table	  10).	  	  The	  median	  score	  for	  MLWHFQ	  was	  6(2-­‐19)	  for	  the	  whole	  group.	  	  
MLWHFQ	  correlated	  with	  both	  age	  at	  clinic	  attendance	  (p=0.002,	  r=0.31)	  and	  age	  at	  original	  repair	  
(p=0.0007,	  r=0.35).	  
	   All	  (n=92)	   Surgery	  type	   p	  
value	  
Surgical	  course	   p	  
value	  




Age,	  years	   31±7	   35±8	   27±4	   <0.0001	   31±6	  	   34±8	   0.03	  
Age	  at	  surgery,	  months	   8	  (0.1-­‐96)	   10	  (0.1-­‐96)	   7	  (0.3-­‐48)	   0.01	   6	  (0.3-­‐96)	   9(0.1-­‐70)	   0.72	  
Male/female	   55/37	   31/24	   36/16	   -­‐-­‐-­‐	   49/27	   15/16	   -­‐-­‐-­‐	  

















RVESVI,	  mL/m2	   41±15	   43±18	   40±12	   0.54	   38±10	   52±23	   0.005	  
RVEF,	  %	   56±7	   57±8	   55±6	   0.53	   56±7	   55±7	   0.83	  
LVEF,	  %	   64±9	   64±8	   66±6	   0.25	   64±8	   64±12	   0.95	  

















QTc,	  ms	   402±27	   403±33	   394±24	   0.09	   400±31	   412±36	   0.14	  
MLWHFQ	  	   6(2-­‐19)	   8(3-­‐28)	   4(0-­‐12)	   0.03	   4(1-­‐13)	   14(4-­‐45)	   0.004	  
CPEX	  	  
CI	  






























































Table	  10:	  	  Showing	  characteristics	  of	  those	  patients	  with	  a	  systemic	  RV.	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Those	  with	  Mustard	  palliation	  had	  a	  significantly	  higher	  score	  than	  those	  with	  a	  Senning	  operation	  
(8(3-­‐28)	  vs.	  4(0-­‐12)	  p=0.03)	  but	  this	  significance	  was	  lost	  when	  adjusting	  for	  age	  (p=0.59).	  	  Those	  
with	  a	  complex	  surgical	  history	  had	  a	  significantly	  higher	  score	  than	  those	  with	  simple	  surgery	  (14(4-­‐
45)	  vs.	  4(1-­‐13)	  p=0.004)	  as	  did	  those	  with	  NYHA	  II	  compared	  to	  class	  I	  (23(7-­‐45)	  vs.	  (4(1-­‐12)	  







Figure	  30:	  MLWHQ	  between	  those	  with	  simple	  vs	  complex	  repair	  and	  NYHA	  class.	  
	  
For	  the	  whole	  group,	  median	  NT-­‐proBNP	  was	  24(16-­‐43)	  pmol/L,	  median	  urea	  5.4	  (4.5-­‐6.3)	  mmol/L,	  
mean	  creatinine	  78±17	  mmol/L	  and	  median	  sodium	  142(141-­‐144)	  mmol/L.	  	  NT-­‐proBNP	  was	  
significantly	  correlated	  to	  MLWHFQ	  (p=0.001,	  r=0.34)	  and	  this	  relationship	  nearly	  maintained	  
significance	  when	  correcting	  for	  age	  and	  age	  at	  palliation	  (p=0.055).	  	  Urea	  was	  also	  significantly	  
associated	  with	  MLWHFQ	  (p=0.003,	  r=0.31)	  and	  this	  relationship	  persisted	  when	  correcting	  for	  both	  
age	  at	  follow-­‐up	  and	  age	  at	  palliation	  (p=0.021).	  	  Sodium	  levels	  revealed	  a	  weak	  relationship	  to	  
MLWHFQ	  (p=0.01,	  r=0.26);	  however,	  this	  became	  insignificant	  when	  corrected	  for	  age	  (p=0.51).	  	  
Creatinine	  showed	  no	  relationship	  with	  MLWHFQ	  score	  (p=0.52).	  	  	  
	  
MLWHFQ	  and	  Electrocardiographic	  Indices	  	  
Mean	  QRS	  duration	  for	  the	  whole	  cohort	  was	  96±20ms.	  	  This	  parameter	  showed	  a	  significant	  
relationship	  to	  MLWHFQ	  score	  (p<0.0001,	  r=0.41.	  Figure	  31)	  that	  persisted	  following	  both	  age	  
corrections	  (p=0.002).	  	  QTc	  interval	  also	  revealed	  a	  weak	  correlation	  to	  score	  (p=0.023,	  r=0.24);	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however,	  this	  significance	  was	  lost	  when	  age-­‐corrected	  (p=0.68).	  	  No	  ECG	  parameter	  at	  peak	  
exercise	  (n=54)	  showed	  any	  relationship	  with	  MLWHFQ	  score.	  	  	  












Figure	  31:	  	  QRS	  duration	  is	  significantly	  related	  with	  MLWHFQ	  score.	  
	  
MLWHFQ	  and	  CMRI	  
Fifty-­‐five	  patients	  underwent	  additional	  CMR	  imaging.	  The	  mean	  values	  of	  the	  CMR	  findings	  for	  this	  
sub-­‐group	  are	  as	  follows:	  RVEDVi	  87±19	  ml/m2,	  RVESVi	  41±15	  ml/m2,	  RVEF	  56±7%	  and	  LVEF	  64±9%.	  	  
Although	  RVEDVi	  did	  weakly	  relate	  with	  MLWHFQ	  (p=0.036,	  r=0.29)	  this	  was	  not	  the	  case	  once	  the	  
values	  were	  corrected	  for	  age	  at	  follow-­‐up	  and	  palliation	  (p=0.9).	  	  No	  other	  measure	  related	  to	  
MLWHFQ	  in	  the	  first	  instance.	  	  	  
	  
9.3.3	  	  Cardiopulmonary	  exercise	  testing	  
Forty-­‐one	  patients	  had	  full	  CPEX	  testing.	  	  Median	  values	  for	  ChI	  were	  0.76(0.67-­‐0.84).	  	  There	  was	  no	  
significant	  difference	  between	  palliative	  subtypes	  (Mustard	  0.75(0.56-­‐0.88)	  vs.	  Senning	  0.77(0.72-­‐
0.83),	  p=0.17);	  however,	  ChI	  did	  relate	  strongly	  to	  both	  age	  at	  follow-­‐up	  (p=0.0005,	  r=0.45)	  and	  age	  
at	  palliation	  (p=0.0004,	  r=0.46).	  	  Interestingly,	  ChI	  did	  not	  differ	  substantially	  between	  those	  with	  
simple	  or	  complex	  surgery	  (0.77(0.69-­‐0.85)	  vs.	  0.73(0.37-­‐0.80)	  p=0.09);	  however,	  when	  NYHA	  I	  was	  
compared	  to	  NYHA	  II	  there	  was	  a	  significant	  difference	  (0.77(0.70-­‐0.85)	  vs.	  0.51(0.26-­‐0.76)	  p=0.01).	  	  
In	  keeping	  with	  this	  finding,	  MLWHFQ	  did	  have	  a	  relationship	  with	  ChI	  –	  p=0.01,	  r=0.34.	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VE/VECO2	  Slope	  
Mean	  VE/VCO2	  slope	  for	  the	  whole	  cohort	  was	  30±6.	  	  This	  parameter	  showed	  no	  significant	  
difference	  between	  either	  palliative	  subtype	  or	  those	  with	  complex	  or	  simple	  anatomy	  (Table	  9.1).	  	  
VE/VCO2	  slope	  did	  not	  relate	  to	  age	  nor	  age	  at	  palliation	  (p=0.25;	  p=0.56).	  	  It	  did	  however,	  show	  a	  
relationship	  with	  MLWHFQ	  (p=0.0028,	  r=0.48.	  Figure	  32a).	  	  	  
	  







































Peak	  VO2	  for	  the	  cohort	  was	  24±7ml/kg/min.	  	  Peak	  VO2	  was	  significantly	  lower	  in	  the	  complex	  group	  
(19±9	  vs.	  25±6ml/kg/min,	  p=0.02)	  and	  in	  those	  with	  Mustard	  palliation	  (21±6	  vs.	  28±56ml/kg/min,	  
p=0.001).	  	  Peak	  VO2	  was	  also	  significantly	  related	  to	  age	  at	  follow-­‐up	  (p<0.0001,	  r=60).	  	  Peak	  VO2	  
correlated	  with	  MLWHFQ	  (p=0.001,	  r=0.49.	  	  Figure	  32b)	  and	  this	  relationship	  persisted	  once	  
corrected	  for	  age	  and	  age	  at	  palliation	  (p=0.003).	  
	  
Neither	  ChI,	  VE/VCO2	  slope	  nor	  Peak	  VO2	  showed	  any	  relationship	  to	  CMR	  measures	  of	  RV	  size	  or	  
function	  (Table	  11).	  	  Neither	  Peak	  VO2	  nor	  VE/VC02	  slope	  were	  related	  to	  any	  ECG	  parameter	  at	  rest	  
or	  on	  exercise	  (Table	  11).	  	  ChI	  was	  however,	  related	  to	  both	  resting	  QRS	  duration	  (p=0.0012,	  r=0.41)	  
and	  QTc	  interval	  (p=0.01,	  r=0.32).	  	  All	  parameters	  showed	  a	  relationship	  with	  NT-­‐proBNP	  (Figure	  33).	  
	  
a	   b	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   Chronotropic	  Index	   VE/VCO2	  slope	   Peak	  VO2	  (ml/kg/min)	  




































Table	  11:	  	  NT-­‐proBNP	  is	  the	  only	  parameter	  to	  show	  significance	  with	  each	  CPEX	  parameter.	  
	  
	  







































Figure	  33:	  	  Graphic	  representation	  showing	  significant	  associations	  between	  NT-­‐proBNP	  and	  both	  VE/CVO2	  
and	  peak	  VO2.	  	  	  
	  
Peak	  exercise	  electrocardiographic	  indices	  
QRS	  duration,	  QTd	  and	  JTd	  showed	  significant	  shortening	  at	  peak	  exercise	  compared	  to	  at	  rest	  
(Table	  12).	  	  No	  exercise	  parameter	  showed	  a	  significant	  relationship	  with	  any	  other	  parameter,	  nor	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   Resting	   Peak	   p	  value	  
QRS	  (ms)	   97±22	   90±18	   0.0008	  
QTc	  (ms)	   403±33	   408±31	   0.06	  
QRSd	  (ms)	   31±11	   30±9	   0.97	  
QTd	  (ms)	   49±15	   41±13	   0.002	  
JTd	  (ms)	   53±15	   41±12	   0.0004	  
Table	  12:	  	  QRS	  duration,	  QTd	  and	  JTd	  show	  significant	  differences	  at	  rest	  and	  peak	  exercise.	  
	  
Discussion	  
This	  is	  the	  largest	  prospective	  study	  to	  date	  examining	  subjective	  self-­‐assessment	  of	  status	  (using	  
MLWHFQ)	  and	  comparing	  it	  with	  a	  variety	  of	  measures	  of	  disease	  severity	  in	  adults	  late	  after	  
Mustard	  or	  Senning	  palliation	  of	  TGA.	  	  
	  
At	  present	  there	  exists	  no	  validated,	  subjective	  patient	  symptom	  score	  for	  those	  with	  CHD.	  	  Smaller	  
and	  heterogenous	  cohorts	  make	  any	  such	  undertaking	  complex.	  	  Further,	  and	  specifically	  in	  those	  
with	  CHD,	  it	  is	  not	  unusual	  to	  see	  patients	  who	  feel	  and	  describe	  themselves	  as	  well,	  despite	  
objective	  findings	  to	  the	  contrary191.	  	  This	  situation	  is	  not	  aided	  by	  the	  lack	  of	  an	  objective	  scoring	  
system	  in	  this	  population	  to	  help	  identify	  those	  at	  high	  risk	  of	  adverse	  events.	  	  Such	  outcomes	  are	  
particularly	  prevalent	  and	  premature	  in	  those	  with	  a	  systemic	  RV,	  in	  particular	  following	  atrial	  
redirection	  surgery	  for	  TGA4,13.	  
	  
This	  study	  demonstrated	  that	  MLWHFQ	  score	  was	  significantly	  associated	  with	  objective	  assessment	  
by	  NYHA	  functional	  class	  over	  and	  above	  the	  effect	  mediated	  by	  age	  of	  the	  patient	  at	  clinic	  
attendance	  or	  palliation.	  	  This	  was	  not	  the	  case	  when	  considering	  palliative	  surgical	  method,	  
suggesting	  that	  this	  alone	  does	  not	  confer	  added	  risk.	  	  This	  is	  supported	  by	  the	  finding	  that	  neither	  
ChI	  nor	  VE/VCO2	  slope,	  both	  proposed	  as	  markers	  of	  disease	  severity	  and	  risk	  in	  this	  cohort162,162	  ,	  
are	  significantly	  different	  between	  the	  two	  palliative	  subtypes.	  	  
	  
Subjective	  symptom	  score	  
The	  MLWHFQ	  is	  a	  simple,	  practical	  and	  readily	  reproducible	  self-­‐assessment	  tool	  easily	  applied	  in	  
the	  out-­‐patient	  setting.	  	  It	  is	  not	  validated	  for	  use	  in	  the	  CHD	  population,	  and	  although	  the	  
questionnaire	  encompasses	  many	  areas	  potentially	  impacted	  by	  disease,	  including	  leisure,	  work,	  
health	  and	  sexual	  functioning,	  it	  is	  not	  designed	  to	  measure	  impact	  on	  one	  dimension	  over	  another.	  	  	  
	  
This	  study	  found	  that	  MLWHFQ	  scores	  relate	  to	  NT-­‐proBNP	  levels,	  but	  only	  a	  clear	  trend	  towards	  
significance	  persisted	  once	  values	  were	  corrected	  for	  age.	  	  Cohort	  size,	  though	  large	  for	  this	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anatomic	  substrate,	  may	  not	  have	  been	  sufficient	  and	  larger	  studies	  may	  be	  necessary.	  	  It	  is	  
interesting	  to	  note	  however,	  that	  a	  study	  comparing	  BNP	  to	  subjectively	  assessed	  health	  status	  in	  a	  
general	  cohort	  with	  heart	  failure	  found	  no	  correlation	  between	  the	  two	  factors,	  despite	  both	  
showing	  a	  correlation	  to	  NYHA	  class214.	  	  The	  proposal	  that	  subjective	  measures	  of	  impact	  of	  disease	  
are	  not	  measurable	  nor	  reproducible	  by	  physiological	  testing	  is	  perhaps	  supported	  by	  another	  study	  
which	  determined	  that	  raised	  BNP,	  in	  association	  with	  depressive	  symptoms,	  was	  associated	  with	  a	  
5.5	  times	  higher	  risk	  of	  cardiac	  events	  than	  when	  BNP	  was	  elevated	  to	  the	  same	  degree	  in	  
isolation215.	  
	  
MLWHFQ	  scores	  were	  highly	  related	  to	  QRS	  duration	  on	  the	  surface	  ECG.	  	  In	  this	  cohort,	  although	  
QRS	  duration	  has	  been	  associated	  with	  increased	  risk	  of	  sudden	  cardiac	  death105,	  other	  studies	  have	  
not	  described	  any	  difference	  in	  QRS	  duration	  in	  those	  who	  suffered	  a	  SCD	  versus	  those	  who	  did	  not	  
106,106.	  	  	  Certainly	  in	  the	  general	  population,	  QRS	  duration	  is	  an	  established	  predictor	  of	  all	  cause	  
mortality118,118119.	  	  Interestingly,	  QRS	  duration	  is	  associated	  with	  ventricular	  size	  in	  those	  with	  a	  
systemic	  RV36,104;	  however,	  in	  this	  study	  MLWHFQ	  did	  not	  relate	  to	  any	  parameter	  measured	  on	  CMR	  
imaging	  once	  the	  values	  were	  corrected	  for	  age,	  suggesting	  that	  both	  the	  questionnaire	  and	  QRS	  
duration	  are	  more	  sensitive	  determinants	  of	  RV	  pressure	  overload	  than	  the	  dimensional	  
measurements	  made	  by	  CMR	  imaging	  alone.	  	  Electromechanical	  uncoupling,	  of	  which	  QRS	  duration	  
is	  a	  marker,	  can	  be	  mediated	  by	  local	  areas	  of	  dyssynchronous	  activation	  and	  subsequent	  
hypertrophy,	  neither	  requiring	  discernable	  volume	  overload	  of	  the	  ventricle	  nor	  necessitating	  
marked	  deterioration	  of	  global	  ventricular	  function	  in	  the	  first	  instance.	  	  	  
	  
MLWHFQ	  did	  show	  a	  close	  association	  with	  measured	  blood	  urea	  that	  was	  still	  present	  after	  
accounting	  for	  age	  of	  the	  patient	  and	  age	  at	  palliation.	  	  Neither	  blood	  creatinine	  nor	  sodium	  showed	  
a	  similar	  relationship.	  	  The	  latter	  was	  recently	  proposed	  as	  a	  strong	  predictor	  of	  mortality	  in	  a	  
heterogenous	  cohort	  of	  adults	  with	  CHD;	  however,	  in	  my	  homogenous	  cohort	  the	  sodium	  levels	  
were	  higher	  than	  in	  the	  similar,	  smaller	  group	  with	  palliated	  TGA	  included	  in	  this	  study	  (142(141-­‐
144mmol/L),	  n=92	  vs	  137.8±1.8	  mmol/L,	  n=43).	  Further,	  even	  when	  directly	  comparing	  NYHA	  class	  I	  
vs.	  class	  II	  in	  the	  cohort,	  no	  significant	  difference	  was	  found.	  	  Further	  study	  of	  this	  parameter	  in	  
homogenous	  cohorts	  with	  CHD	  is	  thus	  considered	  necessary.	  	  	  
	  
It	  is	  interesting	  to	  note	  that	  no	  CMR	  parameter	  of	  systemic	  RV	  size	  or	  function	  correlated	  in	  any	  way	  
with	  MLWHFQ.	  	  This	  supports	  the	  concept	  that	  there	  is	  no	  single	  way	  to	  measure	  HF	  severity,	  but	  
rather	  that	  this	  complex	  disease	  process	  requires	  several	  different	  diagnostic	  and	  prognostic	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measures,	  including	  neurohormonal	  markers,	  measurement	  of	  systemic	  RV	  size	  and	  function	  via	  
CMR,	  symptom	  scoring,	  ECG	  parameters	  and	  CPEX	  testing.	  	  CMR	  imaging	  may	  be	  the	  gold	  standard	  
measure	  of	  systemic	  RV	  function,	  but	  it	  may	  not	  be	  the	  gold	  standard	  measure	  of	  HF.	  	  In	  non-­‐
congenital	  cohorts,	  LVEF	  is	  a	  very	  poor	  predictor	  of	  survival	  in	  acquired	  HF	  reflecting	  the	  fact	  that	  HF	  
becomes	  a	  multi-­‐organ	  disease	  as	  it	  advances.	  
	  
Cardiopulmonary	  exercise	  testing	  
My	  study	  demonstrates	  that	  CPEX	  testing	  is	  a	  valuable	  additional	  tool	  in	  the	  characterisation	  of	  
disease	  in	  adults	  late	  after	  Mustard	  or	  Senning	  palliation	  of	  TGA.	  	  CI,	  VE/VCO2	  and	  Peak	  VO2	  were	  all	  
related	  to	  MLWHFQ,	  but	  only	  the	  latter	  maintained	  significance	  when	  correcting	  for	  underlying	  age	  
and	  palliative	  age.	  	  In	  patients	  with	  repaired	  ToF,	  both	  peak	  VO2	  and	  VE/VCO2	  slope	  were	  found	  to	  
be	  independent	  predictors	  for	  adverse	  cardiac	  events158,	  and	  Peak	  VO2	  recently	  found	  to	  be	  
prognostic	  in	  those	  with	  Ebstein’s	  anomaly159.	  	  In	  a	  cohort	  of	  noncyanotic	  patients,	  Dimopoulous	  et	  
al	  found	  that	  a	  peak	  VO2	  cut-­‐off	  of	  <15.5ml/kg/min	  was	  associated	  with	  a	  2.9	  fold	  increased	  risk	  of	  
admission	  or	  cardiac	  death	  compared	  to	  those	  who	  achieved	  a	  Peak	  VO2	  >15.5ml/kg/min160.	  	  In	  my	  
cohort,	  only	  four	  patients	  (9%)	  achieved	  under	  this	  cut-­‐off	  and	  the	  implications	  of	  this	  can	  only	  be	  
known	  with	  time.	  	  	  
	  
Dimopoulous	  and	  colleagues,	  in	  the	  same	  cohort,	  determined	  that	  those	  with	  a	  VE/VCO2	  slope	  >38	  
had	  a	  higher	  risk	  of	  dying	  within	  two	  years	  (13%)	  than	  those	  who	  did	  not	  (1%)160.	  	  Giardini	  and	  
colleagues	  studied	  adults	  with	  a	  systemic	  RV	  and	  previous	  Mustard	  or	  Senning	  palliation	  and	  
proposed	  a	  VE/VCO2	  slope	  cut-­‐off	  >35.4	  as	  being	  predictive	  of	  four-­‐year	  mortality	  or	  cardiac	  related	  
admission162.	  	  Seven	  patients	  in	  this	  current	  study	  fulfilled	  this	  criterion.	  	  Of	  interest,	  VE/VCO2	  slope	  
was	  the	  only	  CPEX	  parameter	  to	  relate,	  albeit	  weakly,	  to	  RVEF	  as	  determined	  by	  CMR.	  	  This	  suggests	  
that	  CPEX	  parameters	  do	  not	  in	  themselves	  relate	  to	  ventricular	  size	  or	  function	  directly.	  	  In	  this	  
particular	  anatomical	  substrate	  various	  other	  haemodynamic	  pathophysiologies	  may	  exist	  to	  affect	  
cardiopulmonary	  efficacy,	  most	  commonly	  atrial	  pathway	  lesions,	  including	  baffle	  obstruction	  or	  
leak.	  	  The	  inability	  of	  the	  atrial	  pathways	  to	  allow	  increases	  in	  stroke	  volume	  sufficiently	  with	  
exercise	  as	  compared	  to	  the	  physiological	  normal	  will	  further	  compound	  such	  efficacy	  in	  the	  absence	  
of	  visible	  ventricular	  dysfunction.	  	  	  
	  
This	  is	  the	  first	  study	  to	  show	  that	  VE/VCO2,	  ChI	  and	  peak	  VO2	  relate	  strongly	  to	  NT-­‐proBNP	  in	  adults	  
late	  after	  atrial	  palliation	  of	  TGA,	  a	  finding	  that	  is	  consistent	  in	  other	  cohorts	  with	  CHD216.	  	  This	  
suggests	  that	  NT-­‐proBNP,	  as	  well	  as	  being	  a	  measure	  of	  cardiac	  ventricular	  status,	  is	  also	  closely	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related	  to	  overall	  functional	  capacity.	  	  Indeed,	  in	  the	  general	  population	  with	  heart	  failure,	  BNP	  
measurement	  both	  independently	  and	  in	  association	  with	  assessment	  of	  NYHA	  functional	  class	  has	  
been	  determined	  to	  be	  indicative	  of	  aerobic	  exercise	  capacity217,	  and	  further,	  BNP	  levels	  have	  been	  
shown	  to	  decrease	  with	  exercise	  training	  in	  similar	  cohorts	  compared	  to	  those	  without	  exercise	  
training218.	  	  BNP	  is	  a	  molecular	  marker	  of	  myocardial	  hypertrophy219,	  whose	  production	  is	  increased	  
under	  conditions	  of	  cardiac	  stress.	  	  Such	  ventricular	  hypertrophy,	  specifically	  of	  the	  RV,	  is	  anticipated	  
in	  this	  current	  cohort.	  	  BNP	  may	  prove	  to	  be	  a	  valuable	  marker	  of	  early	  RV	  disease	  in	  this	  substrate	  
prior	  to	  the	  progression	  of	  such	  hypertrophy	  to	  adverse	  remodeling	  and	  objective	  heart	  failure	  and	  
as	  such	  guide	  early	  investigation	  and	  timely	  therapy.	  	  Calculation	  of	  RV	  mass	  would	  be	  necessary	  to	  
further	  study	  this	  relationship.	  
	  
Electrocardiography	  
QRS	  duration	  is	  noted	  to	  decrease	  with	  exercise220	  and	  this	  is	  the	  case	  with	  my	  cohort.	  	  Physical	  
exercise	  can	  provoke	  malignant	  arrhythmias	  in	  susceptible	  substrates	  however	  this	  was	  not	  seen	  in	  
this	  investigation.	  	  QTd	  and	  JTd	  are	  measures	  of	  ventricular	  repolarisation,	  as	  QRS	  duration	  is	  a	  
measure	  of	  ventricular	  depolarisation.	  Reduction	  of	  these	  with	  exercise,	  thus	  reflecting	  increased	  
homogeneity	  of	  ventricular	  electrical	  activation,	  would	  suggest	  that	  risk	  of	  malignant	  arrhythmia	  be	  
low	  in	  this	  cohort.	  	  In	  a	  similar	  group	  studied	  with	  repaired	  ToF,	  this	  was	  found	  not	  to	  be	  the	  case221;	  
however,	  the	  change	  in	  measured	  ECG	  parameters	  was	  found	  to	  relate	  to	  degree	  of	  pulmonary	  
regurgitation	  and	  RV	  function	  and	  volume.	  	  I	  did	  not	  find	  such	  a	  relationship;	  however,	  the	  




This	  is	  the	  largest	  prospective	  study	  to	  date	  examining	  the	  inter-­‐relationship	  of	  various	  
measurements	  in	  adults	  late	  after	  atrial	  redirection	  surgery	  for	  TGA.	  	  I	  show	  that	  subjective	  













The	  number	  of	  children	  surviving	  with	  CHD	  is	  increasing	  as	  a	  result	  of	  improving	  surgical	  and	  
catheter	  techniques	  available	  from	  infancy	  onwards.	  	  With	  the	  incidence	  of	  all	  forms	  of	  CHD	  
estimated	  at	  between	  4	  to	  19	  per	  1000	  live	  births,	  there	  are	  now	  equal	  numbers	  of	  adults	  with	  CHD	  
as	  children	  for	  the	  first	  time.	  	  Previously,	  only	  those	  with	  mild	  disease	  tended	  to	  survive	  to	  
adulthood;	  however,	  this	  is	  clearly	  no	  longer	  the	  case.	  	  Increasingly	  challenging	  anatomies	  and	  
physiologies	  are	  being	  encountered	  in	  the	  surviving	  adults;	  however,	  morbidity	  and	  mortality	  in	  
these	  relatively	  young	  patients	  are	  still	  a	  major	  challenge:	  	  This	  burgeoning	  population	  brings	  with	  it	  
new	  clinical	  problems	  to	  be	  identified	  and	  addressed	  following	  successful	  palliative	  and	  reparative	  
interventions.	  	  Increasing	  age	  and	  a	  desire	  and	  ability	  to	  have	  children	  means	  that	  these	  patients	  and	  
their	  physicians	  face	  new	  challenges	  -­‐	  These	  adult	  patient	  cohorts	  still	  remain	  relatively	  
uncharacterised	  compared	  to	  their	  counterparts	  with	  structural	  heart	  disease.	  	  
	  
This	  Thesis	  set	  out	  with	  the	  task	  of	  examining	  the	  right	  ventricle	  in	  adult	  CHD.	  	  In	  this	  challenging,	  
varied	  and	  complex	  patient	  group,	  this	  apparently	  versatile	  chamber	  can	  serve	  as	  both	  the	  sub-­‐
pulmonary	  ventricle	  –	  it’s	  usual	  physiologic	  role	  –	  or	  the	  systemic	  ventricle.	  	  As	  such,	  though	  
morphologically	  similar,	  the	  physiological	  demands	  incurred	  are	  necessarily	  very	  different.	  	  Further,	  
even	  in	  those	  anatomies,	  such	  as	  ToF,	  where	  the	  RV	  serves	  as	  the	  sub-­‐pulmonary	  chamber,	  
significant	  short	  and	  long-­‐term	  haemodynamic	  stresses	  arise	  due	  to	  abnormal	  loading	  conditions	  
relating	  to	  both	  underlying	  anatomy	  and	  previous	  surgical	  intervention.	  	  This	  ensures	  that	  the	  
electromechanical	  status	  of	  the	  RV	  in	  patients	  with	  CHD,	  whatever	  the	  anatomical	  substrate,	  is	  not	  
comparable	  to	  those	  older	  adults	  with	  structural	  heart	  disease:	  Equivalence	  of	  therapies,	  
investigative	  tools	  and	  outcome	  measures	  in	  these	  two	  cohorts	  cannot,	  and	  must	  not,	  be	  assumed.	  
	  
This	  Thesis	  initially	  studied	  adults	  with	  a	  subpulmonary	  RV,	  specifically	  ToF	  and	  corrected	  Pulmonary	  
Stenosis.	  	  Both	  are	  subject	  to	  similar	  haemodynamic	  stressors	  and	  those	  with	  ToF	  specifically,	  are	  
bound	  in	  a	  continuous	  cycle	  of	  risk	  between	  increasing	  RV	  volumes	  and	  conduction-­‐repolarisation	  
parameter	  changes	  on	  ECG,	  a	  phenomenon	  that	  accentuates	  the	  close	  relationship	  between	  
electrical	  and	  mechanical	  interactions	  within	  the	  myocardium.	  	  These	  ECG	  changes	  in	  turn,	  are	  
associated	  with	  increased	  risk	  of	  malignant	  arrhythmias	  and	  premature	  demise.	  	  Earlier	  work	  had	  
already	  established	  that	  PPVI,	  an	  alternative	  to	  formal	  surgical	  pulmonary	  valve	  replacement,	  led	  to	  
haemodynamic	  improvements	  at	  follow	  up	  in	  this	  cohort43.	  	  This	  Thesis	  sought	  to	  study	  the	  
Carla	  Plymen	  MD	  (Res)	   Page	  112	  
	  
hypothesis	  that	  the	  amelioration	  of	  haemodynamics	  seen	  with	  PPVI	  was	  also	  associated	  with	  
recovery	  of	  ECG	  parameters.	  	  The	  minimally	  invasive	  nature	  the	  technique,	  undertaken	  without	  the	  
additional	  confounding	  effects	  of	  open	  heart	  surgery,	  was	  thought	  to	  enable	  isolated	  study	  of	  this	  
phenomenon.	  	  	  
	  
I	  found	  that	  electrical	  remodelling	  does	  indeed	  occur	  following	  isolated	  (pure)	  pulmonary	  valve	  
replacement	  in	  these	  patients,	  and	  that	  improvements	  in	  measured	  electrical	  parameters	  continues	  
at	  1	  year	  of	  follow-­‐up	  and	  that	  these	  are	  accompanied	  by	  the	  expected	  significant	  haemodynamic	  
improvements.	  	  This	  suggests	  that	  neither	  haemodynamic	  nor	  electrical	  lesions	  should	  be	  treated	  in	  
isolation,	  and	  that	  correction	  of	  one	  can	  infer	  a	  positive	  outcome	  on	  the	  other:	  	  Given	  the	  minimally-­‐
invasive	  nature	  of	  PPVI,	  and	  the	  ever	  expanding	  technological	  advances	  making	  such	  interventions	  
more	  amenable	  to	  other	  lesions,	  this	  is	  indeed	  exciting.	  	  	  This	  project	  did	  not	  unfortunately,	  include	  
the	  obvious	  next	  stage	  of	  study,	  which	  would	  be	  to	  determine	  whether	  recovery	  of	  electrical	  
homogeneity	  was	  associated	  with	  reduction	  in	  arrhythmia	  risk	  and	  therefore,	  premature	  sudden	  
cardiac	  death	  -­‐	  further	  longer	  term	  multi-­‐centre	  studies	  are	  necessary	  to	  investigate	  this	  and	  this	  is	  
currently	  being	  undertaken.	  	  
	  
Following	  	  this	  first	  study,	  it	  became	  apparent	  that	  there	  is	  very	  little	  information	  describing	  	  the	  
electrical	  activation	  pattern	  of	  the	  subpulmonary	  RV.	  	  This	  is	  hugely	  relevant	  in	  a	  cohort	  of	  patients	  
at	  risk	  of	  significant	  morbidity	  and	  mortality	  from	  progressive	  HF.	  	  I	  have	  shown	  that	  electrical	  and	  
haemodynamic	  integrity	  are	  indeed	  closely	  related;	  however,	  in	  many	  with	  a	  dysfunctional	  RV	  there	  
are	  no	  suitable	  targets	  for	  haemodynamic	  intervention	  and	  thus	  electrical	  reysnchronisation	  
becomes	  a	  feasible	  alternative	  therapeutic	  target.	  	  	  
	  
Mechanical	  dyssynchrony	  is	  intuitively	  pervasive	  in	  all	  cohorts	  with	  CHD,	  and	  thus	  there	  is	  a	  pressing	  
need	  to	  consider	  long	  term	  CRT	  delivery:	  Despite	  often	  considerable	  technical	  obstacles	  related	  to	  
venous	  and	  cardiac	  anatomy	  there	  are	  already	  encouraging	  reports	  on	  applying	  CRT	  in	  a	  variety	  of	  
CHD	  patient	  groups.	  	  Specifically	  in	  those	  with	  RV	  dysfunction,	  the	  literature	  documents	  some	  early	  
successes	  achieved	  by	  extending	  the	  concept	  of	  CRT	  to	  the	  failing	  sub-­‐pulmonary	  ventricle	  
associated	  with	  RBBB.	  	  My	  second	  study	  thus	  followed	  on	  from	  the	  first	  on	  the	  basis	  that	  in	  the	  same	  
way	  that	  correction	  of	  haemodynamic	  compromise	  can	  lead	  to	  improved	  electrical	  homogeneity,	  
resynchronisation	  of	  electrical	  activation	  can	  be	  assumed	  to	  allow	  recovery	  of	  haemodynamic	  
function.	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In	  order	  to	  appropriately	  select	  patients	  with	  RV	  dysfunction	  for	  CRT	  it	  is	  first	  necessary	  to	  
understand	  the	  intrinsic	  electrical	  activation	  pattern	  through	  the	  myocardium	  in	  this	  anatomical	  
substrate.	  	  Further,	  such	  formal	  study	  of	  the	  electrical	  activation	  pattern	  of	  the	  subpulmonary	  RV	  
would	  facilitate	  targeted	  lead	  placement	  for	  CRT	  in	  this	  population	  that	  would	  maximise	  subsequent	  
haemodynamic	  improvement,	  and	  this	  theory	  formed	  the	  basis	  for	  my	  second	  project.	  	  
	  
My	  work	  identified	  the	  intrinsic	  electrical	  activation	  pattern	  present	  on	  the	  surface	  of	  the	  RV	  in	  
adults	  with	  similar	  haemodynamic	  lesions	  as	  those	  included	  in	  my	  first	  study.	  	  This	  cohort	  however,	  
underwent	  open	  (surgical)	  correction	  of	  their	  haemodynamic	  lesion	  but	  represented	  a	  relatively	  low	  
risk	  group	  for	  inclusion	  in	  the	  study.	  	  I	  was	  able	  to	  generate	  an	  epicardial	  map,	  which	  confirmed	  that	  
previous	  surgical	  insult,	  in	  the	  form	  and	  location	  of	  transannular	  patch	  repair,	  was	  associated	  with	  
greatest	  delay	  in	  electrical	  activation.	  	  Identification	  of	  those	  areas	  of	  the	  RV	  surface	  subject	  to	  
greatest	  delay	  in	  activation	  allowed	  me	  to	  guide	  best	  placement	  of	  epicardial	  wires	  for	  subsequent	  
resynchronisation	  pacing.	  	  I	  found	  that	  single	  site	  RV	  pacing	  targeted	  to	  the	  region	  of	  latest	  intrinsic	  
activation	  induced	  acute	  improvements	  in	  central	  haemodynamics,	  supporting	  the	  concept	  of	  
subpulmonary	  “RV	  CRT”	  in	  this	  cohort.	  	  Targeted	  pacing	  to	  the	  latest	  area	  of	  activation	  in	  such	  
patients	  has	  therapeutic	  potential	  both	  in	  the	  acute	  post-­‐operative	  and	  chronic	  setting,	  and	  is	  
superior	  to	  RV	  apical	  pacing	  which	  may	  be	  detrimental.	  	  This	  latter	  is	  particularly	  relevant	  since	  long-­‐
term	  bradycardia	  pacing	  often	  has	  the	  RV	  lead	  positioned	  at	  the	  RV	  apex.	  	  	  
	  
Future	  work	  would	  involve	  generation	  of	  an	  endocardial	  electrical	  map,	  perhaps	  using	  an	  
endocardial	  array	  possibly	  at	  the	  time	  of	  EP	  study	  or	  pacemaker	  insertion,	  with	  long-­‐term	  follow-­‐up	  
of	  targeted	  pacing:	  It	  would	  be	  interesting	  to	  see	  if	  the	  acute	  haemodynamic	  improvements	  seen	  in	  
my	  preliminary	  study	  translate	  into	  long-­‐term	  reverse	  remodelling	  of	  the	  RV.	  	  	  Further,	  imaging	  
modalities	  and	  parameters	  which	  identify	  dyssynchrony	  and	  predict	  a	  positive	  response	  to	  pacing	  
need	  to	  be	  identified	  and	  their	  relationship	  to	  the	  surface	  ECG	  established.	  	  These	  tools	  would	  
ideally	  help	  identify	  patients	  for	  resynchronisation	  therapy	  in	  the	  same	  way	  that	  currently	  exists	  in	  
the	  general	  cardiac	  population.	  	  Lastly,	  after	  delivering	  CRT	  we	  must	  judge	  success	  using	  clinically	  
meaningful	  endpoints.	  	  
	  
From	  a	  starting	  point	  of	  understanding	  the	  impact	  of	  electrical	  inhomogeneity,	  as	  measured	  by	  
surface	  ECG	  parameters,	  on	  the	  long	  term	  outcome	  in	  those	  with	  a	  subpulmonary	  RV,	  my	  Thesis	  set	  
out	  to	  study	  two	  different	  methods	  of	  ameliorating	  this	  risk.	  	  I	  identified	  the	  electrical	  activation	  
sequence	  and	  examined	  the	  process	  of	  electrical	  resynchronisation	  and	  remodelling	  and	  its	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relationship	  to	  mechanical	  dyssynchrony	  and	  resolution	  of	  haemodynamic	  compromise.	  	  In	  those	  
with	  a	  systemic	  (subaortic)	  RV,	  however;	  very	  little	  is	  known	  even	  regarding	  ECG	  parameters	  that	  
might	  represent	  future	  risk	  in	  terms	  of	  malignant	  arrhythmia	  and	  SCD.	  	  For	  the	  next	  section	  of	  my	  
Thesis	  therefore,	  I	  elected	  to	  undertake	  a	  comparison	  of	  ECG’s	  of	  those	  adults	  with	  a	  systemic	  RV	  
who	  remained	  under	  follow	  up	  with	  those	  who	  had	  died,	  in	  an	  attempt	  to	  identify	  similar	  predictive	  
and	  easily	  applied	  ECG	  parameters.	  	  
	  
I	  determined	  that	  certain	  ECG	  parameters	  are	  indeed	  related	  to	  increased	  risk	  of	  death	  in	  this	  high	  
risk	  group	  of	  adults	  –	  both	  QRS	  duration	  and	  QTc	  interval	  are	  independently	  related	  to	  mortality.	  	  
Interestingly,	  the	  cut-­‐off	  values	  I	  found	  are	  within	  the	  perceived	  ‘normal’	  range	  for	  the	  general	  adult	  
population,	  therefore	  necessitating	  consideration	  of	  the	  highly	  abnormal	  physiological	  stresses	  
placed	  on	  the	  morphological	  right	  ventricle	  in	  the	  subaortic	  position.	  	  I	  propose	  that	  serial	  
monitoring	  of	  the	  surface	  ECG	  for	  these	  parameters	  should	  form	  a	  routine	  assessment	  in	  all	  patients	  
with	  atrial	  redirection	  surgery	  for	  TGA.	  	  In	  association	  with	  a	  clinical	  suspicion	  of	  arrhythmia,	  a	  QRS	  
duration	  >104ms	  and/or	  QTc	  interval	  >406ms	  should	  prompt	  full	  investigation	  and	  consideration,	  as	  
necessary,	  of	  early	  initiation	  of	  anti-­‐	  heart	  failure	  and/or	  anti	  arrhythmic	  therapies.	  	  	  	  
	  
Having	  studied	  potential	  ECG	  parameters	  to	  identify	  risk	  in	  those	  adults	  with	  a	  systemic	  RV,	  I	  was	  
keen	  to	  study	  the	  relationship	  of	  these	  parameters	  with	  the	  function	  of	  that	  chamber,	  and	  further,	  
examine	  other	  markers	  that	  might	  enable	  risk	  stratification	  and	  lead	  to	  targeted	  intervention	  that	  
could,	  in	  the	  long	  term,	  positively	  affect	  outcome	  in	  this	  group	  of	  patients.	  	  I	  therefore	  included	  
measurement	  of	  the	  novel	  biomarker	  NT-­‐proBNP	  with	  study	  of	  the	  relationship	  between	  specific	  
surface	  ECG	  measurements	  to	  the	  function	  of	  the	  systemic	  RV.	  	  NT-­‐proBNP,	  measured	  by	  a	  simple,	  
routinely	  available	  blood	  test,	  has	  recently	  come	  into	  its	  own	  in	  the	  general	  cardiac	  population	  as	  a	  
rule-­‐out	  determinant	  of	  cardiac	  stress,	  and	  I	  was	  interested	  to	  see	  whether	  it	  also	  had	  a	  role	  in	  those	  
with	  systemic	  RV.	  	  I	  showed	  a	  close	  relationship	  existed	  between	  NT-­‐proBNP,	  ECG	  parameters	  and	  
measures	  of	  systemic	  RV	  function	  as	  determined	  by	  CMR-­‐	  considered	  the	  gold	  standard	  tool	  for	  
assessment	  of	  the	  systemic	  RV.	  	  Both	  12	  lead	  ECG	  and	  NT-­‐proBNP	  measurements	  are	  widely	  
available	  in	  the	  outpatient	  setting,	  and	  constitute	  safe	  and	  cost	  effective	  surrogate	  markers	  of	  
systemic	  RV	  function,	  thus	  providing	  useful	  information	  easily	  and	  quickly	  on	  heart	  failure	  status.	  	  
This	  is	  particularly	  important	  since	  these	  patients	  tend	  to	  underreport	  their	  functional	  status	  and	  
these	  tools	  provide	  a	  simple	  objective	  assessment.	  	  My	  findings	  dictate	  that	  this	  same	  cohort	  should	  
be	  studied	  sequentially	  	  to	  fully	  determine	  the	  association	  of	  these	  parameters	  with	  long-­‐term	  
outcome	  –	  in	  the	  same	  way	  that	  ECG	  cut-­‐offs	  are	  found	  within	  the	  perceived	  normal	  range,	  it	  is	  likely	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that	  cut-­‐offs	  for	  NT-­‐proBNP	  will	  be	  different	  from	  those	  currently	  used	  in	  the	  general	  cardiology	  
population.	  	  	  
	  
This	  research	  therefore	  supports	  the	  role	  of	  NT-­‐proBNP	  as	  a	  viable	  blood	  biomarker	  in	  adults	  with	  a	  
systemic	  RV.	  	  Having	  evaluating	  plasma	  biomarkers,	  I	  subsequently	  elected	  to	  examine	  diffuse	  
fibrosis	  on	  CMR,	  to	  evaluate	  	  its	  potential	  as	  an	  imaging	  biomarker	  of	  disease.	  	  Diffuse	  fibrosis	  has	  
previously	  been	  described	  in	  those	  with	  primary	  left	  ventricular	  disease,	  and	  I	  felt	  its	  presence	  in	  the	  
systemic	  RV	  might	  provide	  further	  information	  about	  this	  complex	  disease	  process.	  	  The	  majority	  of	  
adults	  with	  CHD	  will	  undergo	  CMR	  imaging	  at	  least	  once	  in	  their	  lifetimes,	  and	  likely	  many	  will	  
undergo	  this	  serially.	  	  Diffuse	  fibrosis	  in	  the	  systemic	  RV	  was	  found	  to	  be	  significantly	  associated	  with	  
NT-­‐proBNP	  levels,	  further	  supporting	  its	  role	  as	  an	  imaging	  biomarker.	  	  An	  unexpected	  additional	  
finding	  was	  the	  relation	  of	  diffuse	  fibrosis	  to	  chronotropic	  index,	  suggesting	  that	  this	  disease	  
processes	  is	  not	  limited	  to	  the	  ventricular	  myocardium	  since	  this	  heart	  rate	  variation	  is	  mediated	  by	  
the	  sino-­‐atrial	  node.	  	  Diffuse	  fibrosis	  is	  likely	  to	  aid	  identification	  of	  patients	  at	  risk	  of	  developing	  
significant	  bradyarrhythmia,	  and	  it	  would	  be	  interesting	  if	  further	  studies	  could	  extrapolate	  future	  
risk	  in	  this	  regard.	  	  	  Larger	  and	  longer-­‐term	  studies	  are	  therefore	  needed	  to	  determine	  whether	  such	  
diffuse	  fibrosis	  is	  of	  prognostic	  significance	  and,	  importantly,	  whether	  its	  extent	  can	  be	  modified	  
with	  therapeutic	  intervention.	  
	  
To	  complete	  this	  Thesis	  I	  chose	  to	  assess	  objective	  and	  subjective	  measures	  of	  disease	  
characteristics	  in	  those	  adults	  with	  a	  systemic	  RV.	  	  These	  patients,	  like	  their	  peers	  at	  all	  levels	  of	  
CHD,	  tend	  to	  underreport	  their	  symptoms:	  This	  can	  lead	  to	  overestimation	  of	  clinical	  status	  and	  the	  
unfortunate	  possibility	  of	  clinically	  significant	  problems	  presenting	  late.	  	  This	  Thesis	  has	  already	  
provided	  evidence	  for	  the	  role	  and	  application	  of	  several	  early	  warning	  parameters	  and	  I	  was	  keen	  to	  
see	  how	  these	  related	  to	  subjective	  functional	  status	  as	  measured	  with	  the	  MLWHF	  questionnaire.	  	  
This	  latter	  is	  not	  validated	  for	  use	  in	  the	  adult	  congenital	  heart	  population	  despite	  being	  routinely	  
employed.	  	  	  
	  
My	  findings	  confirmed	  that	  this	  well-­‐validated	  tool	  for	  assessing	  symptoms	  and	  quality	  of	  life	  in	  
patients	  with	  HF	  relates	  strongly	  to	  NT-­‐proBNP	  levels,	  ECG	  parameters	  and	  exercise	  capacity	  in	  
adults	  with	  a	  systemic	  RV.	  	  The	  ability	  of	  the	  MLWHFQ,	  or	  similar	  quality	  of	  life	  assessment,	  to	  
identify	  adults	  with	  CHD	  at	  risk	  of	  HF	  related	  events	  needs	  further	  evaluation	  –	  at	  present	  this	  
research	  shows	  that	  it	  constitutes	  an	  important	  screening	  tool	  which	  can	  be	  easily	  applied	  in	  the	  
regular	  outpatient	  clinic.	  	  Future	  work	  would	  see	  this	  tool	  employed	  on	  regular	  visits	  and	  the	  trend	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over	  time	  examined	  and	  related	  to	  the	  other	  parameters	  presented	  in	  this	  Thesis.	  	  With	  time,	  it	  
might	  be	  possible	  to	  propose	  a	  new	  scoring	  system	  targeted	  for	  HF	  in	  adults	  with	  CHD	  by	  using	  
aspects	  of	  both	  the	  current	  NYHA	  classification	  and	  MLWHFQ.	  
	  
In	  conclusion,	  this	  Thesis	  has	  provided	  the	  foundation	  for	  future	  work	  on	  two	  fronts-­‐	  improved	  
identification	  of	  early	  heart	  failure	  in	  CHD	  using	  simple	  plasma	  and	  imaging	  biomarkers,	  and	  the	  
potential	  role	  of	  RV	  resynchronisation.	  	  This	  former	  needs	  to	  be	  expanded	  to	  international	  
prospective	  longitudinal	  studies	  to	  further	  validate	  this	  Thesis’	  conclusions	  and	  identify	  other	  early	  
markers	  of	  decline	  in	  systemic	  RV	  function	  in	  order	  to	  facilitate	  earlier	  device	  or	  pharmacological	  
intervention.	  	  The	  pacing	  study	  illustrates	  how	  early	  intervention	  with	  resynschronisation	  has	  the	  
potential	  to	  reverse,	  or	  at	  least	  stabilise,	  systemic	  RV	  function	  in	  these	  patients:	  Strategies	  utilizing	  
discrete	  targeted	  leadless	  electrodes	  are	  emerging	  and	  these	  offer	  significant	  opportunities	  to	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APPENDICES	  
A.	  Percutaneous	  Pulmonary	  Valve	  Implantation	  
Percutaneous	  pulmonary	  valve	  implantation	  (PPVI)	  was	  performed	  at	  three	  centres	  (The	  Heart	  
Hospital,	  Harley	  Street	  Clinic,	  Great	  Ormond	  Street	  Hospital	  -­‐	  London)	  by	  operators	  trained	  in	  the	  
procedure.	  	  All	  patients	  had	  congenital	  heart	  disease	  and	  right	  ventricular	  outflow	  tract	  dysfunction.	  	  	  	  
	  
PPVI	  was	  undertaken	  in	  all	  patients	  under	  general	  anaesthesia.	  	  Aseptic	  techniques	  were	  observed	  in	  
all.	  	  Haemodynamic	  monitoring	  was	  performed	  invasively	  and	  all	  procedures	  were	  carried	  out	  under	  
fluoroscopic	  guidance.	  	  This	  enabled	  assessment	  of	  the	  right	  ventricular	  outflow	  tract	  and	  
quantification	  of	  pulmonary	  regurgitation	  prior	  to	  commencement	  and	  determined	  final	  suitability	  
for	  the	  procedure.	  	  	  
	  
The	  percutaneous	  pulmonary	  valve	  is	  a	  bovine	  jugular	  vein	  valve	  mounted	  (sutured)	  within	  a	  
platinum-­‐iridium	  stent	  (NuMed,	  Hopkington;	  Medtronic	  Inc,	  Minneapolis,	  USA	  (Figure	  34).	  	  The	  
valves	  are	  preserved	  within	  a	  solution	  of	  glutaraldehyde	  and	  alcohol	  and	  were	  therefore	  washed	  
thoroughly	  with	  saline	  prior	  to	  implantation.	  	  	  
	  
Figure	  34:	  The	  percutaneous	  bovine	  jugular	  venous	  valve	  mounted	  within	  an	  expandable	  platinum-­‐iridium	  
stent	  (Numed,	  Hopkinton,	  USA)	  
The	  valved	  stent	  was	  crimped	  down	  over	  the	  barrel	  of	  a	  sterile	  2ml	  syringe	  and	  then	  front-­‐loaded	  on	  to	  the	  
delivery	  system	  (NuMED,	  Hopkinton,	  USA).	  	  Further	  crimping	  of	  the	  stent	  was	  performed	  to	  mould	  it	  around	  
the	  ‘balloon	  in	  balloon’	  delivery	  system	  and	  it	  was	  then	  carefully	  retracted	  within	  the	  polytetrafluoroethylene	  
sheath	  covering.	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The	  femoral	  vein	  was	  dilated	  to	  22	  French	  and	  under	  X-­‐ray	  guidance	  the	  front	  loading	  delivery	  
system	  was	  advanced	  directly	  into	  position	  over	  an	  ultra	  stiff	  exchange	  guide	  wire,	  which	  was	  
secured	  in	  a	  distal	  pulmonary	  artery.	  The	  sheath	  was	  retracted	  from	  the	  valved	  stent	  and	  partial	  
deployment	  was	  achieved	  by	  inflation	  of	  the	  inner	  balloon.	  	  Following	  final	  angiographic	  
confirmation	  of	  the	  valve	  position,	  the	  outer	  balloon	  was	  inflated	  to	  complete	  deployment.	  	  
Anatomy	  dictated	  balloon	  size,	  varying	  between	  18mm,	  20mm	  and	  22mm.	  
	  
Repeat	  angiography	  and	  pressure	  measurements	  were	  made	  to	  confirm	  a	  positive	  outcome.	  	  
Intravenous	  broad-­‐spectrum	  antibiotics	  and	  heparin	  were	  administered	  at	  the	  time	  of	  the	  
procedure.	  	  On	  site	  surgical	  cover	  was	  available	  during	  each	  procedure	  in	  case	  of	  emergency.	  	  	  
	  
B.	  Surgical	  Pulmonary	  Valve	  Replacement	  
Surgical	  (open)	  pulmonary	  valve	  replacement	  was	  undertaken	  by	  two	  trained	  operators	  (VT;	  TYH)	  at	  
one	  centre	  (The	  Heart	  Hospital,	  London)	  in	  adults	  with	  significant	  pulmonary	  regurgitation	  and	  RV	  
dilatation.	  	  All	  patients	  had	  undergone	  previous	  childhood	  repair	  of	  ToF	  or	  congenital	  pulmonary	  
stenosis.	  	  Each	  patient	  signed	  written	  consent	  for	  inclusion	  in	  this	  study.	  	  The	  surgical	  procedure	  has	  
been	  described	  previously,	  but	  is	  as	  follows221:	  	  
	  
Following	  the	  induction	  of	  general	  anaesthesia	  with	  invasive	  pressure	  monitoring	  and	  the	  placement	  
of	  external	  defibrillator,	  redo	  sternotomy	  was	  undertaken	  with	  an	  oscillating	  saw	  and	  the	  lower	  table	  
of	  the	  sternum	  was	  opened	  with	  Mayo	  scissors.	  	  Adhesions	  were	  divided	  with	  diathermy.	  	  All	  cases	  
were	  performed	  under	  routine	  cardiopulmonary	  bypass	  on	  the	  beating	  heart	  with	  ascending	  aortic	  
and	  bicaval	  cannulation	  at	  28–32°C.	  In	  case	  of	  residual	  ventricular	  septal	  defect	  or	  other	  intra-­‐cardiac	  
lesion	  requiring	  attention,	  aortic	  cross	  clamping	  with	  cold	  blood	  cardioplegia	  was	  used.	  	  
	  
The	  native	  main	  pulmonary	  artery	  was	  dissected	  out	  and	  circumferentially	  transected	  close	  to	  the	  
ventriculo-­‐arterial	  junction.	  The	  branch	  pulmonary	  arteries	  were	  sized,	  and	  dealt	  with	  if	  necessary.	  	  A	  
longitudinal	  incision	  was	  made	  into	  the	  proximal	  outflow	  tract.	  	  Any	  hypertrophied	  muscular	  
trabeculations	  in	  the	  subjunctional	  region	  would	  be	  divided	  to	  create	  a	  widely	  open	  pathway.	  	  In	  
patients	  with	  aneurysmal	  RVOT	  patch,	  the	  akinetic	  thin	  area	  was	  excised	  leaving	  a	  small	  fibrous	  rim	  
at	  the	  muscular	  margin,	  followed	  by	  plication	  with	  4–0	  Prolene	  to	  reconstruct	  the	  outflow	  tract.	  	  This	  
infundibuloplasty	  aims	  to	  improve	  the	  distorted	  right	  ventricular	  outflow	  tract	  geometry	  and	  reduce	  
the	  cavity	  size.	  	  The	  homograft	  was	  tailored	  in	  length	  to	  connect	  with	  the	  distal	  pulmonary	  artery	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using	  5–0	  Prolene.	  	  The	  proximal	  end	  of	  the	  homograft	  valve	  was	  inserted	  within	  the	  newly	  created	  
muscular	  ‘sleeve’	  for	  functional	  support	  (Figure	  35).	  	  Trans-­‐oesophageal	  echocardiography	  was	  used	  




Figure	  35:	  	  Diagrammatic	  representation	  of	  the	  surgical	  technique	  for	  pulmonary	  valve	  replacement	  Coats	  et	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